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QUILL ON SCALPEL

This section
provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs o f surgery.

MULTIPLE TRAUMA*
Multiple trauma is a particularly com 
plex and lethal problem. The injuries may
involve several systems with extensive
blood loss and circulatory collapse; brain,
heart and kidney anoxia can lead to irre
versible changes. The patient is in mortal
danger and his survival is strongly depen
dent on the facilities, energy, organization
and attitudes of the staff in the hospital to
which he is transported.
E mergency D epartment

The problem presents itself to the sur
geon, usually a resident, with the un
announced arrival o f an ambulance at the
door of the Emergency Department. This
is a place devoted to resuscitation of the
patient, not to the reduction of his frac
tures, not to suturing his scalp wound and
not to determining whether he has in
surance or wishes a private room. The de
sign of an emergency department must
facilitate those measures which are critical
to resuscitation. Everything must be close
at hand; endotracheal intubation, supply
ing of oxygen, starting I.V.’s and splinting
of fractures must be carried out quickly
without having to send the nurse down
the corridor looking for the pieces.
The detailed care of the traumatized pa
tient need not be discussed here, but one
point deserves comment, even though it
has been learned and re-learned over and
over again it tends to be forgotten. Every
patient with significant multiple injuries is
in shock, and a normal blood pressure
reading does not change the situation.
Fracture of the femoral shaft means a loss
of one to two units of blood into the sur4Adapted from a paper delivered at the Royal
Alexandra Hospital Clinic Day, Edmonton, Alta.,
March 13, 1970.

rounding tissues and several injuries may
deprive the cardiovascular system of onethird of its circulating volume, without
one drop of blood appearing on the emer
gency room floor. The immediate treat
ment consists of intravenous electrolyte
solutions with cross-matched b lood ad
ministered at the earliest possible moment.
Some patients may need as much as 10 to
12 units and 30 units have been used on
occasion. The late Campbell Gardner,
when lecturing to McGill University stu
dents about surgical shock, was known to
conceal a bottle of outdated Red Cross
blood under his white coat. At an auspi
cious moment during the lecture, he
whipped the bottle out and smashed it to
the floor. This seemed to impress even the
most obtuse student. Nevertheless, some
one would inevitably ask: “H ow much do
you give, sir?” His answer was brief: “All
you’ve got.” “How fast do you give it, sir?”
As fast as you can.” Never confused by
scientific minutia, he made his point. The
treatment is blood (elapsed time for his
lecture, 10 minutes).
The patient should not leave the emer
gency room until he has a relatively secure
grip on life, with airway and circulation
re-established and with a written record
of his vital functions. W e must resist the
temptation to begin definitive therapy
when the patient’s life is still in danger.
There is an almost insurmountable urge to
push the patient about, to apply casts, take
radiographs and otherwise traumatize this
very sick individual. Skull films in the
head-injured patient can wait, and at any
rate they cannot replace a careful physical
examination and a detailed history ob
tained from the patient or his companion.
There must be no interference with re
suscitation.
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I ntensive C are U nit

Admission to hospital is a risky experi
ence for the multiple traumatized patient.
A thousand hurdles stand between the
Emergency Department and a hospital
ward. He is moved, perhaps to a stretcher
and then to a bed, and his I.V. is certain
to infiltrate. A great deal of attention is
given to the management of his valuables
and to recording his date of birth and nextof-kin. He is transferred to the care of a
new group of people who have never seen
him before, and cannot read the hand
writing on the chart. He arrives on a 30bed ward, and is pushed into a private
room—“out of sight, out of mind” . The inservice intern is called to do a history and
physical, which must precede all else, but
he is unfortunately incommunicado in the
operating room and the patient, waiting
with indifferent supervision, may slip back
into danger.
The seriously injured emergency room
patient must never be admitted to the hos
pital ward. If he does not go directly to
the operating room, he should be trans
ferred to an Intensive Care Unit, some
thing which every hospital should have.
Contrary to popular opinion, it is not a
mysterious or complicated place. It is
simply a large room with six to 12 beds
(privacy is not a major consideration), a
few intelligent nurses with no special
training, ample needles, dressings and
other supplies, and some monitoring and
respiratory control equipment which any
of us can leam to use. The unit should be
centrally located so that the patient is
easily accessible to the many people who
must see him. Proximity to the Anesthesia
Department is an advantage and the most
frequent plan is to build the Unit on the
operating room floor. Well-run Intensive
Care Units can be found not only in uni
versity and large city hospitals but also in
community and small-town hospitals, and
here they function successfully without
residents. One of the best I have ever seen
is in the Belleville (Ontario) General Hos
pital, staffed by a group of cool, calm
nurses with an average of 3% years of ex
perience in their Unit.
The multiple trauma patient who has
incurred life-threatening injuries should

remain in the Intensive Care Unit until he
is self-stabilizing, until he can maintain his
own blood pressure, ventilate his own
lungs, pace his own heart and perfuse his
own brain and kidneys—in summary, until
he can be moved to an ordinary hospital
room and left alone for an hour or two
without the risk of sudden collapse or
departure.
W ho T reats

the

P atient ?

The answer to this complex and sensitive
problem varies from community to com
munity, and hospital to hospital. A good
deal of personal and departmental jealousy
can develop, and the competition regard
ing the treatment of injured parts some
times becomes so strenuous that the com
plete patient can be forgotten. The very
nature of the multiple traumatized patient
demands that more than one specialty and
more than one doctor be involved, and
they must be involved in such a way that
their skills and knowledge complement
one another. In small hospitals, only a
single surgeon may be on call and he uses
his discretion in seeking help from others.
In large multispecialty institutions, any
state of affairs may exist varying from a
highly structured plan to no plan at all.
Perhaps the best way to describe the
options is to narrate the history of my
own institution, the Montreal General
Hospital. For many years, multiple trauma
was managed by what I choose to call
“catch-as-catch-can” ; in effect, a race in
which the first service to get to the emer
gency room claimed the patient, and all
other services were obliged to fidget
around awaiting an invitation to help. This
worked moderately well for most patients,
but periodically the attending surgeon was
embarrassed to discover, at some late date,
a concealed and untreated injury related
to another specialty.
Twelve years ago a formal Trauma
Service was established. In this new system
the general surgeons were charged with
the care of chest and abdominal trauma,
the orthopedic surgeons with fractures,
plastic surgeons dealt with faces, hands
and problems of skin loss, and the neuro
surgeons with their traditional field. The
advantages of this organization were many;
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the various specialists became aware of
one another’s problems, co-operation was
the keynote and a weekly Trauma Con
ference was established and continues to
meet, even to the present (proceedings of
this Conference are now published in each
issue of the Canadian M edical Association
Journal). Teaching and research all profited
and above all, the patient received superb
care. The passage of time revealed two
defects: first, the patient occasionally
seemed to reside in limbo, with all services
consulting but no one service assuming
prime responsibility. Second, the concept
of the “traumatic” surgeon emerged. Dur
ing the day, patient care was by defined
specialties, but at night a resident on rota
tion from one of the specialty services was
responsible for the entire Trauma Service.
The hope was that each of these young
men, as a result of broad exposure, would
develop into a traumatic surgeon—a mythi
cal fellow who could deal expertly with
all aspects of the injured patient. In prac
tice the orthopedic resident would occa
sionally find himself dealing with a gun
shot wound of the abdomen, and the
plastic surgeon usually felt fainthearted at
the prospect of a craniotomy. Eventually,
the residents made a quiet deal among
themselves to call in one another at night
so that each could manage the problems
most relevant to his specialty.
The formal Trauma Service concept
slowly evolved to the current “commonsense” approach. When a multiple trauma
patient arrives in the emergency room the
interns, in addition to initiating resuscitative measures, call the surgical chief resi
dent. This individual delegates prime re
sponsibility and seeks consultation from
other specialties as the need becomes ap
parent. The prime responsibility for the
care of the patient may stay with general
surgery, or may be assigned to neuro
surgery, orthopedic surgery or any other
service, depending on the combination of
injuries and circumstances of each case.
The patient is then admitted, usually to
the Intensive Care Unit, where all inter
ested specialties continue to care for him.
Prime responsibility is handed from one
service to another as the patient progresses;
for example, several weeks ago a victim of
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a highway accident arrived with multiple
fractures, facial injuries, a suspected head
injury and a rupture of the aorta. Prime
responsibility was assigned to the cardio
vascular team, while other specialties con
sulted and dealt with the injuries in a
logical sequence. Ten days later he was
recovering well from his thoracotomy and
no longer required intensive care. Respon
sibility was then transferred to the Ortho
pedic Service, with cardiovascular surgery,
plastic surgery and neurosurgery continu
ing to consult. This approach depends very
largely on common sense and gentlemanly
co-operation and an awareness of each
other’s problems. I can recall only one
occasion where the residents vigorously
disagreed on priorities. On investigation,
this turned out to be a clash of personali
ties and with a little firm encouragement
did not recur.
In a recent review1 of 100 severely in
jured patients who most clearly profited
from their stay in the Intensive Care Unit
of the Montreal General Hospital, 41 were
admitted under the prime responsibility of
general surgery, 38 to the care of ortho
pedic surgery, 10 to neurosurgery, six to
cardiovascular and thoracic surgery, four
to plastic surgery and one to urology.
Twenty-four hospital services contributed
to the care of these 100 patients, an aver
age of almost four services per patient.
In summary, there is no magic formula
for the treatment of the multiple trauma
patient. The formation of a trauma service
or unit does not provide an easy or com
plete answer. The care of the patient with
life-threatening injuries requires a good
emergency department devoted to resusci
tation, an Intensive Care Unit devoted to
stabilization and, most important of all, a
state of mind which is difficult to acquire
but worthy of the effort, that is, a sense
of unpretentious and common sense co
operation among the members of many
specialty services.—Jo M il l e r .
The Montreal General Hospital,
Montreal, Que.
Referen c e
1. R od dick DW, M ac L e a n AE, G urd FN : Un

published data, 1969
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TH E BRUCE LEC TU RE
The work of surgeons and physicians
may be regarded as inefficient in the sense
that we often strive to prolong life in weak
and unproductive individuals. We need
not, however, be apologetic about indi
vidual patient care, since the willingness
of society to support its unproductive
members is a measure of its civilization. In
any event, displays of concern and ener
getic participation in community life by
physicians reassures society that the pro
fession is aware of its dual role—those of
practitioner and citizen.
The late Honourable Dr. Herbert A.
Bruce exemplified the concern of the good
doctor for the welfare of both patient and
community. A distinguished clinical sur
geon, he founded the Wellesley Hospital
in Toronto, was a member of the Parlia
ment of Canada, and a LieutenantGovernor of Ontario. After many years as
one of the busiest surgical practitioners in
Ontario, Dr. Bruce devoted the latter half
of his long and productive life to the
affairs of community and state. In his
memory, his widow, Mrs. Angela Bruce,
has endowed a lectureship and the first
Bruce Lecture, by Professor A. P. M. For
rest, appears on page 19 of this issue.
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As inaugural lecturer, Dr. Forrest added
an interesting and generous feature to the
lectureship. He presented the Wellesley
Hospital with a silver tray to carry the
names of future Bruce Lecturers, and
directed that part of his honorarium be
used to send a Surgical Fellow from the
Wellesley Hospital to visit the Bruce Lec
turer at his home university. This arrange
ment, if continued over the years, will
forge valuable links between a series of
young Canadian surgeons and distin
guished surgeons in other parts of the
world. His many friends will be pleased to
learn that “Pat” Forrest has recently been
appointed Regius Professor of Surgery in
the University of Edinburgh.
Dr. Forrest’s gesture will remind many
local surgeons that, in 1922, Harvey Cush
ing contributed the cash award that
accompanied his Charles Mickle Fellow
ship to send a Toronto surgeon to Boston
for training in neurosurgery. The late
Kenneth G. McKenzie persuaded Clar
ence Starr to give him the chance and, as
a result of “seed-money” from a distin
guished guest and the fortitude and per
sistence of a pioneer, Canadian surgery
received lasting benefit.—N e il A. W atters .
The Wellesley Hospital,
Toronto, Ont.
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REVIEW ARTICLE
HETEROLOGOUS ANTILYMPHOCYTE SERUM: A REV IEW
H. F . JE E JE E B H O Y , M .B., B.S., F.R .C .S., P h .D .,° M ontreal, Q ue.

A n tilym ph o c yte serum (ALS), a potent

and effective immunosuppressive agent, is
widely used in clinical transplantation.
This review will consider the salient fea
tures relating to the preparation, standard
ization, use and mode of action of ALS.
Space does not permit comprehensive
coverage, and the references given cover
only a portion of the present literature
pertaining to ALS.
ALS is one of the most potent immuno
suppressive agents available at the present
time, at least in the laboratory animal. It
is prepared by immunizing animals with
xenogeneic lymphoid cells. The antiserum
obtained will, under appropriate condi
tions, effectively depress immune responses
when given to animals of the same species
as the donors of lymphoid cells used for
immunization. ALS should be distinguished
from isoantiserum which is prepared by
immunizing animals with allogeneic lym
phoid cells. Isoantiserum is a much less
potent immunosuppressive agent than ALS
and probably has quite a different mode
of action.
To avoid ambiguity, definitions are of
fered for a few of the terms commonly
used in transplantation biology. “Syn
geneic” refers to animals that are genetic
ally identical to each other as, for example,
highly inbred animals or identical twins.
“Allogeneic” individuals are genetically
unrelated to each other but are members
of the same species—this term would there
fore cover most of the human race. “Allo
grafts” are grafts exchanged between allo
geneic individuals. The words “xeno
geneic” or “heterologous” indicate species
differences between donor and recipient.
It is an axiom of transplantation biology
that allografts or xenografts on unmodified
recipients are always rejected.
“Associate Professor, Department of Surgery
(Division of Surgical Research), McGill Univer
sity, Montreal, Que.

Rejection is mainly effected by lympho
cytes that are sensitized as the result of an
immune reaction induced by the presence
of a genetically dissimilar graft. Circulat
ing (humoral) antibody plays, if anything,
a minor role in the rejection of allografts
and reactions of this type are therefore
referred to as “cell-mediated” immune
responses. The intensity of graft rejection
depends on a number of factors: the
degree of genetic or antigenic difference
between host and donor, the effectiveness
of immunosuppression of the recipient, and
previous sensitization by an antigenically
similar graft. This last factor will result in
accelerated rejection of the second graft.
Immunization with most other antigens—
bacterial, cellular or chemical—results in
an immune reaction that is mainly
humoral. Such a reaction is characterized
by the presence in the serum of free circu
lating antibody produced by plasma cells.
This type of antibody is also produced in
response to allografting and xenografting:
in the latter situation such antibody is
probably the main effector of rejection; in
the former it plays a subsidiary role, bind
ing itself to the vascular endothelium of
the graft and causing platelet aggregation,
endothelial proliferation and occasionally
vascular occlusion.
H isto ric a l N otes

The idea of using heterologous antisera
to inactivate leukocytes dates back to 1899
when Metchnikoff1 induced leukotoxic sera
by injecting emulsions of guinea-pig lymph
nodes and spleen into rabbits. Over the
next half century, several workers de
scribed the ability of such heterologous
antisera to inactivate lymphocytes in vitro
and to depress white cell counts when
parenterally administered.2'10 The ability
of ALS to depress immune responses was
first described in two papers published in
1958. Inderbitzin,11 using serum from rab-
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bits immunized with guinea-pig mono
nuclear cells, was able to inhibit the
tuberculin reaction in guinea pigs. Simul
taneously, Wilhelm, Fisher and Cooke12
reduced contact sensitivity to 2:4 dinitrochlorobenzene in guinea pigs by treating
the animals with rabbit anti-guinea-pig
ALS. Subsequently, Waksman, Arbouys
and Arnason13 showed that rabbit anti
guinea-pig ALS could also prolong skin
allograft survival times when given to
guinea pigs. However, the degree of pro
longation obtained was modest and there
was little interest in the use of ALS until
Woodruff and Anderson14’ 15 and Gray,
Monaco and Russell16 demonstrated im
pressive increases in graft survival ob
tained by ALS treatment. These initial
observations on the immunosuppressive
properties of ALS were soon confirmed
and many workers showed that, in the
laboratory animal, ALS was a most potent
immunosuppressive agent. These findings
were reported in the middle of a decade
of intense interest in clinical transplanta
tion and at a time when the deficiencies of
conventional immunosuppressive therapy
were beginning to be recognized. It was
therefore only natural that ALS should be
seriously considered as an adjunct to con
ventional methods in clinical transplanta
tion. It remained for Starzl et al.17>18 to
show that it could be successfully used in
human patients. The last five years have
been characterized by an intensity of in
terest in the use and mode of action of
ALS which can have few parallels in the
field of transplantation biology, and this
review will attempt to correlate some of
the numerous observations that have been
made. Many of the findings reported are
controversial and some contradict others.
The author therefore apologizes if, in the
interpretation of these findings, his per
sonal biases intrude on what should other
wise be an unbiased communication.
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and peripheral blood. In addition, cells
from patients with lymphatic leukemia19
and cultured human lymphoblasts20 have
been used to prepare sera that appear to
induce good immunosuppression. ALS can
also be made by immunizing animals with
cells that are morphologically unrelated to
lymphocytes, e.g. epidermal cells and
fibroblasts,21 and recently it has been
shown that ALS, which is capable of de
pressing immune responses, can be ob
tained by immunizing animals with subcellular fractions of lymphoid cells22’ 23 or
even their cell sap.23
It is difficult to be categorical about the
best antigen to use for the preparation of
ALS. Certain requirements must be met:
First, it must have been shown that the
antigen being used can produce ALS with
good immunosuppressive properties and, if
possible, that it is superior to, or at least
the equal of, other antigens in this respect.
However, when a panel of animals is im
munized with cells from a single pool of
antigen one usually obtains ALS prepara
tions with a wide range of immunosup
pressive properties, despite the use of
identical immunizing and bleeding sched
ules.24 Hence, it is extremely difficult to
evaluate statistically the superiority of one
antigen over another. It has been stated
that, for the preparation of potent ALS,
thymus cells are superior to other anti
gens,25’ 26 but this has been disputed.27
However, there is certainly no evidence
that thymus cells are inferior to other anti
gens or to thoracic duct cells14’ 15, 28 and
cultured human lymphoblasts.20 Second,
the antigen used should be readily avail
able. In the laboratory thymus cells are
easily obtained for the preparation of ALS
to be used on experimental animals; this
is not so in the human context. Here, cul
tured lymphoblasts and thoracic duct cells
have obvious advantages—they are readily
available, especially if the transplant pro
gram involves preliminary drainage of the
thoracic ducts of prospective recipients.
P reparation of ALS
Third, the antigenic preparation, as far as
C hoice of Antigen
possible, should be free of irrelevant con
Different lymphoid cell types have been taminating antigens such as those present
used to prepare ALS with immunosuppres in plasma proteins, red cells and platelets.
sive properties, including cells from the Antibodies to these antigens could produce
thymus, lymph nodes, spleen, thoracic duct undesirable side effects such as anaphy-
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laxis, anemia and thrombocytopenia. These
antibodies can be removed by appropriate
absorptions before the ALS is injected but,
when large volumes of serum have to be
processed, such absorptions can be logistically formidable procedures. Cultured
lymphoblasts have considerable advan
tages over other antigens because they are
virtually free of contaminating red cells,
platelets and serum proteins.20
M ethod o f Immunization
A large number of immunizing and
bleeding schedules have been used for
the preparation of ALS. None has been
proved to be indisputably superior to
others.
When rabbits are used to produce ALS,
the method commonly used is that de
scribed by Levey and Medawar.25 The ani
mals are injected intravenously with 10°
xenogeneic thymus cells on days 0 and 14,
and bled out on day 21. A variation of this
procedure, described by Manniclc et al.
(personal communication), gives the first
injection subcutaneously in the footpads
after emulsifying the cell suspension in
Freund’s complete adjuvant. In our hands
this latter procedure has consistently re
sulted in the production of potent ALS
while the former procedure has given
somewhat disappointing results.
Horses are usually used to produce anti
human ALS and a large number of dif
ferent immunization and bleeding proto
cols have been used. Generally the best
method is some variation of the procedure
described by Monaco et al.29 to produce a
potent horse antidog ALS. The horse is in
jected subcutaneously with xenogeneic
lymphoid cells in Freund’s adjuvant (the
number of cells varies from investigator to
investigator) and this injection is usually
repeated two or three times at weekly in
tervals. Subsequently the horse receives a
short course of intravenously injected lym
phoid cells and is then bled.
Two points about the preparation of
ALS are noteworthy. The first relates to
the superiority of a short course in im
munization over chronic immunization. In
the rabbit, repeated immunization results
in a significant loss of immunosuppressive
potency of the ALS obtained;21' 30 in these
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animals a short course of injections is in
disputably superior to long-term immuniza
tion. In the horse the evidence on this point
is not quite so clear-cut. Many workers re
peatedly immunize and bleed their horses
and claim that this does not result in any
loss of potency of the ALS so ob
tained.17’ 18' 20,28’ 29 However, as will be
discussed later, the immunosuppressive
potency of antihuman ALS is very difficult
to assess. Hence, it is difficult to be certain
that there is no loss of potency when horse
antihuman ALS is made by long-term im
munization, and this method of ALS
preparation should therefore be avoided if
at all possible.
The second point concerns the use of
Freund’s adjuvant. Jooste et al.sl have
stated that toxic antisera tend to be pro
duced when Freund’s complete adjuvant
is used during immunization. However, the
consensus at the present time seems to
be that this is not so and that ALS pre
pared with adjuvant is more potent than
that prepared without. These are views
which agree with our own experience and
with which we fully concur.
Purification of ALS
Most ALS preparations contain anti
bodies to plasma proteins, red cells and
platelets—antibodies that do not contribute
to immunosuppression and, if injected,
could produce serious side effects. Usually
they should be removed by absorption be
fore injection of the ALS. Red cell anti
bodies can be removed by “decomplement
ing” the ALS (heating at 56° C.) and
then adding packed erythrocytes; after in
cubation the mixture is centrifuged. This
process is repeated until most, if not all,
of the anti-erythrocyte antibodies have
been removed. The use of red cell stroma
rather than whole cells is probably pref
erable because it avoids the hemolysis
that frequently occurs with outdated
human blood.
Antibodies to plasma proteins are re
moved by some variation of the procedure
described by Iwasaki et al,17 One volume
of inactivated serum is incubated with 10
volumes of immune horse serum. After 12
hours at 4° C., the mixture is centrifuged
to remove insoluble antigen-antibody com-

8

THE CANADIAN JOURNAL OF SURGERY

plexes. Unfortunately this procedure leaves
soluble complexes in solution and these
complexes potentially can produce serious
renal lesions when injected.
Finally, to avoid administering large
amounts of potentially toxic, non-antibody
protein, the ALS is fractionated so that
only the active immunosuppressive moiety
will be administered. The bulk of this
moiety resides in the IgG fraction of
ALS17’ 32 34 although some may also be
present in other fractions.27 The IgG frac
tion of ALS is commonly isolated by salt
precipitation with ammonium sulfate17’36,36
or sodium sulfate.37 The IgG preparations
obtained by such precipitation are con
taminated with other serum proteins. The
IgG can be purified further by chromato
graphic or electrophoretic procedures and
some workers recommend these extra pro
cedures.20, 34, 36
The ALS preparation eventually ob
tained should be stored at —20° C. because
marked structural changes may occur in
IgG preparations stored at 4° C. or
higher.37
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strain-specific,21 that is, ALS is not more
effective when given to the animal strain,
which provided the lymphocytes used for
immunization, than to another strain.
Second, when injecting ALS the intra
venous route is probably more effective
than
subcutaneous
or intramuscular
routes.50 Third, the timing of the ALS in
jections is probably of considerable im
portance. With skin grafts in mice, Levey
and Medawar25 showed that ALS given
before grafting is less effective than that
given after grafting. This opinion agrees
with our own observations, but Monaco
et al.ss got better results when their re
cipients were pretreated with ALS. How
ever, with renal allografts in dogs, it has
been convincingly shown that the maximal
immunosuppressive effect occurs only if
ALS treatment is started several days befor grafting.18, 48 Fourth, a number of pro
cedures potentiate the immunosuppressive
properties of ALS, namely, thoracic duct
drainage,14,15 thymectomy of the re
cipient,39, 40,51 whole-body irradiation be
fore injection of ALS21 and certain im
munosuppressive drugs,52 notably 6-mercaptopurine63—the active principle of azaI m m u n o su ppressive E ffects o f A L S in
thioprine, a drug routinely used in clinical
E x p e r im e n t a l A n im a ls
transplantation. It has also been reported
E ffect on Cell-Mediated, Immune
that the effects of ALS can be potentiated
Responses
by corticosteroids21,52 but others dis
Prolongation o f graft survival.—In a large agree.63 Finally, the immunosuppressive
number of animal species, ALS can de properties of ALS are significantly reduced
press the immune response to a variety of if the recipient has been preimmunized
allografts and xenografts. Thus ALS treat with, or has antibodies directed against, its
ment prolongs skin allograft and xeno IgG component.54 Conversely, graft sur
graft survival in mice,16, 21, 25,26,30, 38 vival times are prolonged if the recipient
rats,14,15,39,40 guinea pigs,13 primates41 has been rendered tolerant to the IgG
and man.20,33 Allograft survival in pri present in the ALS being administered.65
mates can also be prolonged by antihuman
Inhibition o f graft-versus-host reactions.
ALS;42 this method is now used to test the —These reactions are produced when imimmunosuppressive potency of antihuman munologically competent allogeneic cells
ALS (see below). ALS treatment increases are injected into animals that are in
the survival of renal allografts in rats43 and capable of rejecting them, either because
of renal, hepatic and cardiac allografts in the recipients are genetically compatible
dogs.18, 44-49 In addition to prolonging the with the injected cells, e.g. parental cells
survival of first-set skin grafts, ALS can injected into F I hybrids, or because they
prolong graft survival on previously sensi are newborn (immunologically immature)
tized mice.25, 39
or because their immune responses have
The degree to which ALS can prolong been depressed by drugs or irradiation.
graft survival depends on a number of The injected cells mount an immune
factors: First, the effect is dose-dependent, response against the recipient and, in the
but there is no evidence that its action is most severe cases, kill the animal. Graft-
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versus-host reactions can be significantly
reduced by ALS treatment of the donor
or the recipient, and also by in vitro in
cubation of the cells in ALS before in
jection .56-60 Particularly pertinent in the
human context are observations of van
Bekkum et al ,60 who have shown that ALS
treatment of the recipient can suppress the
graft-versus-host reaction (“secondary dis
ease”) that follows the transfer of allogeneic
marrow cells to x-irradiated monkeys.
Induction o f tolerance with ALS.—'“Tol
erance” refers to a specific state of no re
activity. Thus, a tolerant animal will not
reject a graft of the genotype to which it
is tolerant but will reject all other genet
ically dissimilar grafts. The use of ALS to
induce tolerance was first described by
Monaco, Wood and Russell.81 They used
a combination of ALS and thymectomy to
render their mice tolerant, but subsequent
investigations62"64 have shown that toler
ance can be induced by ALS treatment
alone. The best results are obtained when
skin grafting is followed by ALS treatment
and intravenous injection of cells, genetic
ally identical to the graft, some four to five
days after completion of the course of ALS.
E ffect on Humoral Antibody Production
ALS suppresses the humoral antibody
response to sheep red cells in a number of
species,38'40, 65' 67 to bovine serum albumin
in rats88 and to salmonella antigens in
mice.38 Timing of ALS injections is espe
cially important because there is practi
cally no suppression of humoral antibody
production if ALS is given after the injec
tion of antigen.65 However, ALS treatment
does not always suppress antibody produc
tion; indeed, with some antigens, e.g. key
hole limpet hemocyanin, antibody produc
tion is enhanced.69 Another antigen against
which antibody production is greater than
normal is the IgG contained in the ALS
administered, that is to say, ALS IgG is
more immunogenic than normal IgG. 43' 70' 71
This is particularly important from a prac
tical point of view because the immuno
suppressive potency of ALS is significantly
reduced if the recipient’s serum contains
antibodies to the ALS IgG .54
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E ffect on Autoimmune Processes
ALS seems to be an effective suppressor
of autoimmune disease processes. Thus,
ALS treatment protects against the devel
opment of experimental allergic encephalo
myelitis,13, 72 autoimmune thyroid dis
ease, 73 and adjuvant arthritis in rats . 70 It
also suppresses the Coombs-positive hemo
lytic anemia in NZB mice,74 although it
does not modify the course of already
established disease or prevent the onset of
autoimmune renal disease in B/W mice . 75
E ffect on Bacterial an d Viral In fection s
We have more information on the effects
of ALS in infections with viruses than in
those with other micro-organisms. ALS
mainly affects infections that are normally
dealt with by cell-mediated rather than
humoral antibody responses. Thus, ALS
treatment hastens miliary spread and death
from tuberculous infection in mice 76 and
promotes the development of tumours in
mice infected with oncogenic viruses77"81
but has no effect on influenza or rabies in
fections. ALS can activate latent infections
such as canine distemper32 and it can
greatly alter the type of infection usually
produced by a given virus. For example,
it can lead to antigen-antibody-complex
nephritis following infection with lympho
cytic choriomeningitis virus.82 Unfortu
nately, very little work has been done on
the effects of ALS in infections with the
common bacteria such as the coliforms and
the cocci.
Pathologic Effects o f A LS Administration
Some of the adverse effects of ALS
treatment are due to the administration of
irrelevant antibodies; for example, anti
bodies directed against red cells account
for the anemia, marrow hyperplasia and
extramedullary erythropoiesis that are
often found . 18 , 29, 83 Other effects are due
to antibodies directed against lymphoid
cells and these include the depletion of
cells in the “thymus-dependent” paracortical areas of the lymph nodes and the
periarteriolar areas of the spleen.83 85
A third group of pathologic lesions re
sults from the foreign protein present in
the ALS administered. The kidney is the
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organ primarily affected and the charac
teristic lesions have been found in both
mice83 and dogs18 receiving long-term ALS
therapy. The lesions include thickening of
the glomerular basement membrane,
hypercellularity of the tufts, adhesions be
tween tufts and capsule, and narrowing or
obliteration of the capillary loops. Deposits
of amorphous material can be found in the
glomerular basement membranes, on the
subepithelial aspects of the glomerular
capillary basement membranes and in the
mesangium. These deposits were found by
Iwasaki et al.17 to contain horse gamma
globulin and dog IgA and /31C globulin.
The highest incidence of lesions was found
in dogs given ALS for the greatest length
of time. These renal lesions are potentially
lethal and are probably caused by the
deposition in the kidney of antigen-anti
body complexes consisting of horse protein,
dog antibodies to this protein and compo
nents of dog complement, resulting in a
Masugi or serum-sickness type of nephritis.
U se o f ALS in C l in ic a l
TRANSPLANTATION

Difficulty in Assessing Value in Clinical
T ransplantation
ALS, or rather its IgG component (ALG),
is widely used in clinical transplantation
at the present time. Administration of ALG
alone can prolong the survival of skin
grafts in humans20,34 and allow the suc
cessful transfer of allogeneic marrow
grafts.86 Despite this obvious ability of
ALG to depress immune responses in
humans, it is extremely difficult to deter
mine whether ALG treatment can improve
the results obtained at present with con
ventional immunosuppressive measures in
clinical renal, hepatic and cardiac trans
plantation. The reasons are as follows:
First, the immunosuppressive potency of
ALS can vary significantly from batch to
batch and, until very recently, there was
no satisfactory assay of the immunosup
pressive properties of ALS (see later). Most
workers have used serum from a number
of different batches on each of their pa
tients and the results are therefore very
difficult to assess. Second, ALG is usually
given to human patients in conjunction
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with other immunosuppressive agents. This
often makes it difficult to determine
whether improvement is due to the ALG,
especially in situations where results are
already very good, as in transplantation
between living related individuals. Third,
in the laboratory, the immunosuppressive
effect of an ALS preparation is easy to
assess because genetic differences between
mice and rats have been determined and
standardized. Because immunogenetic dif
ferences between humans cannot be pre
cisely determined at the present time, it
is difficult to assess results in the individual
because immunosuppressive agents pro
duce longer graft survival times when
genetic differences between host and donor
are weak rather than strong.
D osage Schedules of ALG Used in
Patients
The use of ALG in clinical transplanta
tion was first reported by Starzl and his
associates17,18,87•88 and by numerous
others since then.20,28,35, 89’92 Most have
commented favourably on the results ob
tained. Thus, Starzl et al.27 reported that,
with ALG therapy, the one-year survival
after intrafamilial renal transplantation
rose to 90% and that after cadaveric trans
plantation to 83%. Traeger et al.28’ 93
found that the number of rejection crises
in the first three months after transplanta
tion was significantly reduced by ALG
treatment.
The dosage schedule of ALG given to
patients has varied from centre to centre.
Thus, Najarian et al.20 give a short threeweek course of ALG, beginning a few days
before transplantation. At the other ex
treme, Traeger et al.28’ 93 begin ALG
therapy 10 days before transplantation.
They give one injection a day for the
first month and one injection every two
days during the second month. From the
beginning of the third month, the patients
receive three injections a week indefinitely.
They are the only workers who give ALG
for such long periods and their observa
tions on the relative absence of renal
lesions in their patients (see later) are
therefore particularly relevant. The dose of
ALG given has varied from group to group
and has ranged from 4 to 20 mg./kg. of
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immunoglobulin per injection. All workers
used the ALG in conjunction with other
immunosuppressive agents and many noted
that ALG treatment allowed them to re
duce steroid dosage with a commensurate
decrease in the morbidity associated with
this type of therapy.

L ocal complications.—These include local
pain and tenderness at the site of injec
tions, erythema, induration and occasion
ally abscess formation.18' 28’ 34' 95 These
complications develop when ALG is given
intramuscularly and hence many workers
now administer ALG by intravenous in
jection.

The Use o f A LG to Reverse T hreatened
R ejection

Systemic com plications.—A number of
systemic complications have been reported
after ALG therapy. The following list is
not comprehensive but mentions the more
common ones.
(1) Fever is very common but is usually
of low grade.18,28, 34’ 85
(2) Instances of hypotension and air
hunger have been reported after ALG
therapy.18’ 28’ 95
(3) Skin rashes and generalized pruritus
may develop.18’ 95
(4) ALG treatment depresses peripheral
lymphocyte counts in man,18’ 20- 28 and it
also has a deleterious effect on marrow
cells, at least in the laboratory animal.67’ 96
These effects could have serious conse
quences if the patient’s marrow and lym
phocytes were already depressed by aza
thioprine.
(5) One of the most serious and trouble
some complications of ALG therapy in
man is thrombocytopenia.18’ 95 This com
plication, which is probably due to anti
platelet antibodies in the ALG used, often
makes it necessary to stop ALG therapy.27
However, Traeger et al.28 find that antihuman ALG prepared by immunization
with thoracic duct cells does not produce
this complication to any significant degree,
but still has immunosuppressive properties.
(6) Anaphylactic reactions are probably
due to previous sensitization of the patient
to horse serum proteins. Another acute
reaction is a reverse anaphylaxis owing to
the passive introduction of antibody
directed against human serum proteins.
Hence, one must skin test to determine
hypersensitivity to horse protein before
giving ALG and, before use, should re
move antibody to human serum proteins
by appropriate absorptions.
(7) Patients receiving ALG frequently
develop antibodies to the injected foreign
proteins.18’ 28>93’ 95 Depositions of hetero-

A few patients have received ALG dur
ing threatened rejection, usually because
the azathioprine and steroid dosage could
not be increased because of intercurrent
infection or marrow depression. In some
of these patients renal function was defi
nitely improved.84 There is a good theoreti
cal basis for this form of therapy. Starzl
et al ,27 described an experiment in which
they left 10 canine recipients of renal
transplants untreated until rejection had
begun, as evidenced by a rising blood urea
nitrogen. At this stage the dogs received
ALG and, in three or four of the animals,
there was a prompt reversal of rejection.
E ffect o f ALG on D elayed H ypersensi
tivity Reactions and Autoimmune Dis
orders in Man
ALG can suppress and often completely
abolish delayed hypersensitivity reactions
to a number of antigens.18’ 34 Traeger
et al.28’ 93 have used this property to assay
the immunosuppressive potency of the
ALG they give their patients. They find
that when an effective immunosuppressive
agent is being used the hypersensitivity
skin reactions to P.P.D., candidin and
toxoplasmin become negative five to 10
days after treatment begins.
ALG has been used to treat patients
with autoimmune diseases such as dermatomyositis and to treat diseases such as
multiple sclerosis which might possibly
have an autoimmune basis. This has only
been done for a short time and the results
are therefore difficult to assess although
Traeger et al.28 found that it had no effect
on their patients.
Com plications of ALG Therapy in Man
The following are some of the local and
systemic complications of ALG therapy.
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logous and autologous proteins, presum
ably in a complexed form, have been
demonstrated in the kidneys of human
recipients of ALG. The incidence, how
ever, is small and according to Starzl
et al.,27 horse proteins were found only in
one of 41 of his patients who received
ALG and had their kidneys biopsied two
years later. Hence, the chances of devel
oping a Masugi or serum-sickness nephritis
after ALG seem to be negligible—a con
clusion confirmed by observations reported
by Traeger et al. (personal communication).
However, deposits can appear and various
histologic changes have been described in
the kidneys, including thickening of the
subepithelial and subendothelial basement
membranes and fusion of the epithelial
foot processes.
(8) Another potential, but as yet un
realized, complication of ALG therapy is
the development of renal lesions owing to
the presence in ALG of antibody directed
against glomerular basement membranes.
An ALG preparation of this type has been
recently described by H. Taylor of the
Medical Research Council of Canada (per
sonal communication). It was not used on
human patients but produced a rapidly
developing and fatal renal disease when
given to chimpanzees. Thiel et al.97 have
recently demonstrated antiglomerular base
ment membrane antibody in a number of
horse antihuman ALS preparations. The
incidence was lowest when cultured lym
phocytes, thoracic duct cells or washed
thymus cells were used for immunization,
rather than homogenates of spleen or
thymus. Fluorescent microscopy showed
that the antiglomerular basement mem
brane antibody was deposited in the kid
neys. However, the autologous phase of
nephritis did not develop in these patients.
This was probably because they were
receiving additional immunosuppressive
therapy which, with the ALS, effectively
suppressed the production of autologous
antibody to the complex of basement mem
brane and heterologous antibody.
(9) Several workers have reported tu
mours developing in long-term survivors of
renal transplants,98 in particular, the other
wise uncommon reticulum cell sarcoma.
There is no evidence that ALG therapy is
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uniquely implicated;27 rather, these tu
mours probably represent an inevitable
result of long-term, effective immunosup
pression.
A ssay and M ode o f A ction of ALS

The mode of action of ALS is not yet
known precisely and hence many of the
available methods for assaying ALS in
terms of immunosuppressive potency are
empirical. The following are some of the
more common hypotheses concerning the
depression of immune responses by ALS.
The Cytotoxic Theory
This hypothesis proposes that immune
responses are depressed by ALS because
lymphocytes are destroyed by the aggluti
nating and cytotoxic antilymphocyte anti
bodies present in almost all ALS prepara
tions.31, 38 There are serious objections to
this hypothesis. First, the immunosuppres
sive potency of ALS cannot be correlated
with its content of agglutinating and cyto
toxic antibodies directed against lympho
cytes.24, 30,90 Second, ALS preparations
which lack antilymphocyte agglutinating
and cytotoxic antibodies can be immuno
suppressive.99 Third, ALS is no less effec
tive when given to animals that are
genetically deficient in the fifth component
of complement (C'5).100,101 In the absence
of C'5, cytotoxic lysis of cells cannot occur.
A variation of the cytotoxic hypothesis
is one which states that ALS depresses im
mune responses because it contains an
opsonizing antibody which promotes
phagocytosis of affected lymphocytes.102,103
There is a good correlation between the
immunosuppressive potency of antimouse
ALS and its opsonizing activity, but with
antihuman ALS the correlation is poor.104
T he Blindfolding and the Com petitive
Antigen Theories
According to the blindfolding hypo
thesis, ALS coats lymphocytes and thus
prevents them from recognizing antigen.25
If this hypothesis were valid there should
be a good correlation between the im
munosuppressive potency of ALS and its
content of lymphocyte agglutinating anti
bodies. This is not so and the same objec-

I

January 1971

5
V

A

»

HETEROLOGOUS ANTILYMPHOCYTE SERUM

tion applies to the competitive antigen
theory. This hypothesis postulates that
ALS antibody preferentially binds to lym
phoid cells and “preoccupies” them with
antibody production because the ALS anti
body is antigenic to the recipient. These
“preoccupied” cells are then unable to
respond to other antigens.
A variation of the blindfolding hypo
thesis is one which states that ALS anti
body masks the antigen in the graft
itself108 because renal homografts from
ALS-treated rats survive longer than grafts
from untreated donors. However, we have
recently found101 that, while ALS does
contain antibody which acts on the graft,
this antibody decreases rather than pro
longs graft survival. This graft-rejecting
antibody is C'5-dependent whereas the
antibody responsible for immunosuppres
sion is not.
The Sterile Inactivation Theory

r
V

r

V

ALS antibody has a non-specific mito
genic action on lymphocytes in tissue
culture.106 It has been suggested that in
vivo administration of ALS results in a
non-specific and functionally sterile pro
liferation of lymphocytes which pre-empts
all their functions.21 However, it has not
been possible to correlate the in vitro mito
genic activity of ALS with its in vivo im
munosuppressive potency.107
T he Immunosuppressive Antibody
Hypothesis
In vitro incubation of spleen cells with
ALS decreases their ability to produce
antibody when they are subsequently
mixed with antigen and injected into immunologically incompetent recipients.108
This property of ALS is directly propor
tional to its immunosuppressive potency
but not to its content of antilymphocyte
agglutinating and cytotoxic antibodies.
Hence, it has been suggested that immuno
suppression by ALS depends on its con
tent of a specific immunosuppressive anti
body, which is directed against cells
involved in antibody production and which
is distinct and different from lymphocyte
agglutinating and cytotoxic antibodies.
The test described by Saleh et al.100 for
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assaying the immunosuppressive potency
of ALS probably depends on the validity
of this hypothesis. When mouse or human
cells are injected under the kidney cap
sules of cyclophosphamide-treated rats,
there is an infiltrative and proliferative
reaction of the grafted cells against the
host. This reaction can be inhibited by in
jection of the rat with ALS directed
against the grafted cells. The degree of
inhibition produced depends on the im
munosuppressive potency of the ALS used
but not on its content of antilymphocyte
antibodies. So far, a good correlation has
been obtained between the immunosup
pressive potency of antimouse ALS and
its ability to decrease this type of reaction.
It remains to be shown that this promising
test correlates with the immunosuppressive
potency of antihuman ALS.
T he Antigen Recognition H ypotheses
ALS treatment can significantly depress
the immune response in mice to sheep
erythrocytes if the ALS is given before
the antigen; it has little effect if ALS is
given after immunization.65 Hence, it has
been suggested that ALS acts primarily on
cells which are involved in antigen recog
nition.
The rosette inhibition test described by
Bach et al.110 to assay the immunosuppres
sive potency of ALS probably depends on
this mechanism. The peripheral blood and
spleens of both mice and humans contain
lymphoid cells which, when mixed with
sheep red cells, form clusters or rosettes.
Each rosette consists of a central lymphoid
cell with sheep erythrocytes around it.
The rosette-forming lymphoid cell is pos
sibly secreting immunoglobulin specifically
directed against the red cells and respon
sible for the adhesion. The removal of
these rosette-forming cells from a popula
tion of spleen cells results in a loss of anti
body-producing capacity;111 therefore the
rosette-forming cell might initiate antibody
production by recognizing antigen. In vitro
incubation of spleen or peripheral blood
cells with ALS, before mixing with sheep
red cells, reduces the number of cells cap
able of forming rosettes.110 The reduction
is directly proportional to the immuno-
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suppressive potency of the ALS used. An
excellent correlation has been obtained be
tween the immunosuppressive potency of
antimouse ALS and its ability to decrease
rosette formation .110
The ability of antihuman ALS to inhibit
rosette formation by human peripheral
lymphocytes correlates fairly well with its
ability to prolong skin-graft survival in
subhuman primates.112 This latter test,
which is widely used to assay the im
munosuppressive potency of antihuman
ALS, is based on the assumption that an
antihuman ALS that prolongs allograft
survival in chimpanzees and lower mon
keys42 will have the same effect on allo
graft survival in humans. This assumption
is probably valid but is by no means
proved. Hence, it still remains to be shown
that the rosette-inhibition test and the
primate skin-graft test have a predictive
value in assessing the immunosuppressive
potency of antihuman ALS preparations.
Site of A ction of ALS and the
P rincipal C ell T ypes A ffected

ALS penetrates the central lymphoid
tissues to a slight degree113 and all the
present evidence suggests that the princi
pal site of action of ALS is the peripheral
recirculating
lymphocyte.59, U 3 , 114
The
various cell types involved in antibody pro
duction have not been precisely delineated
—probably at least two different cell types
are implicated, namely, cells of thymus
and marrow origin. ALS treatment has
been shown to inactivate both these cell
types 39, 40, B1> 68, 87
P erspectives

ALS has been a potent immunosuppres
sive agent in every species tested to date.
Its value as an adjunct to conventional
immunosuppressive therapy in clinical
transplantation remains to be proved by
controlled studies, but circumstantial evi
dence suggests that ALS will be a valuable
addition to the clinical transplanter’s arma
mentarium. In this respect a legitimate
question has been raised by Hume et al.,ns
namely, whether ALS is really needed in
addition to conventional immunosuppres
sive measures. If one only considers trans
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plants from related living donors, the
answer is probably “no”, because the
results are so good already. If ALS is really
effective in humans it will prove its worth
in transplantation from cadavers where the
results still leave much to be desired. Per
haps, in the long run, the greatest value
of ALS will be that it will allow steroid
dosages to be reduced in both transplants
from living related and cadaver donors
(much of the morbidity and some of the
mortality in clinical transplantation are due
to the large doses of steroids often ad
ministered).
Finally, Mathe, Amiel and Schwarzenberg 86 have shown that ALS treatment is
an extremely effective method of obtain
ing successful grafts of allogeneic marrow
and that graft-versus-host reactions do not
result in patients treated in this manner. It
is therefore possible that in future, ALS
will be used to obtain the successful hema
tologic and immunologic reconstitution of
patients who have received potentially
lethal doses of irradiation or drugs for the
treatment of malignant disease.
ALS is one of the most potent immuno
suppressive agents described to date. Much
work remains to be done, particularly in
relation to its mode of action and on
methods of effective biologic standardiza
tion. However, one cannot but be optimis
tic about its future usefulness in clinical
medicine and surgery.
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Le serum antilymphocytaire ( SA L), dans les
essais effectues sur toutes les especes, s’est revele
comme un immunodepresseur extremement actif.
II faudra encore, par des etudes approfondies, preciser sa valeur comme adjuvant du traitement im

munodepresseur classique dans les transplantations
d’organes, mais les preuves circonstancielles accumulees permettent d’esperer que le SAL constituera une nouvelle arme precieuse dans l’arsenal
therapeutique des transplantations. A cet egard,
Hume et al. ont pose une question parfaitement
legitime, a savoir si le SAL est reellement necessaire en plus des moyens immunosuppresseurs
courants. Si on envisage des greffes provenant de
donneurs vivants apparentes aux receveurs, la
reponse sera probablement negative, en raison de
l’excellence des resultats obtenus. Si le SAL est
reellement efficace chez l’homme, il ne manquera
pas de prouver sa valeur dans les transplantations
d’organes preleves sur des cadavres, les resultats
de eette operation laissant encore tellement a
desirer. II est possible qu’a la longue, l’atout prin
cipal du SAL sera de pouvoir reduire la posologie
des corticoi'des utilises au cours des transplanta
tions d’organes en provenance des deux sources
preeitees (on sait en effet qu’une partie de la
morbidite et un certain taux de mortalite con
states dans les greffes sont attribuables aux fortes
posologies de corticoi'des auxquelles on a souvent
recours).
Enfin, Mathe, Amiel et Schwarzenburg ont
montre que le traitement au SAL est extremement
efficace pour reussir des greffons de moelle hetero
gene et que, chez les malades ainsi prepares, la
reaction greffe-contre-hote ne se produit pas. II est
done parfaitement possible que, dans l’avenir,
grace au SAL, on parvienne a realiser le retablissement hematologique et immunologique de
malades qui ont regu des doses d’irradiation
potentiellement mortelles ou des medications
destinees a traiter des affections malignes.
Le SAL est un des plus puissants immunodepresseurs que l’on connaisse. Sans doute faudrat-il encore l’etudier encore beaucoup plus a fond,
particulierement en ce qui conceme son mode
d’action et les methodes efficaces d’etalonnage
biologique. On ne peut cependant qu’etre optimiste quant a son utilite future en medecine
clinique et en chirurgie.

KIDN EY C E L L AND LYMPHOCYTE
TYPING BY IMMUNE ADHEREN CE
Our present knowledge regarding human
transplantation antigens and their genetic
control has been derived in great part from
correlations established between graft survival
and in vitro assays using lymphocyte targets.
The immune adherence technique was
modified to permit a direct comparison be
tween the reactivity of lymphocytes and kidney
cells from the same person. These two cells
were typed using 17 well characterized anti
sera. There were 82 significant discrepancies
from a total of 234 direct comparisons. Ab
sorptions with the negatively reacting cell re
sulted in diminished or absent serologic
activity against the positive cell type.
It is stressed that the present studies pro
vide no evidence suggesting that kidney cells

possess unique histocompatibility markers not
present on lymphocytes. It is likely that
kidney-cell-positive lymphocyte-negative reac
tions may be caused by antibodies to antigens
other than HL-A antigens. This concept is
supported by hyperacute rejection reactions
where pretransplantation lymphocytotoxicity
cross-match between the donor and recipient
was clearly negative while the identical serum
sample was shown subsequently to contain
antibodies to kidney cells cultured from the
donor.
The results support the concept that sig
nificant quantitative differences in the expres
sion of isoantigens exist among different cell
types.—dePlanque B, Williams GM, Siegel A,
et al: Comparative typing of human kidney
cells and lymphocytes by immune adherence.
Transplantation 8: 852, 1969.
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THE SURGEON AND CANCER RESEARCH
BRUCE MEMORIAL LECTURE
A. P. M. FO RREST, M.D., Ch.M., F.R.C.S.(Edin., Eng. & Glas.),“ Cardiff, W ales.
H e r b e r t A l e x a n d e r B r u c e (Fig. 1) was
bom in Cartwright, Ontario, in 1868, one year
after Canadian confederation. He spent his
youth on his father’s farm in Port Perry and
in 1888 entered medical school in the Univer
sity of Toronto. He graduated at the top of his
class in 1892 and the following year was
awarded his M.D. with the Ferguson gold
medal.
After spending two years at sea to earn
sufficient supportive funds, he proceeded to
London and, in 1896, became the second
Canadian to become a Fellow of the Royal
College of Surgeons of England. While still
in London he accepted an offer of an associate
professorship of surgery in his alma mater, an
appointment he held until September 1930.
These were pioneer days in Canadian surgery
and Bruce, a resolute and rugged character,
possibly because of his Scots ancestry, was a
pioneer. He had many “firsts” in Canada: the
use of rubber gloves, the performance of gas
serian ganglionectomy, the operative reduc
tion of intussusception, and the excision of a
cortical scar in an epileptic. Small wonder
that soon he had a large and flourishing prac
tice; to support this he purchased, in 1910,
a building in Wellesley Street which in 1911
became his own Wellesley Hospital. The
further history of this now-great institution is
well known, and culminated with its integra
tion, in 1942, with the Toronto General Hos
pital as a teaching institution of the Univer
sity.
Surgery alone was insufficient challenge to
Bruce. In 1913 he was the only Canadian
member of the original Board of Regents of
the American College of Surgeons. In 1914
he went, at his own expense, to view the ac
tivities of the Canadian Medical Service in
France, and returned to Canada to head a
commission that reported adversely on the
organization of the medical services. This re
port led to considerable controversy and, from
some, continued antagonism. He returned to
France as surgeon to the British Army and it
was there that he met his future wife, Angela
Hall, whose generosity has inaugurated this
lectureship.
It could have come as no surprise to those
who then knew him that he could retire from

“Professor of Surgery, Welsh National School of
Medicine, Cardiff, Wales.

Fig. 1.—Herbert Alexander Bruce (1868-1963).

active surgery only if another more demanding
activity required his energy and vim. This
was a call to be Lieutenant-Governor of the
Province of Ontario in 1932—a position he
held with distinction until 1937. In 1931 he
had become also a governor of the University
of Toronto, which in 1933 awarded him an
LL.D.
Even on his resignation as LieutenantGovernor he did not rest for long. W ith the
outbreak of World W ar II, at the age of 72,
he stood for election as member of the House
of Commons. He served his country in this
capacity for a further six years. Finally, he
retired to his farm, only to emerge again at
the age of 90 to publish his autobiography.
He died in 1963 at the age of 94.
Throughout his life Bruce was deeply in
terested in cancer. His last professional task
in 1930 was to visit cancer clinics in Europe;
as a result of this visit he constantly urged
the government to develop facilities for the
treatment of cancer in Ontario—even offering
the use of the Wellesley Hospital for this pur
pose. His promotion of the George V Jubilee
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Cancer Campaign in 1935 he described as “a
cause near to my heart”. It was partly this
interest that prompted me to choose as a title
for this first Bruce lecture “The Surgeon and
Cancer Research”.
No lecture of mine can match the man and
it is with a deep sense of pride and modesty
that I give it.

In discussing the responsibility of the
surgeon for cancer research, I do not in
tend to consider men such as Lister or
Huggins, whose contributions to research—
as Herbert A. Bruce’s were to surgery and
politics—were at the extreme end of the
spectrum of human endeavour. Such men
were outstanding scientists, endowed not
only with great intelligence but with the
persistence and single-mindedness of the
devoted investigator. Rather do I intend
to consider the role of the practical
surgeon.
Many consider that the main, if not only,
priority of the surgeon in practice is the
care of his patients. This is not the case,
for he has an equal responsibility to ad
vance knowledge. Acceptance of this
responsibility- is not easy, for it requires
patience and understanding and denial of
the well-worn dictum that research is the
antithesis of good clinical care.
The contribution of the surgeon is far
from passive, for his role is that of an
equal and full collaborator whose prime
function is to maintain the relevance be
tween investigation and patients. It is this
relevance that underlies the purpose of
clinical research. This can best be con
sidered further under two headings: clini
cal care and clinical investigation.
C l in ic a l C a r e

A worthwhile contribution to cancer re
search is unlikely ever to be made by the
surgeon whose only concern is the indi
vidual patient. The insistence that “every
patient is different”, or that “I am treating
a patient, not a disease”, is often only an
excuse for inactivity in clinical research
and arises from a refusal to admit that one
may be wrong in certain aspects of current
practice. Yet we all do it. In certain dis
eases where cause and cure are well de
fined—the perforated peptic ulcer, the
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acute urinary retention, the fractured tibia
—this approach is justified. But this is not
so with cancer, for neither premise is true.
Yet many surgeons persist in refusing to
practise methods of treatment other than
those that they were first taught, and op
pose vehemently any suggestion that by
such refusal they may not be acting in the
best interests of their patients. These men
condemn outright any participation in a
controlled randomized trial.
The controlled clinical trial has proved
one of our most effective therapeutic
weapons against cancer. Moreover, the
“spin-off” is considerable—better assess
ment of patients both before and after
treatment, meticulous follow-up and rigid
documentation, all factors that bring ad
ditional safeguards to the management of
the patient with cancer.
During the past years we have set up
in Cardiff joint clinics for conducting con
trolled trials of the treatment of primary
and advanced cancer of the breast. Both
are run in co-operation with our radio
therapy colleagues, Drs. J. M. Henk, V.
Jones and C. A. F. Joslin. As it is important
to keep patients with primary and ad
vanced disease apart, we hold the clinics in
different hospitals. The design of the trials,
their conduct and the assessment of results
are complex and require expert statistical
help. This we are fortunate to have
through the co-operation of Professor Hu
bert Campbell.
Controlled randomized trials are of par
ticular value in the assessment of a new
method of treatment. An example is abla
tion of pituitary function in advanced
breast cancer.
Yttrium-90 Implantation
In 1955, contemporaneously with Tallairach and Tournoux,1 we developed a
method of pituitary ablation aimed at
providing a simple alternative to surgical
hypophysectomy in patients with meta
static cancer of the breast.2 This alterna
tive consisted of the implantation of radio
active sources into the pituitary fossa by
transnasal cannulation. Initially radon
seeds were used but, owing to complica
tions from gamma radiation, we substi
tuted the beta-emitter, yttrium-90 (90Y),
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which could cause intense necrosis of the
pituitary without irradiation of surround
ing structures.3
Accurate placing of the sources was
found to be essential if complications were
to be avoided and if complete destruction
of the gland was to be achieved regularly.
Visual damage, cerebrospinal rhinorrhea
and meningitis occurred if the sources were
placed too high in the fossa; paralysis of
nerves III, IV or VI occurred if the sources
were too lateral.
To achieve accurate placing of the
sources in an optimum position, we modi
fied our original method. The 90Y rods
were incorporated in a stainless-steel
screw-threaded base which was screwed
into the bony floor of the fossa.4 Twin
cannulas were inserted, one through each
nostril, and guided radiologically to the
floor of the fossa. Bilateral holes were
drilled in the floor of the fossa and the
screw units, attached to a special screw
driver, were introduced until the yttrium
rod reached the desired position. The
screwdriver was detached and the yttrium
units were left permanently in the fossa
(Fig. 2).

Fig. 2.—Yttrium-90 screw implantation of the
pituitary.

To December 31, 1969, yttrium-screw
implantation of the pituitary has been car
ried out in 387 patients with advanced
cancer of the breast. Since it is a simple
procedure, taking only 20 to 30 minutes to
perform, postoperative death was rare and
occurred only in 3.1% of patients. All had
terminal malignant disease.
The incidence of complications (Table I)
also has proved acceptable. Nine patients
(2.3%) died as a result of complications;
seven from meningitis and one each from
myxedema and adrenal failure.
The incidence of unequivocal remission
of disease in 274 assessable patients was
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15.2%. However, in the face of varying
clinical states of the patients, this figure is
meaningless. Accurate evaluation de
manded a controlled trial against a recog
nized method of treatment; that selected
was adrenalectomy and oophorectomy.
T A BL E I .— C o m p lic a t io n s
the

P it u it a r y

Complications

Meningitis
Rhinorrhea— total
permanent
Visual defects
Extraocular palsy

in

o f 90Y I m p l a n t
3 8 7 P a t ie n t s

of

%
4 .9
5 .2

1.0

1 .8
4 .1

Yttrium-90 Implant Versus
Adrenalectomy and Oophorectomy
Seventy-seven patients with advanced
breast cancer were included in this trial
between 1958 and 1962. All were post
menopausal or castrated, all previously
had been treated by simpler methods of
palliation and all were considered fit for
adrenalectomy. They were allocated ran
domly for treatment either by 90Y implan
tation or by adrenalectomy and oophorec
tomy. Although these patients were not
matched before selection, the similarity of
certain factors in the two groups (age at
endocrine ablation, tumour-free interval,
menstrual status and distribution of dis
ease) confirmed that randomization had
been satisfactory.
The incidence of remission, both clearcut and equivocal, was identical for the
two procedures (Fig. 3). However, the
duration of remission in those patients who
responded to adrenalectomy and oophorec-

Fig. 3.—Incidence of remission (clear-cut and
equivocal) in patients with advanced cancer of the
breast selected randomly for treatment by 90Y
implant of the pituitary, and adrenalectomy and
oophorectomy.
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Grow th-horm one resp on se—Hypoglyce
mia, induced by the intravenous injection
of insulin, releases growth hormone from
the pituitary. Such release can be meas
ured by estimations of the concentration of
the immunoreactive levels of growth hor
mone in serial samples of plasma. This
response has been used to assess the extent
of pituitary destruction following implant.
To define the normal response to insulin
hypoglycemia in patients with advanced
cancer, we carried out tests in 23 patients
who had intact pituitary glands. The con
centration of growth hormone rose from a
Fig. 4.—Duration of remission in responding
mean
fasting value of 7.5 ng. to a mean
patients.
maximum of 34.8 ng./ml. (Fig. 5), a
tomy has now proved significantly longer response no different from that of normal
than those responding to 90Y implant (Fig. individuals.
Studies were carried out also in 30 pa
4). As a method of controlling advanced
cancer of the breast, pituitary ablation by tients following 90Y implant, all but one
screw implant is thus marginally inferior of whom had grossly abnormal responses.
These fell into three main groups: (1) “ab
to adrenalectomy and oophorectomy.
sent”, in which an insignificant rise in
growth hormone (< 4 ng./ml.) was associ
Extent o f Destruction
ated with low fasting levels (< 4 ng./ml.);
It was important to determine the ex (2) “unresponsive”, in which there was no
tent to which pituitary function was response to insulin hypoglycemia, although
ablated by this method. This has been fasting levels greater than 4 ng./ml. were
assessed in two ways: (1) plasma growth- found, and (3) “responsive”, in which a
hormone response to insulin hypogly significant rise of growth hormone (> 4
cemia,5 and (2) postmortem histologic ex ng./ml.) followed insulin stimulation (Fig.
6). An increment of this degree, which
amination of the gland.
was taken as unequivocal evidence of
residual pituitary function, was observed
in six patients (20%).
Histology.—Postmortem step-sections of
the pituitary have been examined histo
logically by Dr. A. T. Sandison of the
Department of Pathology, Western In
firmary, Glasgow, Scotland, in 77 patients
with breast cancer who had been treated
by yttrium implantation using the screw
technique. Pituitary remnants of greater
than 15% of the gland have been observed
in one-third of the patients.
As a result of these studies we conclude
that 90Y implant of the pituitary cannot
consistently achieve complete destruction
of the gland. This finding adequately ex
plains its inferiority to adrenalectomy as a
method of palliation. Nevertheless, because
it is simple to perform and causes little
upset to the patient, it has a place in the
Fig. 5.—Growth-hormone response to insulin
management of those patients who are
hypoglycemia (0.15 units/kg.) in 23 patients with
unfit for adrenalectomy.
advanced cancer of the breast.
Clear - c o t

iso,

9 0 y (8 )

A x»)

Equivocal

9 0y (6)

A x is)
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out by a system of sealed envelopes within
the 24 subgroups. One hundred and one
patients were admitted to the trial, the
preliminary results of which have been
reported elsewhere.6
Although the immediate postoperative
period proved more troublesome for the
hypophysectomy patients, a slightly higher
incidence of complications was observed
in the yttrium group. More patients treated
by yttrium implant also had regression of
disease, but the difference was not signifi
cant (Table II). The duration of survival

r
>

*
*

>
*

TABLE II. — C om parison o f T ra nsethm oidal
H ypophysectom y and 90Y I m pla n tatio n o f th e
P it u it a r y

in

A dvanced

C ancer

of

th e

B reast

M eth od o f h yp o p h y secto m y

ft-

.

Fig. 6.—Growth-hormone response to insulin
hypoglycemia (0.10 units/kg.) in 30 patients with
advanced cancer of the breast treated by “ Y im
plant of the pituitary.
Tramethmoidal Hypophysectomy

A

\

An accurate assessment of morbidity and
clinical value is not always practised by
those who advocate a new method of treat
ment. Despite scant evidence to support
their view, many now regard transethmoidal hypophysectomy as a procedure of
negligible morbidity which regularly
achieves complete removal of the gland
and gives excellent clinical results. For this
reason, in collaboration with Mr. S. H.
Richards of the Department of Otolaryn
gology in Cardiff, we decided on a further
trial to compare 90Y implantation of the
pituitary with transethmoidal hypophysec
tomy in patients with advanced cancer of
the breast.
The design of this trial differed from
that previously described. Before randomi
zation, patients were carefully matched
according to four factors known to in
fluence prognosis, viz. the presence of the
primary tumour, the time from the meno
pause, the tumour-free interval and the
distribution of metastatic disease. Ran
domization for either transethmoidal hypo
physectomy or yttrium implant was carried

Total number
Response rate (clearcut and equivocal
remission)
Incomplete
hypophysectomy

90 y

T ran sethm oid al

SO

51

32%

18%
24%

13%

of patients in the two treatment groups
was identical (Fig. 7). Tests for residual
pituitary function by the growth-hormone
response to insulin hypoglycemia indicated
that the incidence of incomplete hypo
physectomy following the two methods
was the same (Table II).
The findings suggest that 90Y implant of
the pituitary and transethmoidal hypo
physectomy, as performed in our centre,
are more or less of equal value. Certainly,
at this point in the trial, we have no
reason to assume that transethmoidal
hypophysectomy is superior.
C linical I nvestigation

By clinical investigation I mean those
investigations which, although not per
formed exclusively in the patients’ own in
terests, are essential for the advancement
of knowledge of their disease with benefit
to patients of the future. Such investiga
tions may be trivial and demand only a
chest radiograph or a urine sample; others
are more complex. The rule is inflexiblepermission must be given freely by the
patient in complete understanding of the
nature of the studies proposed and with-
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Fig. 7.—Cumulative survival curves of 101 patients with advanced breast cancer allocated ran
domly for treatment by transethmoidal hypophysectomy and “°Y implant of the pituitary.

out fear that to refuse might prejudice her
relationship with her doctor.
Some surgeons refuse “on principle” to
allow investigations of this type on their
patients. They are hiding from reality be
cause, without careful studies of this type,
false premises are accepted and unproved
methods of treatment used.
Immunity and Cancer
An example of a field of study requiring
careful clinical investigation is that of im
munity and cancer. Nowhere in modem
cancer therapy is there greater danger
that an uncritical approach may cause ac
tive harm to the patient.
Evidence that the behaviour of human
cancer of the breast is affected by the im
mune system is far from clear and rests
mainly on the demonstration that certain
factors, which may indicate an immune
response, are related to prognosis. Thus,
tumours of smooth contour,7’ 8 with
marked lymphocytic infiltration,9 12 and
those that are associated with enlarge
ment13, 14 and sinus histiocytosis15 17 of the
regional lymph nodes, have been reported

to have a better prognosis that those that
are spiculated, have little lymphocytic re
action or have failed to evoke a reaction in
the lymph nodes.
In Cardiff, Dr. H. J. Stewart has carefully
assessed the contour of 75 tumours by pre
paring whole breast sections by the tech
nique described by Gough and Went
worth.18 The breast, following excision,
was impregnated with gelatin, frozen and
cut into 400 //, slices on a sledge micro
tome. It was then stained with eosin and
hematoxylin and mounted on filter paper
between layers of cellophane.
Tumours were classified into four con
tour types: smooth, spiculated, mixed (tu
mours with both well-defined, smooth and
spiculated parts to their outline), and con
glomerate (tumours with a mulberry-like
appearance).19
Contrary to the reports of others, tu
mours of smooth contour not only proved
to be more extensive at the time of primary
treatment than those that were spicu
lated,19 but their mortality, at two years, is
greater than that of other types (Table III).
Im m une responsiveness.—The mechanism
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TAB LE III.— R e l a t io n s h ip of C o n t o u r of
T u m o u r (D e f i n e d b y W h o l e S e c t io n s o f t h e
B r e a s t ) to S u r v iv a l a t T w o Y e a r s in 75 P a t ie n t s
W it h P r i m a r y C a n c e r o f t h e B r e a s t
Contour
Spiculated
Smooth
Conglomerate
Mixed

Dead at 2 yrs.
No.

(% )

22
10
25
18

36
60
36
33

by which an immune reaction may keep a
tumour in check is believed to involve
predominately the small lymphocyte. Fol
lowing detection of an abnormal antigen
in the tumour, messenger lymphocytes in
duce a change in the regional lymph nodes
by which large pyroninophilic immunoblasts are formed (Fig. 8). These form a

CONTROL
(7 6 )

PRIMARY
(5 8 )
Age

LOCAL
(3 6 )

GENERAL
(7 8 )

4 0 - 7 0 years

Fig. 9.—Delayed hypersensitivity response to
intradermal streptococcal antigen. Response in
age-matched normal women, patients with benign
breast disease and patients with breast cancer.

Fig. 8.—Mechanism of immune response
“foreign” tumour antigen.

to

new progeny o f small lymphocytes which,
being sensitized against the antigen, can
react against the tumour. In this reaction
macrophages also may be concerned.
Some have suggested that failure of this
“reflex” may promote dissemination of
cancer. Studies are being carried out in
Cardiff by Dr. M. M. Roberts with Dr.
W. Jones Williams to test the integrity
of this mechanism in patients with cancer
of the breast.20' 21 In the first study,
she has assessed the ability of patients to
react to a previously encountered antigen
by delayed hypersensitivity, and in the
second, the capacity of the patient’s
lymphocytes to react in vitro to phytobemagglutinin, a non-specific but potent
mitogenic agent.
For the delayed hypersensitivity reac
tion, streptococcal antigen (Varidase) was
used in the belief that a large part of the

population would have been sensitized
previously against it. The test consisted of
the intradermal injection of five units of
Varidase, with measurement of the result
ing reaction 48 hours later. Because the
response in control women was found to
be related to age, comparisons have been
made only between women 40 to 70 years
of age, the most common decades for
breast cancer. Seventy-six control normal
women, 58 patients with primary breast
cancer and 114 with advanced cancer (of
whom 36 had localized recurrent disease
only) were within this age group. A signifi
cant reduction in the ability to respond to
the streptococcal antigen was observed
only in patients with disseminated malig
nancy (Fig. 9). In these patients the
presence or absence of this response was
related to survival, those patients with a
positive reaction surviving for a signifi
cantly longer time than those in whom it
was negative (Table IV).
T A B L E IV. — C o m p a r is o n

o f S u r v i v a l o f 47 A g e M a t c h e d P a t i e n t s U n d e r 60 Y e a r s W i t h A d 
v a n c e d C a n c e r o f the B r e a s t o f D is s e m in a t e d
T y p e i n R e l a t i o n to t h e R e s p o n s e t o D e l a y e d
H y p e r s e n s i t i v i t y (P = 0.02)

Delayed hypersensitivity
reaction to Varidase
Positive
Negative

No. of
patients

Survival
(weeks)

23
24

47.4 ± 3 2 .4
28.1 ± 2 3 .7
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The technique for determining the
ability of peripheral lymphocytes to trans
form with phytohemagglutinin is now well
established. White cells, obtained from the
peripheral blood of normal women and pa
tients with breast cancer, were incubated
in tissue culture medium, fetal bovine
serum and phytohemagglutinin for three
days, after which they were harvested,
stained with aceto-orcein and examined
microscopically. The transformation rate
was established by counting the number
of immunoblasts in at least 500 cells, and
subtracting from it the number counted in
control cultures to which no phytohemag
glutinin was added. All counts were per
formed in triplicate.
The rate of transformation was identical
in all groups of patients and no difference
was observed between control women and
patients with primary or advanced cancer
of the breast (Fig. 10).
60

40

Fig. 11.—Comparison of delayed hypersensi
tivity to intradermal Varidase lymphocyte trans
formation in 140 normal women and patients in
whom both tests were performed. All were be
tween the ages of 40 and 70 years.

Such tests are artificial and non-specific
in that they test the reaction of the patient
to a foreign antigen and not to her tumour.
In additional studies, Dr. Roberts is using
homogenates of the patient’s own tumour
to induce delayed dermal hypersensitivity.
To date, positive reactions have been ob
served in six of the 21 patients with
primary cancer of the breast who have
been tested.
Steroid Hormones

/o

20

CONTROL
( 12)

PRI MA R Y
(48 )

LOCAL
( 14)

GENERAL
(30)

Fig. 10.—Lymphocyte transformation following
exposure to phytohemagglutinin in normal women,
and patients with benign breast disease and breast
cancer (all ages).

One hundred and two patients between
the ages of 40 and 70, included in these
two studies, had both skin and lymphocyte
transformation tests (Fig. 11). Again, the
only difference observed was a reduced
response to Varidase in those patients with
advanced generalized cancer.
These studies indicate that, in carefully
staged and age-matched patients, evidence
of diminished responsiveness (by failure
to react to a previously encountered anti
gen) has been observed only in patients
with disseminated cancer.
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Investigations such as I have described
are technically simple and can be carried
out easily by a clinical research assistant.
Others, such as the estimation of adreno
cortical steroids, require complex bio
chemical techniques. In Cardiff we are
fortunate to be associated with the Tenovus Institute for Cancer Research, in which
Drs. K. Griffiths and E. H. D. Cameron
direct a steroid hormone group.
In common with others, we have been
interested in the work of Bulbrook and
his colleagues from the Imperial Cancer
Research Fund Laboratories which indi
cated that a discriminant function, based
on the relative excretion of etiocholanolone and 17-hydroxycorticosteroids in the
urine, is related to the response of patients
with advanced cancer of the breast to
endocrine surgery.22 These workers re
ported that those patients whose urinary
discriminant function was negative (i.e. one
in which the contribution made by the
excretion of etiocholanolone is low) have
less chance of benefit than those in whom
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Fig. 12.—Relationship of urinary excretion of
etiocholanolone (log. ftg./24 hrs.) in 21 normal
women and 63 women with benign breast disease
(all ages).

it is positive. Recently Atkins et al.,2S have
reviewed the results of estimating this
function in 206 patients and found that its
prognostic value is strengthened if one also
takes into account the duration of the “free
period” and the menstrual status of the
patient.
Although developed primarily to predict
the response to endocrine surgery, the Bulbrook discriminant and the absolute levels
of urinary steroids on which it is based,
have also been found to be abnormal in a
proportion of women with primary cancer
of the breast in whom it also is of prog
nostic value.24 Recently it was reported
that the eight-year survival rates of 71
patients treated for primary cancer of the
breast were three times more favourable in
those with positive than with negative
discriminants.25
Because we were interested in this pos
sibility, we have carried out similar
analyses in 177 women: 21 normal, 63 with
benign breast disease, 30 with primary
cancer of the breast and 63 with advanced
disease.28 To standardize conditions, pa
tients were admitted to hospital and two
consecutive 24-hour specimens of urine
collected. Etiocholanolone, androsterone
and dehydroepiandrosterone (DHA) were
estimated by gas chromatography using
the method of Thomas and Bulbrook27
modified by the addition of radioactive
steroids as markers at several stages in the
assay. Urinary 17-hydroxycorticosteroids
were estimated by the method of Few28
but because these did not vary significantly
they will not be considered further here.

27

It had been shown by Bulbrook29 that
the excretion of etiocholanolone decreases
with age. To establish this relationship in
our patients, we calculated the best fit for
the regression of etiocholanolone against
age in normal patients and those with be
nign disease. This was parabolic, the ex
cretion rising to a peak at the age of 38
to 40 years and thereafter descending in
linear fashion (Fig. 12). Provided only
women of 38 years or more are considered,
linear regression analysis was a valid
method of comparison between groups.
When this was done, the excretion of etio
cholanolone in patients with primary
cancer of the breast was identical to that
of normal women and those with benign
disease. However, significantly lower levels
were found in patients with advanced
cancer (Fig. 13).
For some time we have been impressed
that advanced cancer of the breast, local
ized to the chest wall or regional nodes,
behaves differently from that which is
widely disseminated. Patients with local
ized disease tend to respond badly to
endocrine ablation. Further, in a controlled
randomized trial to determine whether
early endocrine ablation (90Y implant of
the pituitary) carried any advantage over
delaying it until simpler measures had
been tried, we found that patients with
localized disease again behaved differently
from those in whom dissemination has oc
curred.30 Twenty-one of our 63 women had
localized and 42 had generalized disease.
When we further analyzed our steroid
data according to disease type, the group
that stood out as different from all others
was that with localized advanced disease
in which the levels of etiocholanolone
were significantly less than those in all
other groups (Fig. 14).
The excretion of androsterone and de
hydroepiandrosterone behaved similarly.
These results indicate that an abnor
mality of 17-oxosteroid excretion is present
only in patients with advanced cancer of
the breast. This consists of abnormally low
levels of etiocholanolone, androsterone and
possibly
dehydroepiandrosterone.
This
change was most pronounced in patients
with advanced localized disease who have
been noted previously to respond poorly to

28
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Fig. 13.—Relationship of urinary excretion of etiocholanolone (log. y .g j 24 hrs.) to age in normal
women, patients with benign breast disease, patients with primary breast cancer and patients with
advanced cancer over the age of 38 years.

endocrine surgery. Patients with primary
cancer did not show any abnormality of
steroid excretion.
Endocrine function of tumour—To some
it may appear that the surgeon has a re

mote role in these investigations. This is
far from the truth. Unless there is a strong
link between the steroid chemist and the
clinician (who, being responsible for the
patient, only can assess the clinical situa-

Fig. 14.—Relationship of urinary excretion of etiocholanolone (log. /tg./24 hrs.) to age in normal
women and patients with benign breast disease and cancer of the breast over the age of 38 years.
Patients with advanced cancer of the breast have been subdivided into those with localized and
generalized disease.
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tion), the validity of the results in terms of
the patient may be open to question.
In certain allied investigations the sur
geon has an even more vital part to play,
such as in those which we are carrying
out to study the ability of human breast
cancer to metabolize steroids.31 At opera
tion radioactive precursors (dehydroepiandrosterone sulfate, androstenedione and
testosterone) have been injected into a
small artery supplying the tumour before
its removal. The tumour is then homo
genized and the steroid metabolites are
characterized. In vitro studies have also
been carried out in which preparations of
breast cancer cells have been incubated
with radioactive steroids. The results of the
two types of study are in agreement and
have shown that human breast cancer pos
sesses the enzyme systems required for
steroid biosynthesis (Fig. 15). This finding
i

1

____________ p e r f u s io n
I ‘ “ ‘■ s tr a te s

___________ in c a b a t io n

16 cC- h y d r o x y

e s tro n e

DHA

1 6 < - h y d ro x y
t e s to s te r o n e

29

centre in Toronto which, largely through
the efforts of men like H. A. Bruce, has a
tradition for the investigation and treat
ment of cancer of the breast. It is only by
such research that the ultimate goal can be
reached—the cure of cancer.
“The magnificent achievements of mod
em medicine . . . have been achieved by
patient research, by mastery of every con
ceivable factor in a given situation, even
those factors which almost defy visibility,
and by experimentation after experimenta
tion until a specific remedy has been
found.”
So wrote Dr. Herbert Brace.
Cancer research demands co-operation and the
work reported here is that of the Cardiff Breast
Group. I would like to thank in particular my
surgical and radiotherapy colleagues (especially
Drs. C. A. F. Joslin and Vera Jones) without
whose help and interest these studies could not
have been made.
The Tenovus Institute for Cancer Research in
Cardiff, supervised by Drs. K. Griffiths and
E. H. D. Cameron, was provided and is main
tained by Tenovus, Cardiff, to whom all of us owe
a great debt of gratitude.
Referen c es
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Fig. 15.—Pathways of steroid biosynthesis de
fined by incubation and perfusion of breast cancer
tissue with steroid substrates. This diagram com
bines the results of incubation and perfusion ex
periments.

introduces the exciting concept that hor
mone dependence may be determined by
the presence or absence of pathways for
synthesizing growth-promoting steroids at
tumour level.

C onclusions
In this lecture I have attempted to show
the ways in which a surgeon has consider
able responsibility for the advancement of
knowledge in the field of cancer research.
I have used as examples work being car
ried out in Cardiff, but appreciate that
similar work is going on in your own
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R esu m e
La presente conference inaugurale du Bruce
Memorial souligne l’importance d’une etroite col
laboration entre le clinicien et les scientifiques
d’autres disciplines, dans le domaine des recherches sur le cancer. La necessite de cette col
laboration est illustree par des exemples puises
dans le service de ehirurgie de l’auteur et dans
les archives du Tenovus Institute for Cancer Re
search de Cardiff ( Royaume-Uni). On y donne
notamment
les
resultats
de
1’implantation
d’yttrium-90 dans l’hypophyse, de hypophysectomie transethmoi'dale, de la reaction immunitaire et de l’excretion de stero'fdes chez des
malades souffrant de cancer mammaire. On y fait
allusion a des travaux sur les fonctions paraendocriniennes du cancer mammaire.
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CYSTOSARCOMA PHYLLOIDES (CELLULAR INTRACANALICULAR
FIBROADENOMA): CLINICAL-PATHOLOGICAL RELATIONSHIPS*
D. B. RIX, M.D., C .R .C ,P.[C ],t S. J. TR E D W E L L , M.D. and
A. D. FORWARD, M.D., F.R .C .S.[C ], Vancouver, B.C.

The prolonged and interesting clinical
course of a patient referred to one of our
colleagues with the diagnosis of cystosarcoma phylloides stimulated our interest
in this tumour. Cystosarcoma phylloides,
first described by Johannes Muller in
1838,1 is a rare tumour which makes up
2.5% of all fibroepithelial tumours of the
breast and only 0.3% of all mammary
neoplasms found among patients admitted
to a general hospital.2 To be regarded as
cystosarcoma phylloides, neoplasms must
contain fibrous and epithelial tissue, and a
greater degree of stromal cellularity than
a fibroadenoma. Histologically the stromal
cellularity distinguishes it from a fibro
adenoma. Although the tumour has many
synonyms, e.g. giant fibroadenoma, Brodie’s
tumour, cystosarcoma phylloides, the cor
rect name is that established by the World
Health Organization, viz. cellular intracanalicular fibroadenoma.3
Material and M ethods

Norris and Taylor,4 in an excellent re
view of 94 cases, correlated the clinical
course with the tumour’s various patho
logical characteristics such as size, mitotic
activity, nuclear atypism and contour.
Using a similar pathological classification
on 20 cases of cystosarcoma phylloides
seen at the Vancouver General Hospital
between 1954 and 1966, we tabulated the
clinical data from hospital charts and ana
lyzed it using the following gross and
microscopic features:
(1) The contour of the tumour periphery
was divided into pushing or infiltrating
types on the basis of multiple random
sections (Fig. 1).
(2) Nuclear atypism was graded as I
(minimal) to III (maximal) atypism (Fig. 2).
“Presented at the Annual Meeting of the Royal
College of Physicians and Surgeons of Canada,
Vancouver, B.C., Jamiarv 1969.
t Assistant Professor of Pathology, Faculty of
Medicine, University of British Columbia, Van
couver, B.C.

(3)
Mitotic activity was graded on the
number of mitotic figures per 10 highpower fields determined in the areas of
greatest mitotic activity (Fig. 2c).
Each tumour was graded separately by
Drs. Tredwell and Rix and the results were
compared. When there was a marked dif
ference, the opinion of another senior path
ologist was sought. Initially, standard slides
showing classes I to III atypia were set up
so that the slides of individual tumours
could be compared to them. This was
done so that accurate uniform results
could be obtained. Initially all slides of
the tumour were scanned for areas of
greatest mitotic activity, then these areas
were counted and the average was taken.
Unfortunately tumour size was not re
corded on each patient and therefore this
important finding had to be dropped from
our study. We obtained a follow-up in
every patient either by contacting the doc
tor or, in some cases, by telephoning or
writing to the patient directly.
P athology

Gross
The cystosarcomas varied greatly in con
sistency, colour and outline. They ranged
from a hard gritty consistency to soft
fleshy areas with localized areas of hemor
rhagic and cystic change. In size they
ranged from 1.5 to 30 cm. in diameter.
M icroscopic
All cystosarcomas contained an epi
thelial element and a stromal hypercellularity that distinguishes them from a fibro
adenoma. The epithelial elements ranged
from normal (15 specimens) through
hyperplasia (2), in situ adenocarcinoma (1)
to frank adenocarcinoma (2). Stromal com
ponents showed marked variation within
a single tumour, ranging from regular fusi
form fibroblasts to highly anaplastic
bizarre cells. Myxoid change was seen in
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Fig. la

Fig. lb
Fig. 1.—A cellular intracanalicular fibroadenoma on the right, and breast stroma on the left; the
margin contour of the adenoma is (a) pushing and (b) infiltrating (original magnification X 74).
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Fig. 2c
Fig. 2.—(a) Class 1 nuclear atypism of the stroma. Note also the hyperplasia of the ductal epi
thelium. (b) Class II nuclear atypism of the stroma, (c) Class III nuclear atypism of the stroma. Note
also the large number of mitotic figures ( x 890).
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TABLE I . —-S u m m a r y

op

E x p e r ie n c e W it h C e l l u l a r I n t r a c a n a l ic u l a r F ib r o a d e n o m a (C IF )

1954 t o 1966
Age at
Pre/post
Case diagnosis
(years) menopausal
no.

Margin
contour

Mitotic
activity

Nuclear
alypism

Size
(cm.)

Survival
(years)

i
2
3
4
5

35
36
37
39
40

Pre
Pre
Pre
Pre
Pre

Pushing
Pushing
Pushing
Infiltrating
Pushing

3
1
3
5
3

I
I
I
II
II

7X7X7
4 X 3 X 1.5
2.5 X 2.0
11X7X6
Unknown

7.5
6.0
8.0
4.0
3.5

6
7

41
43

Pre
Post

Pushing
Pushing

1
7

I
III

30 X 30 X 30
5X4

13.5
2.1

8
9
10
11

50
57
58
58

Post
Post
Post
Post

Pushing
Pushing
Pushing
Pushing

2
3
2
2

II
III
I
II

12 X 8 X 8
4X4X4
3X2X4
2X2

2.6
4.75
8. 0
9.2

12

59

Post

Pushing

3

I

24 X 19

1.25

13
14
15
16
17
18
19
20

62
65
69
70
73
75
76
77

Post
Post
Post
Post
Post
Post
Post
Post

Infiltrating
Infiltrating
Pushing
Infiltrating
Infiltrating
Pushing
Pushing
Infiltrating

5
1
1
7
2
2
2
7

III
I
I
III
II
I
II
III

2.5 X 2.5
4X2X1
3X2
12 X 8 X 6
5X5X5
1.7 X 1.7
6X6X6
4X3X2

2.0
4. 6
12.6
1.1
12.0
4.75
2.75
1.1

one tumour and heterotopic ossification in
one other.
R esults

Table I gives a summary of the findings
in our 20 cases. The patients varied be
tween 35 and 77 years of age; 14 patients
were postmenopausal. The average age in
the premenopausal women was 38 years
and in the postmenopausal, 64 years. The
overall average age of our patients was
56 years. The presenting symptom in 19 of
the 20 was a lump in the affected breast.
TABLE I I . — S u m m a r y

of

Cause
of death
CIF
Alive
Alive
CIF
Adenocarcin
oma of sigmoid
Alive
Myocardial
infarction
Alive
Alive
Alive
Adenocarcin
oma of breast
Myocardial
infarction
Alive
CIF
Hip pneumonia
CIF
Alive
Alive
CIF
CIF

In one patient, the lesion was an incidental
finding on her hospital physical examina
tion. Eleven of the 20 tumours were in the
left breast and nine were in the right. Two
patients gave a history of recent increase
in size and complained of significant pain.
Survival D ata

Eleven patients died, six from their dis
ease (Table II) giving a 30% mortality
rate. Nine of these patients are alive, five
having survived five or more years after
initial treatment.

P a t i e n t s D y in g o p C e l l u l a r I n t r a c a n a l ic u l a r F ib r o a d e n o m a

Histologic criteria
at time of diagnosis
Case Age
no. (years)

Initial
treatment

Local
recurrence

i

35

Excision
biopsy

X 3

4

39

Excision
biopsy

X 2

14

65

Excision
biopsy

X 2

16

70

19

76

20

77

Simple
mastectomy
Simple
mastectomy
Simple
mastectomy

—

—
X 1

Second
treatment

Size
(cm.)

Margin
contour

(1) Radical
7 X 7 X 7 Pushing
mastectomy
(2) Chemotherapy
(1) Radical
1 1 X 7 X 6 Infiltrating
mastectomy
(2) Chemotherapy
Extended
Infiltrating
radical
4X2X1
mastectomy
1 2 X 8 X 6 Infiltrating
(1) Radiation
(2) Chemotherapy
6 X 6 X 6 Pushing
Radiation
Resection of
recurrence

4X3X2

Infiltrating

Nuclear Mitotic nival
alypism activity (years)
I

3

7.5

II

5

4.0

I

1

4.6

III

7

1.1

II

2

2.75

III

7

1.1
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TA BLE I I I .

S um m ary op L ocal R e c u r r e n c e o f C e l l u l a r I n tr a ca n a licu la r F ib r o a d e n o m a .
N o te T e n d e n c y T ow ard s I n c r e a se in H ist o l o g ic A g g r e s s iv e n e s s o f R e c u r r e n t T u m o u r s

Original tumour—
Mitotic activity
Case
no.

Size
{cm.)

i

7 X 7X7

Initial
treatment

Second
treatment

Margin
contour

Initial

Recurrence

Excision X 3
Excision biopsy Radical
mastectomy

Pushing

3

2

Excision X 3
4 X 3 X 1.5 Excision biopsy Simple
mastectomy

Pushing

1

4

Excision X 1
11 X 7 X 6 Excision biopsy Radical
mastectomy

Infiltrating

5------------- > 7

-> 3

2 X 3 X 4

Excision X 1
Excision biopsy Simple
mastectomy

Pushing

2

14

4X2X1

Excision X 1
Excision biopsy Radical
mastectomy

Infiltrating

1-----------------* • I

20

4X3X2

Excision X 1
Resection of
recurrence

Infiltrating

7

C o r r e l a t io n o f P a th o lo g ic a l
F e a tu r e s W it h S u rv iv a l D ata

Various pathological features such as
contour of tumour, cellular atypism and
mitotic activity were correlated with the
clinical course of the tumour. Although
the number in this series is too small to
be statistically significant, it soon became
apparent that increasing prominence of the
following features—infiltration, high degree
of nuclear atypism, or mitotic activity, in
dicated a poor prognosis. This relationship,
demonstrated in Table III, parallels the
results obtained by Norris and Taylor4 in
their analysis of 94 cases.
One of our patients demonstrates the as
sociation of pathological changes and
prognosis clearly.
Mrs. S.S. (Case 2, Table I), a 36-year-old
woman, was first admitted to the surgical
service at Vancouver General Hospital in
September 1965. She had had biopsies of her
right breast in 1956, 1962 and 1964, the last
two of which were reported as “fibroadenomata of a cellular nature”. When seen in
1965, she gave a nine-month history of a
slowly enlarging mass in the right breast. She
had a firm mass in the outer lower quadrant
of the right breast, which was not fixed to
the chest wall. There were no palpable nodes
in the axilla or supraclavicular fossa. On ex

Initial

Recurrence

I

10

Simple
mastectomy

Recurrence

Nuclear atypism

-► 3

I ---------- ► I I I

I I ---------- > II

I---------- * II

I---------- > I I I

III

cision biopsy the mass was 4 x 3 x 1.5 cm.
and, after pathological examination, was de
scribed as a “cellular fibroadenoma”, but
“cystosarcoma phylloides” was offered as an
alternative diagnosis.
The patient returned again in June 1968
because she again had a slowly enlarging
mass in her right breast. The large lobular
mass was not fixed and we detected no nipple
discharge and no palpable lymph nodes. On
June 24, 1968, a simple mastectomy was per
formed.
Microscopically the 6-cm.
firm
pinkish-white nodular mass was described as
a cellular intracanalicular fibroadenoma (cystosarcoma phylloides). The patient was dis
charged on the fifth postoperative day.
Review of all her microscopic slides since
1962 clearly demonstrates the increasing ag
gressiveness of this slowly growing tumour.

Year

Margin
contour

N uclear
atypism

M itotic
activity

1962
1964
1965
1968

Pushing
Pushing
Pushing
Pushing

Class
Class
Class
Class

Grade
Grade
Grade
Grade

I
I
II
III

1
1
3
3

T h era py

Initially these 20 patients were treated
by various means—chiefly simple mastec
tomy, radical mastectomy and simple ex
cision.
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Table III summarizes the frequency of
local recurrence of these cellular intracanalicular fibroadenomas. The lesion re
curred in six patients (30%). Five of the
six were treated by excision only and in
four of these five the recurrent tumour
showed evidence of an increasing aggres
siveness when examined histologically.
Even a low-grade cystosarcoma phylloides
has a tendency to recur until it is com
pletely removed, as in Cases 2 and 10.
When cystosarcoma phylloides does
metastasize, it spreads like other sarcomas
by the blood stream, chiefly to the lung5
as in the following case.

Vol. 14

completely removed. When they do meta
stasize, they spread by the blood stream
chiefly to the lung. Generally in our series,
the survivors were younger women with
lower grades of mitotic activity. Simple
mastectomy was the treatment of choice.
In Norris and Taylor’s series only three
of 94 tumours went to axillary lymph
nodes and of these, only one was proved
histologically. In our series of 20 cysto
sarcoma phylloides, none spread to lymph
nodes; however, they did spread locally
and deeply. Our experience suggests that
the treatment of choice is an adequate
simple mastectomy, i.e. complete removal
of breast tissue with or without a skin graft.
In evaluating the possibility of metastases,
the most important histologic feature is
the mitotic activity. Other studies of softtissue fibrosarcomas and uterine smoothmuscle tumours also have demonstrated a
direct relationship between mitotic activity
and metastases.

Mrs. A.B. (Case 20), a 77-year-old woman,
was admitted to the Vancouver General Hos
pital in May 1957, because of a swelling in
the left breast of several months’ duration.
The breast was enlarged by a diffuse mass
that showed no fixation, ulceration or nipple
discharge. On May 2, 1957, after a left simple
mastectomy, pathological examination re
vealed a cellular intracanalicular fibroadenoma
Sum m ary
(cystosarcoma phylloides), a scirrhous adeno
carcinoma and evidence of metastases of the
Twenty patients with cellular intra
adenocarcinoma to three lymph nodes in the canalicular fibroadenoma (cystosarcoma
axillary tail of Spence. After postoperative
irradiation she was discharged on June 7, phylloides) were seen at the Vancouver
1957, on her thirty-sixth postoperative day. General Hospital and at the British
By November 1959, chest films revealed wide Columbia Cancer Institute over a 13-year
spread metastatic lesions in both lung fields period from 1954 to 1966.
suggestive of sarcoma. She died on November
All tumours were graded histologically
28, 1959, three weeks after her final admis on the basis of contour, cellular atypism
sion and 30 months after her original opera and mitotic activity, and the results of this
tion.
assessment were compared to the patient’s
At autopsy, both lungs contained extensive clinical course. These features—contour,
metastases that varied in consistency from soft
atypia and mitotic activity—have prog
and fleshy to hard and bony. She also had
nostic
value because they indicate the tu
metastases over the pleural surface, dia
phragm, peritoneum, liver and in the left mour’s potential to metastasize.
All cellular intracanalicular fibroade
humerus. On histologic examination these
metastatic deposits were cystosarcoma phyl nomas should be treated as sarcomas of
loides. We found no evidence of the previ varying degrees of malignancy. The best
ously reported mammary adenocarcinoma.
initial therapy of these patients appears to
D isc u ssio n

Our small series of 20 tumours demon
strates that cystosarcoma phylloides is too
variable to classify on the basis of one
histologic feature alone. However, the cri
teria described in this paper permit us to
make some prediction of this tumour’s
tendency to metastasize. All are malignant
to some degree and hence will recur unless

be simple mastectomy with or without skin
grafting.
The authors wish to express their thanks to
Dr. F. R. C. Johnstone for his interest which en
couraged this study.
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R esum e
Nous avons etudie, chez 2 0 femmes souffrant
de cette tumeur, les constatations cliniques et
pathologiques dans le but de tenter d’etablir un
lien entre les constatations pathologiques et le
comportement clinique. L ’age moyen de nos
malades etait de 56 ans et le symptome principal
etait une “bosse” dans le sein affecte. L a fre
quence des recidives etait de 30%. Onze de nos
malades sont mortes, dont six de leur maladie, ce

PERIN EA L WOUND HEALING IN
U LC ERA TIVE C O LITIS
The perineal part of rectal excision has
changed little since abdominoperineal excision
for carcinoma of the rectum and terminal
portion of the pelvic colon was first per
formed in 1908. Initially, partial suture with
open drainage was done, but later (1926)
the perineum was packed. The authors, and
others, believe that defective healing of the
perineal wound is much more common after
radical operation for ulcerative colitis and
Crohn’s disease than after abdominoperineal
resection for cancer of the rectum. This paper
analyzes the results in 106 patients with ulcer
ative colitis to assess the factors, both sys
temic and local, which appear to influence
healing. The authors arbitrarily defined a
perineal sinus as a “perineal wound which has
remained unhealed for more than six months
after operation”. They noted that only 44%
were completely healed in less than six
months, and 7% were still not healed after two
years.
Age at the time of operation did not appear
to have a significant influence on healing time.
Women in whom packing had been used had
a significantly higher incidence of perineal
sinus. When the perineum was sutured, there
was no difference between men and women.
Healing was delayed in patients who pre
sented during the first attack of the disease,
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qui donne un taux de mortalite de 30% . Neuf
femmes sont encore vivantes, dont cinq ont
survecu au moms cinq ans a la premiere opera
tion.
Les conclusions de notre etude rejoignent celles
de Norris et Taylor (C a n c e r, decembre 1967)
notamment sur le fait qu’aucune caracteristique
pathologique n’est assez significative pour preciser
la nature agressive de ces tumeurs. II est cependant possible de se faire une idee de leur potentiel metastatique en leur appliquant divers criteres pathologiques.
L e traitement ideal est la mammectomie simple,
parce que la tumeur se propage principalement
par le courant sanguin. Nous n’avons decouvert
aucune metastase dans les ganglions lymphatiques.
Selon la gradation pathologique de la tumeur,
il peut etre nccessaire de pratiquer une mam
mectomie plus radicale.
Nous conseillons de proceder precocem ent a la
gradation pathologique de tous les cas de cystosarcome phyllode, de fagon a leur appliquer
d’emblee le traitement chirurgical convenable.

that is, within six months of the onset of their
symptoms. This study failed to confirm the
findings of others that a long history of the
disease increased the incidence of perineal
sinus.
Preoperative complications such as stricture,
pseudopolyps, or toxic dilatation, did not in
fluence the healing rate. In this series, pre
operative steroids did not, to any significant
extent, affect the incidence of sinus formation.
Sepsis in the perineal wound, seen as a frank
purulent discharge in the early postoperative
period, was associated with defective healing
and packing appeared to increase wound
sepsis. Local instillation of antibiotics did not
affect the occurrence of early postoperative
sepsis. Recently the perineum has been closed
with the use of suction drainage led out from
a sacral hollow via laterally placed stab in
cisions. This method is an improvement, but
40% of these wounds still failed to heal com
pletely within six months.
The recent use of an omental pedicle graft
to fill the dead space is technically easy and
may prove a valuable addition to perineal
suture. Wound healing differs in patients with
carcinoma (sinus formation is ra re ). After
ulcerative colitis, the inflammation may pre
dispose to defective wound healing. Further
research into the type of wound healing in
colitis and the diseases of this nature should
prove rewarding.—Jalan KN, Smith AN, Ruckley CV, et al: Perineal wound healing in ulcer
ative colitis. B rit J Surg 5 6: 757, 1969
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BONE AND SKELETAL BLOOD FLOW IN MAN MEASURED
BY A RADIOISOTOPIC METHOD0
SUN-SHIK SHIM, M.D., M.Sc., Ph.D., F.R.C.S.[C], F.A.C.S.,
S. MOKKHAVESA, M.D., C.M., G. D. McPHERSON, M.D., M.Sc., F.R.C.S.[C] and
J. F. SCHW EIGEL, M.D., F.R.C.S.fC], Vancouver, B.C.
A t present, no satisfactory method exists

for measuring the rate (volume/time) of
bone-blood flow. Consequently little is
known about the rates of individual bone
and skeletal blood flow in man. Several
groups of workers measured the rates of
bone-blood flow in animals by indirect
methods using radioisotopes such as 85Sr,
47Ca and 8GRb. Available data indicate that
blood flow of various bones in the rat,
rabbit and dog ranges between 5 and 20
c.c./min./lOO g. of wet bone. The entire
skeletal blood flow in these animals is
about 4% to 10% of the resting cardiac
output. Kane,1 Kelly2 and Shim3 recently
reviewed this subject.
This paper has two aims: (1) to describe
an indirect method of bone-blood-flow
measurement in man based on the bone
clearance from blood of a bone-seeking
radioisotope; and (2) to report the rates of
blood flow in various bones including the
cortical, cancellous, long and short tubular
bones in man. This appears to be the first
report of blood-flow measurement of many
bones in man.
T he Problem

Obviously, we cannot measure directly
the blood flow of any bone in man and
animals because this would require the
cannulation of a vessel, and any one bone
has many small arteries and veins. Al
though Shim and Patterson1 have used a
direct method in animals to evaluate rela
tive changes in blood flow of bone, it can
not be applied to many bones and it does
not give a measure of total blood flow in
any bone. The direct method is unsuitable
“From the Division of Orthopedic Surgery, Uni
versity of British Columbia and the Vancouver
General Hospital, Vancouver, B.C.
Presented at the Annual Meeting of the Royal
College of Physicians and Surgeons of Canada,
Montreal, Que., January 1970.
Supported by Medical Research Council of Can
ada Grant MA-2642.

because the cannulation of any vessel of a
bone requires considerable surgical mani
pulation in the surrounding soft tissues and
even then the blood flow through the cannulated vessel is only a small fraction of
the total blood flow of the bone because
many other vessels sustain the same bone.
The necessity of an indirect method of
bone-blood-flow measurement has been
realized for a long time. Edholm, Howarth
and McMichael5 in 1945 used venous oc
clusion plethysmography for this purpose.
In the light of our knowledge of plethys
mography and of the circulatory anatomy
and physiology of bone, it is hard to con
ceive that plethysmography could give re
liable bone-blood-flow measurement. Matumoto and Mizuno6 developed an indirect
method based on clearance of a radiopaque
dye; the dye is injected into bone and,
using a theoretical exponential correlative
curve, the clearance rate is converted to
blood flow.
A more generally applicable and reliable
indirect method must be developed if we
are to measure the total blood flow of
many individual bones in different species
under varying conditions. The method
must be based on sound principles, and
its validity, general applicability and use
fulness must be proved. Copp and Shim,7
and Shim, Copp and Patterson,8 described
such a method and applied it in a number
of studies.911 Their method is based on the
clearance of a circulating bone-seeking
radioisotope, e.g. 85Sr or 47Ca, and uses an
adaptation of the Fick principle originally
proposed by Frederickson, Honour and
Copp.12 Kelly,2 and Ray, Aouad and
Galante13 also studied this method.
White, Ter-Pogossian and Stein14 pro
posed another indirect method based on a
dilution principle using 51Cr-tagged red
blood cells. Van Dyke et al.15 showed that
blood flow of bones could be measured by
studying the uptake of radiofluorine with
a positron camera. More recently, Kane1
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proposed another indirect method based
on bone clearance of circulating 42K and
86Rb. All of these indirect methods using
radioisotopes have their advantages and
limitations. The major advantage all these
methods have is their general applicability
to many bones in animals, whereas they
are all impracticable in man because the
bone must be removed from the body to
measure the blood-flow rate. However,
these methods can be used in man when
a limb is amputated, a bone biopsied, or
an operation done on bone.
M aterial

and

M ethod

W e measured the blood flow of various
bones in the lower extremity in a 26-yearold man just before a high-thigh amputa
tion for osteogenic sarcoma of the distal
femoral metaphysis without any known
metastasis. Under general anesthesia, with
the patient in a supine position, two
readily inflatable tourniquets were applied
above and below the level of amputation
through the upper thigh. A branch of the
dorsalis pedis artery was cannulated with
a fine polyethylene tube to collect the
dripping blood continuously to determine
the average isotope concentration in the
arterial blood. Then, after a percutaneous
puncture in the femoral triangle, 100 /xc.
of radioactive strontium (85Sr) was slowly
injected over 1% minutes into the ipsilateral femoral artery. After five seconds
transit time was allowed, the dripping
arterial blood collection was begun. At the
end of three minutes the two tourniquets
were instantaneously inflated and the
blood collection was stopped. Then a highthigh amputation was done between the
two tourniquets and all bones below the
knee of the amputated limb were removed
and weighed, after the soft tissues were
completely removed.
The rates of blood flow of these bones
were calculated as follows: the collected
blood was mixed well and an average
radioactivity for 1 c.c. blood was measured
using a gamma scintillation counter.® The
background count of the open well was
70 counts/min. (cpm), and the standard
error of the count was 1%. The average
0Autowell II, Picker Nuclear, White Plains, N.Y.
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radioactivity of 1 c.c. blood with the back
ground count correction was 9728 cpm. By
Using the same equipment and open well,
radioactivity of each bone for the threeminute uptake was measured and this was
divided by three to give the one-minute
bone uptake of the isotope by each bone.
Finally, the rate of blood flow o f each
bone, as its 83Sr clearance, was calculated
by dividing the one-minute bone uptake
by the 1 c.c. arterial blood radioactivity. In
the calcaneus, for example, the one-minute
bone uptake was 16,926 cpm. Dividing this
by the 1 c.c. arterial blood radioactivity,
9728 cpm, gives the rate of blood flow of
the calcaneus as 1.74 c.c./m in.
TABLE I . — R

of B lood F l o w o f V a r io u s
B o n es in a M a n

a te s

Rale of blood flow
(c.c./min.)
Weight
(?•)

Bones
Patella
Tibia
Fibula
Calcaneus
Talus
Navicula
Cuboid
3 cuneiforms
Metatarsals:
First
Second
Third
Fourth
Fifth
Great toe
Other toes
TOTAL

Per bone

Per 100 g.
wet bone

35
516
125
120
65
20
25
35

2.44
12.33
1.75
1.74
1.00
0.44
0.58
0.92

6.97
2.47
1.32
1.40
1.54
2.20
2.32
2.63

43
30
30
26
25
15
20

1.28
0.74
0.48
0.37
0.42
1.03
1.90

2.98
2.44
1.58
1.50
1.68
6.87
5.45

1130

27.42

2.43
(Average)

R esults

The results are summarized in Tables I
and II. In Table I the rates of blood flow
of all bones in the limb below the knee,
including the patella, are shown in two
ways: that per minute per individual bone
weight, and that per minute per 100 g. wet
bone.
TABLE

II.— E s t im a t e d E n t i r e S k e l e t a l B l o o d
F low

Body weight of the man
Skeletal weight (15% of body weight)
Cardiac output
Rate of blood flow of bone (min./lOO g.)
Rate of skeletal blood flow per minute
As of cardiac output

65 kg.
9.75 kg.
5.0 1.
2.43 c.c.
237 c.c.
4.74%

Vol. 14

THE CANADIAN JOURNAL OF SURGERY

40

D iscussion

To date we have no satisfactory method
of measuring bone-blood flow in man and,
hence, have little information on the rates
of blood flow o f bones and skeleton. Sev
eral groups of workers have introduced in
direct methods of bone-blood-flow meas
urement in animals using radioisotopes,
and reported reliable and comparable data
on the blood flow of various bones. The
radioisotopic method for use in man, de
scribed in this study, which is a modifica
tion of a method described earlier by
Copp and Shim,7 and Shim, Copp and Pat
terson,8 is based on the bone clearance of
circulating
bone-seeking
radioisotopes.
Used in several studies of bone-blood-flow
rates in animals, this appears to be the
first description of its application in man.
Most bones have comparable rates of
blood flow—between 0.5 and 2.5 c.c./m in./
actual weight o f individual bone—except
the tibia, the largest and heaviest bone
studied, whose rate of blood flow was 12.33
c.c./min. for 516 g. Blood-flow rates calcu
lated on the basis of 100 g. bone are better
for comparison because the size and
weight o f bones vary greatly. In this way,
we found that, regardless of the size and
weight o f the bones, the flow rates are in
the range of 1.5 and 3.0 c.c./m in./100 g.
wet weight, except for the patella and
phalanges whose rates are between 5.5 and
7.0 c.c./m in./100 g.
The total weight of the bones in our
patient’s limb was 1130 g. and the total
blood flow in these bones was 27.42 c.c./
min. The rate of blood flow of the average
bone was 2.43 c.c./m in ./100 g. wet weight.
Taking the blood flow in 1130 g. bone as
27.42 c.c./m in., the skeletal weight as 9.75
kg. (1 5 % of the body weight—65 k g.) and
the cardiac output as 5 l./min., the rate
of blood flow o f the skeleton was estimated
as 237 c.c./m in. or about 4.7% of the
cardiac output (Table II).
In this study, the rates of blood flow of
various bones in man are quite comparable
to each other. However, the average rate,
2.43 c.c./m in ./100 g. bone, is somewhat
lower than the rates in the rat, rabbit and
dog measured by the same method and by
other methods. Frederickson, Honour and
Copp12 calculated that the blood flow in

the bones of the rat was 10 to 30 c.c./m in./
100 g. bone. The values obtained by Shim,
Copp and Patterson8 in 270 bones of 80
rabbits were 9.60 ± 3.28 c.c./m in./100 g.
bone, and the values in 46 bones in 10
dogs were 10.15 ± 4.12 c.c./min./100 g.
bone. The value obtained in the dog by
Ray, Aouad and Galante13 using a similar
method was about 5.0 c.c./min./lOO g.
bone, and by Weinman et al.16 in mature
dogs was 5.6 c.c., and in immature dogs
was 7.7 c.c./min./lOO g. bone. Kane1 ob
tained higher values in dogs, 16 c.c./m in./
100 g. bone, using a different isotopic
method.
Ray, Aouad and Galante13 and Copp
and Shim7 found that the bone extraction
rates of 85Sr and 47Ca (the efficiency with
which bone took up these isotopes from
blood passing through it) were 50% to
75% in the first five to 10-minute period.
With 86Rb and 42K, Kane1 observed ex
traction rates in the dog’s tibia as high as
95% in the first minute. These findings
indicate that the blood-flow rate measured
by the bone clearance of 85Sr or 47Ca
represents only 50% to 75% of the actual
blood-flow rate. Thus, if the values ob
tained by Ray, Aouad and Galante,13
Weinman et al.16 and Shim, Copp and
Patterson8 are corrected for the extraction
efficiency of bone, the values compare well
with those obtained by Kane.1
In this study the average rate of blood
flow of various bones in a young man was
2.43 c.c./min./lOO g. bone. Corrected for
the 85Sr extraction rate of 50% to 75%, the
true blood-flow rate would become 3.23
to 4.86 c.c./min./lOO g. bone.
When the estimated skeletal-blood-flow
rate of 237 c.c./min. or 4.7% of the resting
cardiac output is corrected for the 85Sr
extraction rates (7 5 % ), the actual bloodflow rate of the skeleton would be 6.25%
T A B LE III.— S k e l e t a l B lo o d F l o w E s t im a t e d
as

P e r c e n t a g e o p R e s t in g C a r d ia c O u t p u t

%
Rat
Rabbit
D og
Mature
Puppy
Man

Author

4.3
Van Dyke et <d.u
7.1 ± 2 .3 Shim, Copp and Patterson8
7 .3 ± 3 .0 Shim, Copp and Patterson8
3.5— 9.4 Ray, Aouad and Galante13
5.0— 7.0 Weinman et al.16
8.0— 10.0 Weinman et al.w)
4.7— 6.3 Shim et al. (this paper)
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of the resting cardiac output. As shown
in Table III, all values agree well with the
data obtained in the rat, rabbit and dog.

11.

Su m m a r y

A method of radioisotopic measurement
of blood flow of bones in man is described.
The method is based on the bone’s clear
ance of a bone-seeking isotope from blood.
The blood-flow rates of various human
bones (cortical and cancellous, and long
and short tubular bones) were measured.
This appears to be the first report of bloodflow measurement of many bones in man.
The total weight of all the bones below
the knee was 1130 g. and the total bloodflow rate in these bones was about 27.5
c.c./min. The rates of blood flow of various
individual bones were similar—an average
of 2.5 c.c./m in ./100 g. wet bone. The rate
of the blood flow of the entire skeleton
was estimated as about 250 c.c./m in.—
about 5% of the resting cardiac output.

12.

13.

14.

15.

16.

Clearance of Radiostrontium (Sr85), PhD
Thesis, University o f British Columbia,
1965, p 137
S h i m SS, C o pp DH, P a t t e r s o n FP: Measure
ment of rate and distribution o f nutrient
and other arterial blood supply in long
bones of rabbit; study o f relative contribu
tion o f three arterial systems. J Bone Joint
Surg [Brit] 50B: 178, 1968
F r e d e r ic k so n JM, H o n o u r AJ, C o p p D H :
Measurement o f initial bone clearance o f
Ca45 from blood in rat (abstract). F ed
Proc 14: 49, 1955
R a y RD , A o u a d R, G a l a n t e J: Isotopic
studies of circulatory dynamics o f bone, in
Neuviem e Congres International de Chirurgie Orthopedique, Symposiums e t Com 
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edited by B a i l l e u x A, Bruxelles, Imprimerie des Sciences, 1964, p 27
W h it e NB, T e r -P o g o s s ia n MM, S t e i n AH:
Method to determine rate o f blood flow in
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R esum e
Le present article decrit une methode de
mesure indirecte de la circulation sanguine dans
1’os et indique le debit ( volum e/tem ps) de la
circulation dans divers os chez Thomme ( os tubulaires, longs et courts, os spongieux, cortex). C e
rapport est, semble-t-il, le premier du genre sur
le sujet. La methode utilisee est basee sur l’epuration par le sang a partir de 1’os d’une substance
isotopique osteotrope ( “ S r). Elle a etc appliquee
a un jeune homme souffrant d’un sarcome osteogene et chez lequel on a mesure le debit circulatoire dans tous les os de la jarnbe, au moment de
l’amputation. A cet effet, on a introduit une sonde
en polyethylene dans l’artere pedieuse. On a place
deux tourniquets sur la cuisse, mais sans les
gonfler. On a injecte par ponction porcutanee
environ 100 microcuries de “ Sr dans l’artere
femorale homolaterale et on a recueilli le sang
de l’artere pedieuse pendant les trois premieres
minutes jusqu’au moment ou les deux tourniquets
ont etd instantanement gonflds. On a alors ampute
la cuisse entre les deux tourniquets. Tous les os,
sous forme de son operation en “ Sr, on a divise
la captation d’isotope de chaque os par la radio
activity ernise par 1 c.c. de sang de Tartere
pedieuse. Le debit circulatoire a etc a peu pres
semblable dans tous les os. le debit moyen ayant
etd evalue a 2.5 c.c./m in/lO O g d’os humide. On
a evalue a environ 250 c.c./m in le debit de la
circulation sanguine dans la totalite du squelette,
ce qui represente 5% du debit du coeur au repos
chez Thomme.
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RADIOGRAPHIC CONFIRMATION OF SITE OF CENTRAL VENOUS
PRESSURE CATHETERS*
MERVYN DEITEL, M.D., F.R.C.S.[C] and
J. A. McINTYRE, M.D., F.R.C.S.[C], F.A.C.S., Toronto, Out.
C e n t r a l venous pressure (CVP) is used
widely to monitor intravenous replacement
in shock states112 and in the elderly cardiac
patient.1317 In addition, a central vein
catheter is being used for long-term intra
venous hyperalimentation in nutritionally
depleted patients.18"24 In each of 245 con
secutive central venous catheter insertions
at St. Joseph’s Hospital, Toronto, a chest
radiograph was done to check the location
of the catheter tip. The study included all
surgical patients with central venous
catheters, and patients with these catheters
from all services in the intensive care and
shock unit. The catheters were inserted
by the various doctors on these services.
Most roentgenograms were done by port
able anteroposterior technique at the bed
side. In 71 radiographs (28.98%) the
catheter tip was found to be in an incorrect
location.
M a l p o sit io n s

Catheters Introduced Via Arm Veins
Fig. 1 shows the positions where cath
eters introduced via an arm vein most
commonly lodge. If the plastic catheter
has a slight curve, it may drive upwards
into one of the veins draining the neck,
and frequently passes into the ipsilateral
internal jugular vein (Fig. 2). When this
occurred in our series, the catheter was
partially withdrawn under sterile condi
tions, twisted slightly, and on reinsertion
passed readily into the superior vena
cava. This malposition could often be
prevented by turning the patient’s head
to the side on which the catheter was
being introduced; this caused the internal
“ From the Department of Surgery, St. Joseph’s
Hospital and the University of Toronto, Toronto,
Ont.
Supported by a grant from St. Joseph’s Hospital
Research Foundation and Abbott Laboratories
Ltd.
Reprint address: Dr. M. Deitel, St. Joseph’s Hos
pital, 30 The Queensway, Toronto, Ont.

Fig. 1.—Solid line shows the correct location
with the catheter tip in the superior vena cava.
Broken lines show the catheter lodged in the in
ternal or external jugular veins.
jugular vein to meet the subclavian vein
at an acute angle.
In one patient, a catheter that had been
introduced through the cephalic vein just
above the elbow entered and became
wedged in veins over the shoulder, an
terior and superior to the clavicle, where
it was palpable subcutaneously; this
catheter gave a falsely elevated reading.
Catheters introduced via the cephalic vein
in the arm could rarely be made to tra
verse the subclavian vein because the tip
abutted on the inferior wall of the sub
clavian vein.
In another patient the catheter kinked
back on itself (Fig. 3) giving a marked
and falsely elevated CVP. When the
catheter was withdrawn, slightly twisted
and reinserted, it readily passed to a satis
factory location.
In one patient the catheter lodged in the
right ventricle and gave a high manometer
reading. In three patients the catheter
curled up in the right atrium (Fig. 4), a
position that has produced cardiac
arrhythmias by contact stimulation in the
region of the tricuspid valve.25 These
catheters were withdrawn the proper dis
tance.
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Fig. 2b
Fig. 2.—The most common malposition, (a) Catheter high up in the neck, associated with an in
correctly elevated manometer reading, (b) Acute bend taken by a catheter (arrow points to the tip).
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Fig. .3 .— Catheter is kinked and has not entered thorax (see inset).

C atheters Introduced Via External
Jugular Vein
A catheter passed down the external
jugular vein frequently travels laterally
through the subclavian vein towards the
arm (Fig. 5). Whether this happens de
pends on the angle of entry of the external
jugular vein into the subclavian vein; this
is variable and is often in a lateral direc
tion. Hold-up here can often be corrected
or prevented by turning the patient’s head
to the sam e side as the catheter as it is

being repositioned. When the catheter in
troduced via the external jugular vein
enters the thorax, it must bend medially
(Fig. 6).
In Fig. 7, the catheter inserted into the
external jugular vein entered the trans
verse cervical or suprascapular vein
superior to the clavicle. The catheter may
occasionally kink back on itself (Fig. 8).
C atheters Introduced Via Subclavian
Puncture
When a catheter has been inserted via
percutaneous, subclavicular, subclavian
puncture, one would assume that the
catheter had passed down into the superior
vena cava. However, in this series, routine
films occasionally showed that the catheter
had entered the internal jugular vein and
had passed well up into the neck (Fig. 9).
If the catheter is carefully withdrawn,
slightly twisted, and reinserted under
sterile precautions, the tip may still pass
into the superior vena cava, especially if
the head is turned towards the same side
as the puncture. Pressure above the clavicle
while the catheter is being threaded in,
will inhibit its passage up into the neck.
Infrequently in this series the catheter
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Fig. 5a

Fig. 5b
Fig. 5.—(a) Catheters introduced into the external jugular vein frequently pass laterally to
wards the arm. (b) Catheter advancing dow n the external jugular vein may halt when the tip abuts
against the inferior rim o f the subclavian lumen.
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Fig. 6.—As the external jugular catheter enters the thorax, it bends medially-

had curled in the internal jugular vein
(Fig. 10) or innominate vein (Fig. 11).
When taking the radiograph after sub
clavian puncture, we abduct the arm,
thereby elevating the clavicle so that it
will not overlie and obscure the catheter
on the film (Fig. 12).
R esu lts

Table I summarizes our total experience.

D iscussion

Fig. 13 shows the venous system drain
ing into the upper thoracic area and the
many abnormal routes these catheters can
take.
The lumen of a catheter that is wedged
or kinked may close so that, when filled,
the manometer column does not fall to its
TABLE I.— C e n t r a l V e n o u s C a t h e t e r s :
R e s u l t s o f 245 I n s e r t io n s
Site of
introduction

No. of
insertions

Malpositions

Arm vein*...........
External
jugular vein........
Subclavian vein
puncture..............
Cephalic vein
cutdown§............

137

38f

28

14

79

19f

1

0

Total

245

71

‘ Includes seven introductions through the cephalic
vein, with only one successful.
fThe malposition occurred twice in four patients.
fOne patient had three malpositions after sub
clavian punctures.
§In the deltopectoral groove.
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Fig. 8.—Our routine radiograph showed the external jugular catheter kinked, entering a medial
branch (see inset).

proper level or fluctuate with respiration.
When the catheter enters small veins,
venous resistance, venospasm, the impe
dance of valves, or external pressure by

p

>

#■
#

skeletal muscle produces an incorrectly
high CVP. These pressures are often m ore
than tw ice the actual value and are as
sociated with lessened fluctuations with
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Fig. 10b
Fig. 10.—(a) Catheter curled. Hypaque (sodium diatrizoate) injection demonstrates the catheter
bulging the internal jugular vein, (b) Catheter looped in the internal jugular vein.

respiration. Such venous catheters are less
sensitive to changes in effective blood
volume and cardiac function.
To avoid thrombophlebitis in peripheral

veins, these abnormal positions must be
avoided when hypertonic, high-caloric
solutions of protein hydrolysates and sugar
are infused over a long period. In patients
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Fig. 12.—Abducting the arm during roentgenography will raise the clavicle off the catheter for
better detail. (Vertical opaque line is on a chest-tube.)
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Fig. 13.—Venous system draining into the upper thorax. (CVP catheter is inserted through the
basilic vein.)

Fig. 14.—Although blood had been aspirated through the syringe during introduction, routine
radiograph disclosed infusion entering the mediastinum.
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on intravenous hyperalimentation we have
used central vein catheters inserted via the
arm for 25 days or, more commonly, via
subclavian puncture for more than 30 days
at a time without complications.
In one patient who had a subclavian
puncture intended for infusion of hyper
tonic solutions, although blood had been
aspirated before the catheter was threaded
in, the radiograph disclosed the infusion
entering the mediastinum (Fig. 14). No
problem resulted because, until the radio
graph had been made, only normal saline
had been infused: the catheter was re
moved at once. The next day the width of
the mediastinum had returned to normal
on radiography. Serious respiratory com
plications due to infusion into the medi
astinum have been reported;20,27 these can
be avoided through a routine radiograph.
The literature on CVP catheters stresses
certain problems, such as venous throm
bosis (especially when the inferior vena
cava was used) with pulmonary em
bolism,28 phlebitis,29’ 30 septicemia,20,29 33
pneumothorax4, n - 16, 27, 32, 34 and atrial
perforation (if the catheter tip is below the
superior vena cava).27,35,36 To prevent
shearing and catheter embolus, the operator
must never withdraw a plastic catheter
when the needle is in the skin.4, 16,37,38
During prolonged use, rigid asepsis and
meticulous
maintenance
are manda
tory.18’20, 22,30, 31 Some have reported that,
in certain instances, central venous pres
sure is unreliable as a guide to fluid
therapy,30-41 but in some of these cases
the catheter tip may have been in an in
correct location.
To date, the frequent malpositions of
these catheters have not been adequately
stressed. In this study approximately 29%
of such catheters were positioned in
correctly. In the one similar series so far
reported, Gilday and Downs42 had similar
findings. We have attempted to point out
techniques that will prevent these mal
positions.
Many centres use radiolucent catheters.
Some pride themselves on the threading in
of sterile infant-feeding tubes, which may
not be radiopaque. Because we found that,
in 71 of the last 245 central venous
catheter insertions, the catheter tips had
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assumed abnormal positions, we recom
mend that: (1) radiopaque catheters be
employed, and (2) radiologic confirmation
of the catheter site be obtained whenever
possible, and the catheter be carefully re
positioned if necessary.
Summary

Central venous pressure is a valuable
guide for fluid replacement in shock and
cardiac patients. Of 245 central venous
catheter insertions, a routine radiograph
showed that the catheter tip was in
correctly located in 71 (29%). These mal
positions may be prevented or corrected.
Catheters that come to rest outside the
thorax can give incorrectly elevated and
misleading values and, when prolonged
hyperosmolar infusions are necessary for
nutrition, may induce phlebitis rapidly. It
is recommended that radiologic confirma
tion of the catheter site be obtained when
ever possible and that, if necessary, the
catheter be carefully repositioned.
For their assistance during this study, we wish
to thank the Department of Photography, St.
Joseph’s Hospital, Toronto, Mr. A. Sarson, Dr.
Wallace Roy and the Department of Radiology,
the nurses of the Intensive Care Unit, Dr. E.
Grundy, Sister Mary Fintan, Drs. Y. M. Bushan
and S. Jalil.
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R esume
L ’etude de la pression veineuse centrale est un
guide precieux de la serotherapie chez les
cardiaques ou les malades en etat de choc. Or,
des radiographies courantes ont montre que sur
245 introductions des sondes intraveineuses, le
bout du catheter etait mal place dans 71 cas
(soit 29% ). II est possible d’eviter ou de corriger
ces positions vicieuses. Des catheters qui viennent
a reposer en dehors du thorax peuvent donner
des lectures exagerement elevees ou fausses. Dans
les cas ou il faut donner longtemps des perfusions
hyperosmolaires, on risque de provoquer rapidement un phlebite. Les auteurs conseillent done de
verifier par radiographie la position exacte de la
sonde et, le cas echeant, de la remettre en bonne
position.
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COLITIS CYSTICA PROFUNDA

COLITIS CYSTICA PROFUNDA: A RARE LESION OF THE COLON*
S. E. O’BRIEN, M.D., F.R.C.S.[C], F.A.C.S., K. J. SHIER, M.D., F.C.A.P., C.R.C.P.[C]
and R. J. TUTTLE, M.D., F.R.C.P.[C], Hamilton, Ont.
C o l it is cystica profunda, a rare benign
lesion o f the large bow el, was first d e
scribed in the American literature in 1957
by Goodall and Sinclair.1 Only 36 cases
have been reported in the surgical litera
ture to date. The chief importance o f this
condition lies in its differentiation from
mucus-producing carcinoma of the colon,
which it mimics very closely.
The purpose of this paper is to report
an additional case and review the litera
ture on this most unusual condition.
C ase R e p o r t

A.C., a 65-year-old Italian, was admitted to
hospital on June 6, 1969. For approximately
six weeks he had been complaining of vague
abdominal discomfort associated with loose
bowel movements. He had also noticed small
amounts of blood and excessive mucus in his
stools. He denied weight loss. He had had
minimal pulmonary tuberculosis as a young
man and had been followed with regular chest
films since with no recurrence. He had had
no previous operations.
He was a stocky well-nourished elderly
man. Clinical examination of the head and
neck, chest and heart showed no abnormali
ties. His blood pressure was 160/85 mm. Hg.
The abdomen was not distended. There was
no tenderness and no mass could be palpated.
The liver and spleen were not palpable. There
were no hernias. Rectal examination was
negative.
Urinalysis was normal. His hemoglobin was
14.7 g./lOO ml. A barium enema revealed a
grossly redundant sigmoid colon with the apex
of the sigmoid loop located in the right upper
quadrant. There was a polypoid lesion in the
sigmoid loop 5 to 6 cm. long which presented
several small filling defects. There was no
evidence of obstruction. No other lesions were
noted in the colon.
With a preoperative diagnosis of carcinoma
of the sigmoid colon, a laparotomy was done
on June 12, 1969, through a right paramedian
incision. The sigmoid colon was markedly
redundant and the apex of the sigmoid loop
was in the right upper quadrant. At this point,
“From the Departments of Surgery, Pathology
and Radiology, St. Joseph’s Hospital, Hamilton,
Ont.

there was a well-defined lesion 10 to 12 cm.
long without evident obstruction. The in
volved segment was thickened and firm with
multiple small 1-cm. translucent cysts scat
tered throughout the serosa. The mesentery
was normal and there were no enlarged
mesenteric nodes. The liver was also grossly
normal.
A segmental resection of the sigmoid colon
was carried out with a two-layer end-to-end
anastomosis. The patient made an uneventful
recovery and was discharged on June 26,
1969.
The gross specimen consisted of a 19-cm.
section of large bowel containing a discrete
9-cm. segment which was abnormally thick
ened. The overlying mucosa was intact
throughout and irregularly bosselated. The
mucosal folds were swollen and in parts raised
by the submucosal collection of cysts measur
ing from 2 to 6 mm. in diameter. The cysts
replaced the entire submucosa and extended
into the muscularis propria. Their linings were
smooth, glistening and translucent. In several
areas the cysts penetrated the entire thickness
of the bowel wall into the serosa. The cyst
cavities were filled with clear viscid mucoid
fluid.
On microscopic examination, some of the
cysts appeared connected to the bowel lumen
by narrow-necked channels, and appeared as
intramural diverticula. These cysts retained
part of their epithelial linings. In most others
the lining was reduced to a single layer of
flattened cells which appeared compressed

T
Fig. I.—Low-power magnification of the wall of
the involved colon showing large cystic spaces in
the submucosa extending through the muscularis
almost to the serosa and com pletely replacing the
submucosa.
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and rendered atrophic by accum ulated mucus
(Fig. 1). Som e of the cysts contained histio
cytic foam cells and occasional multinucleated
giant cells.
Cysts that penetrated through the entire
w all form ed diverticulum-like outpouchings
with very thin and delicate walls. The latter
were com posed of two layers: the flattened
atrophic epithelium and peritoneum (Fig. 2).
Inflammatory changes in the surrounding un
involved m ucosa were scanty.

Fig. 2.—Higher-power view of large submucus
cyst extending through the serosa resembling a
typical colonic diverticulum. The cyst wall is
composed of two layers—a flattened atrophic epi
thelium and peritoneum.
D isc u ssio n

Mucous cysts of the colon were first de
scribed by Stark in 17662 after he encoun
tered two cases in seven autopsies
performed on patients with chronic dysen
tery. Virchow3 described this lesion in
1863 and gave it the name “colitis cystica
polyposa”. Subsequently several reports
mentioned colitis cystica profunda as a
sequel to bacillary dysentery, rather than
as a separate entity.
The basic pathological feature of this
disease is the mucous glands and cysts lying
deep to the muscularis mucosae. This
distribution distinguishes it from colitis
cystica superficialis in which multiple tiny
mucous cysts are scattered throughout the
colon but are confined to the mucosa. The
latter condition is said to be limited to
patients with pellagra and occasionally
sprue.
Colitis cystica profunda may present as
a single lesion usually in the rectum and
sigmoid, or as a diffuse process involving
the entire colon. The single lesion, which
seems to be considerably more common,
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is seen more frequently in young adults in
the fourth and fifth decades, and has no
specific sex incidence. The chief symptoms
are diarrhea with excess mucus and oc
casionally blood in the stool, abdominal
cramps, and tenesmus. The symptoms may
be present for a few weeks to several
years.
Physical findings are usually confined to
sigmoidoscopy. The lesion usually presents
as a polypoid or nodular structure varying
in size to a maximum of 3 cm. in diameter
and located in the submucosa. The overlying mucosa may be congested and ede
matous with occasional superficial ulcera
tion. Biopsy is frequently misinterpreted as
either chronic inflammation or mucusproducing carcinoma. Occasionally, un
necessary abdominal perineal excisions
have been carried out for this benign
lesion. The radiologic picture usually con
sists of single or multiple polypoid filling
defects in the colon, most commonly in the
rectum and sigmoid. The differential diag
nosis includes multiple polyposis, endo
metriosis, cystic pneumatosis, granuloma
tous colitis, mesenteric vascular occlusion
and carcinoma of the colon. In a few cases
this lesion has been reported in chronic
ulcerative colitis.
Grossly in this disease the involved
bowel is thickened and slightly nodular.
Excessive viscid mucus is present. Super
ficial ulceration of the overlying mucosa
and fibrosis of the submucosa surrounding
the cysts may occur. This fibrosis may
result in some degree of obstruction.
Microscopically, the mucosal cysts are
lined with columnar or cuboidal epi
thelium although in places the epithelium
may be flattened or even absent, leaving
collections of mucoid material free in the
submucosa. It is this mucoid material
which may give the false impression of
mucinous carcinoma. However, the ab
sence of atypical epithelial cells should
confirm the benign nature of the lesion.
Frequently, one may see downgrowths
of epithelium and mucus glands protrud
ing through defects in the muscularis
mucosae. There may be areas of ulceration
of the mucosa and frequently an inflam
matory infiltration of polymorphs, plasma
cells, and lymphocytes in the submucosa
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as well as fibrosis surrounding the glandu
lar structure.
Both congenital and acquired causes
have been proposed.4’ 5 Ectopic colonic epi
thelium has been discarded as an explana
tion because this phenomenon has not
been seen in a large series of children’s
autopsies. A congenital defect of the
muscularis mucosae, allowing submucus
extension of glandular elements, has also
been proposed as in diverticulosis. Finally,
some have postulated that colitis cystica
profunda represents a sequel to chronic
inflammatory processes. In the healing of
follicular abscesses, the down-growing epi
thelial tracts may penetrate the muscularis
mucosae, forming new glands in the sub
mucosa. Such lesions have been demon
strated histologically. Furthermore, sub
mucus glands are not infrequently seen in
association with chronic ulcerative colitis.
The treatment of choice is surgical ex
cision. If the benign nature of the lesion
is recognized, local excision may be carried
out. This is particularly important in the
rectal lesions where more radical excision
would require a permanent colostomy.
Lesions more proximally located in the
bowel can be treated, as in this patient,
by segmental resection.
Su m m a r y

A 65-year-old man had colitis cystica
profunda in a redundant sigmoid colon.
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This rare lesion has commonly been mis
interpreted as carcinoma. The pathology
and pathogenesis of this interesting condi
tion have been reviewed.
R efe r e n c e s

1. G o o d a l l HB, S in c l a ir IS: Colitis cystica
profunda. J Path B ad 73: 33, 1957
2. S t a r k W : Specimen Septem Historias et Dis-

sectiones D'^^ntericorum Exhibens, L eiden,
T H aak, 1766
3. V ir c h o w R: Die krankhaften Geschw iihte,
v 1, Berlin, A H irschw ald, 1863, p 243
4. E p s t e in SE, A s c a r i E Q , A b l o w RC, e t al:
Colitis cystica profunda. A m er J Clin Path
45: 186, 1966
5. W a y t e D M , H e l w i g EB: Colitis cystica p ro 
funda. Amer J Clin Path 48: 159, 1967

R esu m e
L a colitis cystica profunda est une lesion bcnigne, du reste rare, du colon. On ne trouve dans
la litterature q u e 36 cas publies. C hez le m alad e
qui fait l’o bjet du present article, une lesion de
cette nature siegeait sur le sigm olde et a p u etre
resequee avec succes. Ces lesions, qui sont
limitees au cdlon et au rectum , p e u v en t etre
simples ou multiples. Le m alaise h ab itu el est la
diarrhee, les selles contenant d u m ucus et du
sang. Au po in t de vue pathologique, la lesion se
compose de petits kystes m uqueux qui surgissent
dans la sous-muqueuse et s’ete n d e n t souvent vers
la sereuse. O n suppose que ces lesions sont
acquises et q u ’elles constituent des sequelles de
processus inflammatoires chroniques, survenus anterieurem ent dans la paroi intestinale. L e traiternent consiste a les exciser chirurgicalem ent. L e
degre de gravite de cette pathologie s’evalue p a r
sa differentiation de l’adenocarcinom e m ucineux,
dont la semeiologie est tres voisine.
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MICROANGIOGRAPHY IN EXPERIMENTAL
MYOCARDIAL INFARCTION*

•»

C. E. KINLEY, M.D., M.Sc., F.R.C.S.[C], F.A.C.S.f and
R. L. de C. H. SAUNDERS, M.D., F.R.S.E., F.R.S.A.,1 Halifax, N.S.

M yocardial infarction is the subject of
clinical and experimental research on a
widely expanding scale.1 The pathology of
the infarct itself has not received a great
deal of attention, although the basic histo
pathologic changes were described years
ago.2’ 3 We are now assessing alterations in

the pattern of the microcirculation after
acute coronary occlusion in dogs. The
microcirculation patterns are correlated
with the gross and histopathology in in
farcts of various ages. The purpose of this
study was to establish an experimental
model with which to compare infarcts pro-
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Fig. 1.—Microangiogram of a 2-mm.-thick cross-section of ventricles. Micropaque was injected
into the ADA. The arrow indicates a transmyocardial artery. VS = ventricular septum (original mag
nification X 2.5).

*From the Departments of Surgery and Anatomy,
Dalhousie University, Halifax, N.S.
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This work was supported in part by a grant-inaid from the Canadian Heart Foundation.
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duced in animals receiving various treat
ments for infarction.
E xperimental T echnique

Mongrel dogs are anesthetized with
thiopental (Pentothal), supplemented by
nitrous oxide and fluothane. The chest is
opened by a left fourth interspace incision.
The anterior descending coronary artery

r*
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Fig. 2.—The inferior surface of (log ventricles
with the coronary arteries injected. The arrow
indicates an intercoronary collateral on the left
ventricle near the apex (original magnification X
1.5).

A
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Fig. 4.—A front view of a heart with a 4-dayold infarct. The arrow indicates the right border
of the infarct, along the interventricular groove.

Fig. 4
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Fig. 3.—Microangiogram of a heart injected two hours after ligation of the ADA. Arrows indi
cate the borders of unfilled (ischemic) myocardium ( x 2).
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Fig. 5.—Histology of a 4-day-old infarct. The arrow indicates the posterior extent of the infarct,
in the ventricular septum (original magnification X 4).

(ADA) is tied off, just below the first major
branch passing to the left over the front
of the left ventricle; this site is distal to the
origin of the major septal artery.
Within a minute of ligation of the ADA,
the anterolateral surface of the left ventricle
assumes a deeply cyanotic hue. The area
of colour change is roughly pear-shaped;
its right border is the interventricular
groove and the left border, which is clearly
demarcated, runs several millimetres below
and parallel to the oblique branch of the
ADA proximal to the point of ligation. In
another few minutes the ischemic area
usually stops moving and may show some
degree of paradoxical systolic expansion.
The chest is either closed and the animal
studied again days or weeks later, or
microangiograms are prepared immedi
ately. For coronary injection a cannula
passed into the ascending aorta enters the
left coronary artery and is secured by a
ligature outside the artery. Intravenous
heparin is administered before eannulation.
Micropaque* is then injected at a pressure
not exceeding 150 mm. Hg. The heart is

cooled, removed, and fixed in formalin for
24 hours. The fixed specimen is sliced from
base to apex into 2-mm. sections, contact
microangiograms are made,4 and standard
histologic sections are prepared.

“A barium sulfate compound, supplied by
Damancy and Co. Ltd., Slough, Bucks., England.
The manufacturers emphasize that Micropaque is
not suitable for angiography in humans.

Fig. 6.—Microangiogram of a 2-mm.-thick crosssection of the ventricles in a 4-day-old infarct.
Arrows indicate the borders of unfilled ischemic
myocardium (original magnification X 2).

R e s u l t s o f A c u t e E x p e r im e n t

This acute experiment has been com
pleted in 60 dogs. The acute mortality of
ADA ligation at this level was 15%, similar
to other studies.5- 6 Fig. 1, a microangio-
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Fig. 8.—Microangiogram of the top section in
Fig. 7 showing that the microcirculation is not
filled in the area of the infarct (arrows), although
some injectant has entered the epicardial vessels
on the surface of the infarct (original magnifica
tion X 2).

Fig. 7.—Cross-sections of ventricles with a 2week-old infarct. The top section is taken from
near the apex, and the infarct occupies about
50% of the circumference of the left ventricle.

gram prepared after injection of the ADA
at the site chosen for ligation, shows that
this vessel supplies mainly the front wall
of the left ventricle and the adjacent an
terior one-third of the ventricular septum.
In addition, a fringe of anterior right
ventricle bordering the septum has filled
and, via connections with the posterior
descending artery, a portion of the
posterior wall of right ventricle has filled.

This figure also shows the distinctive
“transmyocardial” arteries passing verti
cally through the heart from epicardial to
endocardial surfaces. These arteries, which
are 200 to 300 n in diameter at their ori
gins, give off side branches at all levels of
their course, but significant collateral
communications between transmyocardial
arteries are not apparent. There are, how
ever, consistent grossly visible collateral
channels on the epicardial surface, be
tween branches of the ADA and branches
of the left circumflex coronary artery. Some
of these surface collaterals are shown in
Fig. 2, the smallest being about 100 n in
diameter.
In animals whose left coronary artery
was injected within two hours of ADA
ligation (Fig. 3), the anterior wall of the
left ventricle and adjacent portion of ven
tricular septum showed no microcircula
tion filling at the injection pressures used.
There is no filling despite the normal inter
coronary collateral channels on the heart
surface, connecting branches of the ADA
and the left circumflex coronary artery.
The lack of significant intramyocardial
collateral arteries, combined with the
functional inadequacy of the epicardial
collateral channels, results in a sharp de
marcation between injected and uninjected
microcirculation. This means that the
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Fig. 9.—Histology of a 2-week-old infarct shows muscle necrosis with a rim of leukocytes and
granulation tissue (arrows) (original magnification X 3.5).

acutely ischemic and cyanotic area seen
on the surface of the left ventricle in vivo,
reflects similar ischemia throughout the
ventricular wall underneath. Standard
histology of these acutely ischemic speci
mens in the first few hours shows no
visible alteration.
R esults in S xjbacute
E x p e r im e n t s

or

C h r o n ic

The surface appearance of a 4-day-old
infarct is shown in Fig. 4. The infarct is
pear-shaped, the narrow superior border
situated a small distance below the site of
ADA ligation. In vivo this area was
akinetic. On histologic examination (Fig. 5)
there was extensive muscle necrosis and a
surrounding border of neutrophil infiltra
tion. On microangiography (Fig. 6) the
microcirculation did not fill in the area of
infarction. Myocardial veins accompany
many arteries, and such venous filling was
found in all hearts that were not injected
immediately after ADA ligation.
Three sections from a heart with a 2week-old infarct are shown in Fig. 7. The

top section is near the apex, and the in
farct at that level occupies about 50% of
the circumference of the left ventricle. A
microangiogram of this section (Fig. 8)
shows that the swollen infarct area is not
filled by the Micropaque. Histologically
(Fig. 9) there is massive muscle necrosis
with a rim of leukocytes and granulation
tissue.
Fig. 10 shows a 3y2-week-old infarct in
cross-section. In vivo the anterior wall of
the left ventricle (arrow) was aneurysmal.
A microangiogram (Fig. 11) shows that the
microcirculation in the centre of the swol
len infarct area contains no Micropaque,
but vessels in the surrounding developing
granulation tissue have filled. Some col
lateral channels are visible in the septum.
The microangiogram in Fig. 12 shows
thinning of the anterior wall of the left
ventricle at the site of a 5 x/2-week-old
infarct. Note the transversely oriented col
lateral channels situated deep in the ven
tricular wall. The infarct was akinetic in
vivo.
Microangiograms of an 8-week-old in
farct are shown in Figs. 13 and 14. In Fig.
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Fig. I I .—Microangiograms of two sections from
a heart with a 3%-week-old infarct. The micro
circulation of the infarct area is unfilled, but ves
sels in the surrounding granulation tissue area are
well injected (original magnification X 2).
D isc u ssio n

L°____t!°,------ -------- L3. —
Millimetres
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_ _

Fig. 10.—Cross-sections of ventricles with a 3%week-old infarct (arrows).

13 note the tortuous vessels, tending to a
transverse arrangement in the infarct area.
Fig. 14 shows collateral channels appear
ing in the ventricular septum, particularly
in the anterior third.
In cross-sections of a 22-week-old infarct
(Fig. 15), arrows indicate scarring in the
anterior left ventricle and adjacent sep
tum. Histologic appearances are shown in
Fig. 16 and a microangiogram in Fig. 17.
The latter shows that the scarred infarct
area is relatively avascular and contains
numerous transversely oriented vessels,
supplied by tortuous collaterals at the
margins and outer surface of the infarct.

Research on myocardial infarction is
often hampered by unsatisfactory experi
mental models. To assess the effect of as
sisted circulation on acute infarction,
workers have used staining techniques to
quantitate reduction of infarct size in
treated animals, after only a few hours or
days of infarction.7 9
We have constructed a model of acute
myocardial ischemia which shows consis
tent changes in gross and microscopic
pathology,
and similarly predictable
changes in the structural pattern of the
microcirculation. The model allows objec
tive assessment of various treatment pro
grams, not only immediately after the
onset of ischemia, but also at subsequent
intervals of weeks or months.
We feel that the microangiograms pre
pared in the first hours after coronary
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Fig. 12.—Microangiogram of a cross-section of a ventricle with a 514-week-old infarct (arrow).
Note the transversely oriented collaterals in the infarct area (X 2.5).

occlusion are significant. The injectant has
a viscosity similar to blood. The mean in
jection pressure of 150 mm. Hg is higher

than that seen after acute coronary liga
tion. The absence of filling of the microcirculation in the infarct was seen in all

Fig. 13.—Microangiogram of a 2-mm.-thick cross-section of ventricles with an 8-week-old infarct.
Note the collaterals, tending to a transverse lie, in the area of the infarct (arrow) (X 2).
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Fig. 14.—Microangiogram of a heart with an 8-week-old infarct, at a higher level than Fig. 13.
Note the extensive development of collaterals in the ventricular septum (arrow) (original magnifica
tion X 2).

stages of this study and correlated well
with the areas of muscle necrosis histo
logically. We therefore assume that our
patterns of microcirculation, shown by in
jections at various stages of infarction,
reflect similar functional patterns of flow
in the areas of, and adjacent to, infarction.
Grossly visible collateral channels are
regularly seen on the epicardial surface of
the normal dog heart. However, in our ex
periments, these could not prevent exten
sive myocardial necrosis. Counterpulsation
may achieve improved myocardial per
formance by allowing effective perfusion
of these surface collateral channels.10 Simi
lar improvement has been noted in experi
mental infarction after the use of vaso
pressors.11
Intramyocardial collateral channels have
not been seen in the ventricles of normal
dog hearts including the subendocardial
area. There are communications between
adjacent transmyocardial arteries of 30 to
40 /x in size. Significant intramyocardial
collaterals, 100 to 150 ix in size, are ap
parent by two weeks, but by then myo
cardial necrosis has already occurred.
Sum m ary
Millimetres

Fig. 15.—Cross-sections from a heart with a 22week-old infarct. Arrows indicate scarring in the
anterior left ventricle and adjacent septum.

The authors have devised an experimen
tal model of myocardial infarction. The
model shows consistent correlation be-
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Fig. 16.—Histology of the infarct shown in Fig. 15. Scar tissue occupies the full thickness of
the ventricular wall (original magnification X 4.5).

tween alterations in angiographic patterns
of microcirculation and standard pathological preparations. It is expected that the

model will prove useful in assessing
various treatment methods for myocardial
infarction.

Fig. 17.—Microangiogram of a 2-mm.-thick cross-section of ventricles with a 22-week-old infarct
(arrows). The infarct area is relatively avascular, despite collateral vessels adjacent to the arrow on the
left (original magnification X 2).
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TRANSPOSITION O F TH E GREAT
A RTERIES
Transposition of the great arteries is one
of the commonest forms of congenital heart
disease and, unfortunately, is one of the most
lethal. Initial palliation achieved by Rashkind’s balloon septostomy, followed later by
total surgical correction by atrial septopexy.
has stimulated interest anew.
Twelve patients were seen since December
1967. Their age ranged from 1 day to 20
months—10 patients were less than 6 weeks
of age when first seen. Seven patients had
associated defects including ventricular septal
defect alone in three, patent ductus arteriosus
in three, and both ventricular septal defect
and patent ductus arteriosus in one. The re
maining five patients had no associated defects
other than the essential atrial shunt.
Cardiac catheterization was performed
under local anesthesia through a femoral vein,
and balloon atrial septostomy was performed
at the conclusion in nine patients. Five pa
tients died. Of these, two were moribund
when first examined. No deaths or serious
complications were attributed to the balloon
septostomy, although in four of nine patients
the results were unsatisfactory. In three of
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R esu m e
Les auteurs ont congu un modele experimental
d’infarctus du myocarde. Ce modele a permis aux
auteurs de mettre en evidence une etroite corre
lation entre les modifications des traces angiographiques de la microcirculation et les prepara
tions pathologiques classiques. Les auteurs estiment que ce modele pourra etre utile pour
evaluer diverses methodes therapeutiques de l’infarctus du myocarde.

these four, the balloon septostomy was re
peated after three to four weeks because of
the unsatisfactory initial result, but no further
significant improvement was achieved. Two of
these patients were then treated by a BlalockHanlon atrial septectomy. One had moderate
improvement but died at home three months
later. The other had good results. T he third
child died after pulmonary banding.
For reasons not yet understood, pulmonary
vascular resistance rises in these patients at
an accelerated rate compared with similar size
ventricular septal defects, but with normally
placed arteries. Three of four patients with
ventricular septal defect had high pulmonary
vascular resistance. In one patient, it was
equal to the systemic resistance when first
measured at 3 years of age. In two patients,
increases have been documented by serial
catheterizations between 18 and 34 months,
and between three and 13 months. Pulmonary
artery banding was successfully performed in
these instances. The authors perform pulmo
nary banding in all such patients as early as
possible to protect the pulmonary vascular
bed, so that total repair may b e subsequently
performed.—McCredie RM, W right JS: Man
agement of transposition of great arteries.
M ed J Aust 1: 202, 1970
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EM ERGENCY TRANSUMBILICAL PORTAL DECOMPRESSION FOR
BLEEDIN G ESOPHAGEAL VARICES*
YVAN J. SILVA, M.D., F.R.C.S.fC], F.A.C.S. and
ALEXANDER J. WALT, M.D., F.R.C.S.fC], F.A.C.S., Detroit, Mich., U.S.A.

M assive hemorrhage from esophageal
varices in patients with cirrhosis of the
liver presents several frustrating problems
in control and management. The North
American literature over the past 20 years
indicates that only one in three cirrhotic
patients hospitalized with their first epi
sode of bleeding leaves the hospital alive.1
Control of hemorrhage is usually accom
plished by balloon tamponade and man
agement includes treatment of hypo
volemia, correction of electrolyte and
acid-base imbalance and prevention of
liver failure by catharsis, protein restric
tion and control of ammonia production
by bacteria in the alimentary tract using
antibiotics. Pitressin has been used to
lower portal pressure but has little benefi
cial effect.2 The surgeon may intervene by
directly oversewing or resecting the
varices, constructing a portosystemic shunt,
or by cannulating the thoracic duct to
decompress indirectly the portal venous
system but, in the face of deteriorating
liver function, results are poor.
In recent years at the Detroit General
Hospital, using both conservative and
operative approaches, the mortality rate in
these patients has been greater than 70%.
Balloon tamponade has been used rou
tinely to control bleeding, but complica
tions such as gastroesophageal ulceration,
esophageal perforation, atelectasis, pneu
monia and massive aspiration occasionally
follow its use. Any method of portal de
compression that will buy time and allow
liver function to recover before major
surgery is worth exploring.
“From the Robert S. Marx Surgical Laboratories
and the Department of Surgery, Wayne State
University School of Medicine, Detroit, Mich.
Presented at the Annual Meeting of the Royal
College of Physicians and Surgeons of Canada,
Montreal, Que., January 24, 1970.
Supported by a grant from the Detroit General
Hospital Research Corporation.
Reprint address: Dr. Y. J. Silva, 1400 Chrysler
Freeway, Detroit, Mich. 48207.

Since umbilical vein cannulation in the
adult was described in 19593 this method
of gaining access to the portal venous
system has become well established.* Since
1966 several authors5'7 have described
portal decompression by umbilicosystemic
shunting. We use an extracorporeal Silas
tic-tube shunt between the reopened um
bilical vein and the systemic circulation.
Before being used in patients, we tested
these shunts in laboratory animals to en
sure that they could produce adequate
portal decompression8 and, in 1969, re
ported its successful use in three patients.2
The objectives of the present study
were: (a) to assess the feasibility of using
a wide-bore extracorporeal umbilico
systemic shunt; (b) to observe its efficacy
in attaining and maintaining portal de
compression; (c) to determine the duration
of patency and occurrence of thrombosis;
and (d) to determine its value as an alter
native to balloon tamponade in the
primary control of variceal hemorrhage.
T he Shunt

The shunt, made of Silastic tubing with
an incorporated side-arm, is fabricated to
our specifications.® The umbilical limb has
a flange at its tip and the systemic limb
has an impregnated barium-sulfate radio
paque marker at its distal end. The shunt
is approximately 36 inches long—the um
bilical limb is six inches and the systemic
limb 30 inches (Fig. 1). It is available in
two sizes: large—OD 7.5 mm. (0.295 inches)
and ID 4.8 mm. (0.188 inches), and small—
OD 6.4 mm. (0.250 inches) and ID 4.3 mm.
(0.170 inches).
M aterial

and

M ethod

We selected nine patients who had
severe hepatic decompensation and had
recently had massive variceal hemorrhage.
“Aid to Medical Research, Dow Corning Corpora
tion, Midland, Mich.
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Fig. I.—Extracorporeal umbilicosystemic shunt:
the flange-tipped umbilical limb is six inches long;
the systemic limb, with a radiopaque marker tip,
is 30 inches long; at the point marking the divi
sion between the two limbs, a side-arm is in
corporated.

Diagnosis was confirmed by the onset and
type of bleeding, stigmas of liver failure,
barium swallow and/or esophagoscopy,
control of bleeding by balloon tamponade
and portal pressure greater than 30 cm.
H20 demonstrated at umbilical vein cannulation. In all patients, portal cirrhosis
was confirmed by liver biopsy at the time
of operation. After the insertion of a
Sengstaken-Blakemore tube, ice-saline gas
tric lavage and correction of hypovolemia,
the patients were taken to the operating
room and the umbilical vein was cannulated using an extraperitoneal tech
nique.9 The umbilicoportal junction was
dilated to 7 or 8 mm. with Bakes’ dilators
and a No. 14 F. polyethylene catheter in
serted into the left portal vein to measure
pressure (zero point mid-axillary line).
After portal hypertension was confirmed,
the umbilical limb of the shunt was in
serted in the umbilical vein and the flange
impacted in the left portal vein. The shunt
was filled with heparinized Ringer’s solu
tion (10 mg. heparin/1000 c.c.) and, under
T A B L E I.— R e s u l t s

N am e

—J

A.J.
C.H.
C.B.
J.McC.
F.J.
J.B.
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local anesthesia, the skin over the right
groin was incised and the saphenofemoral
junction identified. The junction was dilated
with Bakes’ dilators to 6 or 7 mm., the
systemic limb of the shunt introduced into
the inferior vena cava through an incision
in the saphenous vein and threaded up so
that the tip was in the supradiaphragmatic
vena cava; this was confirmed by fluoro
scopy.3 A three-way stopcock attached to
the side-arm was used (a) to monitor
pressures intermittently and (b ) for con
tinuous infusion of heparinized Ringer’s
solution at the rate of 25 c.c./hr. through
a Harvard peristaltic pump.
Thirty minutes after the shunt was
established the gastric and esophageal bal
loons were deflated. Further bleeding was
monitored by irrigation of the stomach
with ice-saline. Every two to four hours
the systemic limb was clamped and the
portal pressure was measured with the tip
of the side-arm at the mid-axillary line.
The portosystemic shunt pressure at the
level of the side-arm was recorded inter
mittently. Side portal flow was measured
by clamping the systemic limb and bleed
ing the side-arm into a cylinder, the tip of
the side-arm being elevated to the height
of the central venous pressure to compen
sate for the resistance offered by this pres
sure. This flow was measured every 12
hours and the blood thus acquired was
submitted for laboratory examination of
various biochemical and coagulation para
meters.
R esults

We could not insert the shunt in three
of the nine patients for technical reasons.
Six patients were decompressed immedi
ately; their portal pressures ranged from 35
to 90 cm. H 20 and the shunt pressures
from 10 to 47 cm. HaO (Table I). Bleeding

U m bilico sy stem ic S h u n t in g

in

VARICES

S ix P a t ie n t s W it h B l e e d in g E s o p h a g e a l

Sex

Age
(years)

Portal pressure
(cm. H , 0 )

Im m ediate shunt
pressure
(cm. H ,0 )

F low
(c .c ./m in .)

M
F
M
M
M
M

50
41
48
38
40
56

90
35
48
40
37
51

47
20
36
22
10
30

80
110
120
108
100
600
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PT: CB a 48 yrs.
Cirrhosis of liver

Fig.
shunting.

2.—Hemodynamic profile during 23 days of extracorporeal umbilicosystemic

stopped two to seven hours after the shunt
was inserted and the shunts were left in
place from one to 23 days.
Of the six shunts, one had to be re
moved within 36 hours because of clotting
attributed to portal thrombosis. In this
patient an umbilical vein catheter had
been left in place for seven days before
the shunt was set up. The catheter was in
serted initially to measure portal pressure
and was left in place in anticipation of re
current bleeding. When this did occur on
the seventh day, we introduced the shunt
but flow ceased after 36 hours. At autopsy
this patient had portal vein thrombosis.
The other five patients had no clotting
and, in four, the shunts were removed at
time of death, one, four, nine and 12 days
after insertion. The sixth patient in whom
the shunt was maintained for 23 days, was
discharged because he refused definitive
shunt surgery. This 48-year-old white man
was admitted with a second episode of
massive bleeding from esophageal varices.

His portal pressure was 48 cm. H20 when
the shunt was set up; the portosystemic
shunt pressure on the first day was 35 cm.
H20 and decreased on continued shunting.
His portal pressure showed a steady de
cline over the 23 days (Fig. 2). On the
eighteenth day during transfer to an x-ray
table, he suddenly bled from his varices
during a Valsalva maneuver. At that time,
the systemic limb was clamped and we
found that the portal pressure was greater
than 100 cm. H20 . Shunting was reinsti
tuted immediately and bleeding stopped
within 30 minutes. Nine months later he
was readmitted after another bout of
bleeding for definitive shunt surgery and,
at operation, had portal vein thrombosis.
In one of these patients, a 41-year-old
woman, the umbilical vein was cannulated
three times on separate hospital admis
sions; first, during the investigation of
upper gastrointestinal bleeding; second,
approximately three months later, during
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Fig. 3.—Portal pressure profile in a patient (A.J.)
who died of hepatic failure nine days after shunt
ing was begun.

an episode of bleeding which subsided
spontaneously; and, finally, nine months
later to insert an umbilicosystemic shunt
which functioned for four days before she
died from hepatic failure.
In one patient we could not establish
a shunt because of a technical failure, but
he is included in this report because of an
important observation. During dissection
we noted that the umbilical vein contained
blood; this was confirmed by venotomy.
During dilatation, the umbilicoportal junc
tion could not be entered and a false pas
sage was created. We opened the peri
toneum and found approximately 500 c.c.
of blood. This blood had accumulated from
back bleeding from the left portal vein
into the peritoneum and then had escaped
from a rent in the posterior wall of the
umbilical vein. The falciform ligament was
ligated at the hepatic hilus and the opera
tion was terminated.
D iscussion

Liebowitz10 believes that a precipitous
upheaval of circulatory dynamics within
the splanchnic and portal venous systems
initiates varix wall rupture. In all six pa
tients, true portal pressures were lowered
by shunting and, unless bleeding recurred,
remained at levels lower than those re
corded when bleeding began (Figs. 2 and
3).
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Shunt thrombosis remains a significant
problem in these patients. Primarily shunt
patency depends on the size and type of
tubing used, the pressure gradient between
the high portal pressure and the intrathoracic negative pressure in the supra
diaphragmatic vena cava, and also the
sucking action of the chest. While we can
not correlate the side portal flow in these
patients with the efficacy of decompres
sion or maintenance of patency, these
measurements are reproducible and can be
used for comparison, especially when
studying the action of drugs on the portal
system.2
If a surgeon is to use this method of
portal decompression he must first catheterize the umbilical vein. This may be
impossible with a small or friable umbilical
vein or if bosselations of cirrhotic liver
encroach upon the umbilicoportal junc
tion.9 Unless blood flows freely from the
left portal vein, catheter clotting results.
Previous catheterization of the umbilical
vein is not a contraindication and re
catheterization is frequently technically
easier because the lumen is easy to identify
and reopen. In one of these patients (C.H.)
the umbilical vein was reopened three
times. Furthermore, this method of portal
decompression lends itself well to the
study of portal hemodynamics.2
Summary

Six patients had extracorporeal umbilico
systemic portal decompression using a
Silastic tube with an incorporated sidearm. These patients had effective decom
pression lasting one to 23 days; esophageal
bleeding stopped two to seven hours after
insertion of the shunts. The portal vein
thrombosed in two patients in whom the
umbilical vein had been catheterized for
eight and 23 days.
We recommend this method for selected
patients in whom the procedure is techni
cally feasible, either as an alternative to
balloon tamponade or to assess temporary
portal decompression during preparation
for emergency or definitive shunt surgery.
Shunting should probably not be continued
longer than seven days because portal
thrombosis can occur.
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CANCER O F THORACIC ESOPHAGUS
AND CARDIA
Tlie authors explored 51 of 66 patients
reviewed between 1959 and 1966.
Major resection was performed in 37 (75%).
The overall operative mortality rate was 40%
and the five-year survival rate was 10%.
Laparotomy was performed first to exclude
intra-abdominal metastases. The chest was
then opened, and the lesion was resected if at
least 5 cm. of proximal clearance could be
obtained. Partial esophagectomy, total gastrec
tomy with splenectomy, and excision of the
tail of the pancreas were done in 15 patients:
10 had colonic replacement of their esophagus
and stomach, while five had a Roux-en-Y esophagojejunal anastomosis. Partial esophago(77%)
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R esu m e
Chez neuf cirrhotiques qui avaient ete choisis
parce qu’ils presentaient une hemorragie massive
et une decompensation hepatique, les auteurs ont
precede, sous anesthesie locale, a un catheterisme
ombilical extraperitoneal. Leur traitement a ete
couronne de succes chez six malades. Ils ont
utilise a cette fin un tube de Silastic de fort
calibre pourvu d’un embranchement lateral. L ’extremite a bout renfle du tube ombilical a ete
introduite dans la veine porte gauche et l’extremite de la portion du tube destine a la grande
circulation ( introduite par une incision de la veine
saphene) a ete mise place sous observation
fluoroscopique jusque dans la portion supradiaphragmatique de la veine cave inferieure. La
pression de la circulation porte, la pression dans
le shunt au niveau de la branche laterale et le
debit de la circulation porte derivee ont ete surveilles continuellement. Chez les six malades, on
a pu realiser une decompression efficace de la
pression porte qui est tombee de 35 a 90 cm de
HlO a des pressions de derivation variant de 10 a
47 cm de FLO. L ’hemorragie a ete enrayee dans
un delai variant de deux a sept heures apres la
creation des shunts: 1’arret de l’hemorragie a ete
confirme par lavage gastrique. Les derivations ont
fonctionne pendant une periode variant de un
jour a 23 jours. Le debit de la circulation porte
dans la derivation a ete de 80 a 600 c.c./mn.
Chez deux malades dont la veine ombilicale avait
ete sondee pendant une periode de huit a 23
jours, s’est developpee une thrombose porte.
Chez des malades ou cette methode peut etre
appliquee du point de vue technique, la deriva
tion ombilico-svstemique enraye temporairement
l’hemorragie. Cette methode constitue du reste
un excellent moyen d’etude de Themodvnamique
de la circulation porte. L ’intubation prolongee de
la veine ombilicale risque de se compliquer de
thrombose porte.

gastrectomy with an esophagogastric anas
tomosis was done in the remaining 22 patients.
Of the 10 patients with the colonic replace
ment after total esophagogastrectomy, six died
in the immediate postoperative period, and
three died within the first year. Death was
most commonly due to infarction of the inter
posed colon. One patient was alive and well
nine years after operation. Five patients lived
more than four years without late morbidity.
Three of four patients who were long-term
survivors had squamous carcinoma; one had
an adenocarcinoma of the gastric fundus. In
view of the results of the alternative methods
of treatment, the authors believe that an ag
gressive surgical approach is still justified.—
Wosornu JL , Fraser K: Carcinoma of thoracic
oesophagus and cardia. Brit J Surg 57: 42.
1970
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PATHOLOGIC CHANGES WITH INTERVERTEBRAL
JOINT ROTATIONAL INSTABILITY IN THE RABBIT0
JAMES D. SULLIVAN, M.D., C.M., F.R.C.S.JC],
H. F. FARFAN, M.D., C.M., F.R.C.S.fC] and DAVID S. KAHN, M.D., Montreal, Que.

I n the whole intervertebral joint in the
rabbit we studied the pathologic changes
that accompany the instability created by
removing a single posterior facet process.
Since the studies of Schmorl1 in 1927,
disc degeneration has been attributed to
vertical compression forces acting on an
incompressible nucleus pulposus.2'7 This
force transmitted to the annulus fibrosus,
ruptures it and allows nuclear material to
escape through the rent in the annulus.
This theory, however, is inconsistent with
certain facts about the physical properties
of the intervertebral disc. In degenerated
discs, the nucleus itself is not less com
pressible than the annulus8'10 especially
when the nucleus is fibrotic1, 9 or if it is
calcified5 or contains air.2’ 11 The central
portion of the vertebral plate is permeable
and tissue fluid moves easily in and out of
the nucleus, as can be demonstrated in
discograms,12-14 and under mechanical
stress.15 The vertebral end-plate is
strengthened for the sake of the annulus
rather than the nucleus; the greater bulk
of the disc is annulus and its weight-bear
ing capacity cannot be ignored.12'14’ 16
Finally, the compression strength of the
intervertebral disc is more than twice that
of the vertebral body.17 These facts sug
gest strongly that, in degenerated discs,
the nucleus pulposus does not act as an
incompressible body, and hence Schmorl’s
theory cannot account for disc protrusion.
Neither can compression force alone ex
plain the damage seen in disc degenera
tion.
Studying cadaver spines subjected to a
rotation force (torque), we demonstrated
that intact intervertebral joints could be
ruptured by a torque of 500 to 1000 in.lbs.18 Of this value, 40% of the torque was
attributable to the facet joints. Because
“From the Division of Orthopedic Surgery and
the Department of Pathology, St. Mary’s Hospital,
Montreal, Que.
Supported in part by Medical Research Council
of Canada Grant MA-2125.

the facet joint provided much of the rota
tional stability of the whole joint, we con
cluded that intervertebral joint instability
was related to improperly aligned facet
joints. Should one or the other of the facet
joints be improperly aligned (obliquely
placed), repetitive or sustained rotatory
force to that side could eventually rupture
the disc. This conclusion was supported by
our clinical study of back pain in which
we found that disc prolapse was associated
with facet joint asymmetry and sciatica.19
To test this hypothesis in the rabbit, we
created rotational instability by removing
a single facet process of the posterior
intervertebral facet joint complex and
studied the pathologic changes that de
veloped subsequently in the contralateral
facet joint and intervertebral disc.
M aterial

and

M ethods

We used 39 white male domestic im
mature rabbits averaging 2.5 kg. in weight.
Under general anesthesia, an incision was
made over the lower lumbar region ex
posing four intervertebral joint levels. The
paravertebral muscles were retracted. In
25 rabbits at each of the two middle joints
but on opposite sides, the inferior articular
facet process was resected with a small
bone-cutting forceps (Fig. 1). The exposed
joints above and below the joints with
partial facetectomy served as controls. The
fascia and skin were closed in separate
layers.
In 14 rabbits before closure and under
direct vision, we rotated the spine force
fully at the operated level to study the
healing process in the disc subjected to
rotation.
After they recovered from the anes
thesia, the rabbits were allowed full ac
tivity. All the animals used in the study
were fully ambulatory one week after
operation and showed no signs of neuro
logic deficit.
The rabbits were killed at intervals of
two weeks, one, two, four, six, nine and
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Fig. 2.—Discogram showing dye within the disc
at all four levels. The intervertebral joint is nar
rowed at the lower of the two operated levels
(arrow).

12 months. The segment of spine contain
ing the two operated joint levels and the
normal joints above and below was re
moved en b loc and cleared of muscle. The
intervertebral disc at each level was in
jected with contrast material (Lipiodol)
through a 25-gauge needle inserted anterolaterally into the disc. Radiographs in the
anteroposterior and lateral projections pro
vided discograms of the control vertebra
as well as the joints with partial facetec
tomy (Fig. 2).
The radiologic criteria for a degenerated
intervertebral disc were: (a) disc space
(height) of less than 1 mm. by direct
measurement (normal value 1 mm. to 1.4
mm.), or (b) acceptance of sufficient dye,

or (c) extravasation of dye into the epi
dural space (Fig. 3).
From each of the four discs, transverse
histologic sections were obtained at three
levels: (1) near the superior end-plate, (2)
mid-disc and (3) near the inferior endplate (Fig. 4). The sections were mounted
and stained with hematoxylin and eosin
(Fig. 5).
R adiologic D iscographic S tudies

D iscography
These studies were inconclusive. Gen
erally an unoperated rabbit disc accepted
less than 0.1 ml. of contrast (Lipiodol), in
sufficient to be visible on radiographs,
although, in 10 rabbits, apparently normal
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Fig. 4.—Levels for histologic sections at control
and operated levels.

Fig. 3.—Discogram showing intervertebral joint
narrowing at operated levels as compared to con
trol levels (arrows). Note the dye within the
epidural space.

discs accepted as much as 0.5 ml. How
ever, in rabbits killed between six and 12
months, the operated joints accepted more
dye than control joints and, in 10, the dye
escaped into the epidural space (Fig. 3).
Disc Narrowing
The unoperated lumbar discs had an
average height of 1.0 to 1.5 mm. Using the

Fig. 5.—Section taken at a control level to show
the normal appearance of the posterior facet
joints and intervertebral disc. Part of the outer
annulus on one side was lost in processing (origi
nal magnification X 40).
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Fig. 6a
Fig. 6b
Fig. 6.—(a) Radiograph showing fracture involving a vertebral end-plate, (b) Specimen cut
longitudinally through the lumbar spine of the rabbit seen in (a) killed at 12 months. The upper disc is
at an operated level and shows a fracture of the end-plate with an attempt at healing. The lower disc
is at a control level and shows an intact end-plate (original magnification X 40).

arbitrary lower limit of 1.0 mm., we found
that the vertical height of the disc in the
operated joints was reduced in 50% of the
rabbits at six months. In rabbits killed at
nine to 12 months, 74% of the operated
joints had narrowed discs (Fig. 3).
It is interesting to note that in rabbits
killed early 12% of control joints showed
observable disc narrowing; this figure in
creased to 46% in those killed at nine to
12 months.
One of the animals had a fracture of the
end-plate (Fig. 6). Three others had con
trast medium in the vertebral body, sug
gesting that the end-plates were fractured
or fissured (Fig. 7). The radiographs did
not show osteophyte formation or help us
to follow changes in the facet joints.

The 14 rabbits subjected to forced rota
tion of the spine at operation showed no
evidence of injury to bone. The radio
graphs of these rabbits were indistinguish
able from those of the remainder.
M icroscopic F indings

Disc
The earliest changes were seen in the
periannular areolar tissue at the postero
lateral angles of the disc and were particu
larly marked on the operated side. This
reaction did not seem to be due entirely to
the recent injury because it persisted and
even increased up to the time fibrous scar
formed.
Some of the rabbits killed at four
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tion in the vicinity of the extrusion. Never
theless, it is reasonable to conclude that
the annulus had been weakened—a con
clusion supported by the fact that one of
the protrusions occurred in a joint sub
jected to forced rotation in a rabbit killed
at two weeks. The other four rabbits (Nos.
7, 14, 15, and 23) were not subjected to
torsion and were sacrificed at nine and 12
months.
Other changes in the disc involved both
nucleus and annulus and, though not so
apparent in the first six months, are clearly
demonstrated in those killed at nine to 12
months. The posterior annulus thins in the
midline and the slightly rounded postero
lateral angle seems to bulge much more
prominently (Figs. 11 and 12).
The area occupied by the nucleus seems
to have increased and the nucleus appears
to be edematous and to have lost some of
its normal organization.
We observed peripheral circumferential
slits in the annulus particularly at the
posterolateral angle, although these may
be artefacts.
Facet Joints

1

jangi

Fig. 7.—Discogram showing contrast material
within a vertebral body which presumably en
tered through a fissured end-plate (arrows).

months showed fresh polymorph exudate
in the same location (Fig. 8) suggesting
that recent new injury may have occurred
to the annulus at this point.
One disc showed a small chondrophyte
at the posterolateral angles of the disc and
three rabbits killed at 12 months had wellformed small osteophytes there (Fig. 9).
In the 14 rabbits subjected to forced
rotation at operation, the changes in the
disc were identical in all respects with the
others.
Five rabbits had extruded nuclear mate
rial through the posterior annulus into the
epidural space (Fig. 10). In all of these we
believe the extrusion was a postmortem
accident because there was no tissue reac

The partial facetectomy healed in one of
several ways. At four months, these joints
showed either a fibrous non-union or a
complete bony ankylosis (Fig. 13). Rabbits
killed at two weeks, one month, and two
months showed abundant fibrous-tissue
proliferation.
In the first four months, the contralateral
facet joints showed no changes; the carti
lage maintained its normal thickness com
pared to controls above and below the site
of operation. In the two rabbits killed at
six months, and in later groups, the nonoperated facet joint showed signs of early
degeneration. At first there was fibrillation
followed by thinning of the articular carti
lage (Fig. 14). This progressed to almost
complete loss of articular cartilage with
eburnation of the underlying bone (Fig.
15).
D iscussio n

The changes observed in this study sug
gest that resection of one articular process
of one posterior facet at the intervertebral
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Fig. 8.—Focal acute inflammation with fibrin and polymorphs within the epidural space at an
operated level in a rabbit killed at four months (arrows) (original magnification X 80).

Fig. 10.—Annular and nuclear disc protrusion
Fig. 9.—Early posterolateral osteophyte forma into the epidural space and substance of the
tion at an operated level. Note Assuring of the spinal cord (arrows indicate tear and nuclear pro
trusion) (original magnification X 80).
posterior annulus (original magnification X 80).
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Fig. 11.—Annular thinning posteriorly and bulg
ing posterolaterally in a rabbit killed at 12
months. Note the nuclear disorganization, and
compare with Fig. 5 (original magnification X 40).

Fig. 12.—Section showing extreme posterolateral
bulging of the annulus with nuclear disorganiza
tion (original magnification X 40).

joint level altered the mechanics of the
whole joint and precipitated a progressive
change in the disc and also in the contra
lateral facet joint. The appearance of the

Fig. 13.—Bony ankylosis of one facet joint at
an operated level in a rabbit killed at four months
(original magnification X 40).

Fig. 14.—Fibrillation of the articular cartilage
of the non-resected facet joint at an operated
level (original magnification X 80).
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itself, it is apparent that the response of
the disc to direct injury does not resemble
natural disc degeneration. In these experi
mental joints, the periannular tissue reac
tion was related to injury to the annulus
and not to the operation on the facet joint.
One of the principal roles of the lumbar
posterior facet joints is to protect the disc
against rotational stresses. In this experi
ment, the facet joint instability probably
allowed abnormal rotation stresses to act
on the disc, producing the observed
changes. These changes resemble those
noted in humans at disc operation—a find
ing that corroborates our earlier work on
the effect of torque on whole intervertebral
joints in the cadaver and our clinical study
correlating disc prolapse and sciatica with
facet joint asymmetry.
Su m m a r y
Fig. 15.—Extensive degenerative changes of the
hyaline cartilage involving the contralateral facet
joint at an operated level (original magnification
X 80).

experimental joint is quite distinct from
that of the controls. The developing patho
logic processes are reflected in changes in
the radiologic appearances of the joints.
The facet joint changes observed here
are typical of advancing osteoarthritis and
resemble the changes described by other
authors6 in human facet joints. The patho
logic changes in the disc are less dramatic.
Although the experiment did not produce
disc degeneration in all respects typical of
that described in human lumbar joints,
several features in the experimental joints
at least suggest a similar degenerative
process.20 Thus, radiologic evidence of disc
thinning and fracturing of the end-plate
are both constant findings in human disc
degeneration. The spill of radiologic con
trast into the spinal theca is also typical
of disc degeneration with annular rupture.
In these intervertebral joints the annulus
seems to thin with eventual weakening.
These changes, although not dramatic, are
clearly discernible and increase with the
passage of time.
When these disc changes are compared
with those observed by workers21'25 who
made a direct surgical assault on the disc

In the rabbit a single posterior facet
process was removed to study the patho
logic changes so produced in the whole
intervertebral joint. The changes in the
disc and posterior facet joints at the
operated levels differed significantly from
those observed at control levels. The de
generative changes in the disc and
posterior facet joints were caused by an
indirect surgical assault on the disc and
were similar to the changes seen in human
disc disease. We believe that the main role
of the posterior facet joint is to protect the
disc against rotational stresses and that the
removal of one facet produces rotational
instability and subsequent degeneration of
the whole joint. These findings appear to
support this hypothesis and to corroborate
an earlier experimental and clinical work
on this subject.
R eferen ces

1. S c h m o k l G: Die pathologische Anatomie der
Wirbelsaule. Verb Dtsch Orthop Ges 21:
3, 1927
2. F e r n s t r o m U: Disco graphical study of rup
tured lumbar intervertebral discs. Acta
Chir Scand ( Suppl 2 5 8 ): 1, 1960
3. I n m a n VT, S a u n d er s JB : Anatomicophysiological aspects of injuries to intervertebral
disc. J Bone Joint Surg 29: 461, 1947
4. S hands AR, R a n e y RB, B r a sh ea r HR:
Handbook of Orthopaedic Surgery, sixth
ed, St Louis, The CV Mosby Company,
1963, p 348

January 1971

IN TERVERTEBRA L JOINT IN STABILITY

5. C a l v e J, G alla n d M: Sur une affection particuliere de la colonne vertebrate simulant
le mal de Pott ( calcification du nucleus
pulposus). / Radiol E lectr 6: 21, 1922
6. H a r r is RI, M a c n a b I: Structural changes in
lumbar intervertebral discs; their relation
ship to low back pain and sciatica. J Bone
Joint Surg [Brit] 36B: 304, 1954
7. N a y l o r A, S m a r e DL: Fluid content of
nucleus pulposus as factor in disk syn
drome: preliminary report. Brit M ed J 2:
975, 1953
8. V irg in W J: Experimental investigations into
physical properties of intervertebral disc.
J Bone Joint Surg [Brit] 33B: 607, 1951
9. D onohue W L: Pathology o f interverteb ral
disc. Amer J M ed Set 198: 419, 1939
10. S aund ers JB, I n m a n VT: Pathology of inter
vertebral disk. Arch Surg IC h ica g o ) 40:
389, 1940
11. G ersh o n -C o h en J :

12.

13.

14.

15.

16.

17.

P han tom nucleus pu lpo

sus. Amer J Roentgen 56: 43, 1946
C o v en t r y MB, G h o r m l e y RK, K er n o h a n
JW : Intervertebral disc: its microscopic
anatomy and pathology. Part I. Anatomy,
development and physiology. J Bone Joint
Surg 27: 105, 1945
C o v en t r y MB, G h o r m l e y R K , K ern o h a n
JW : Intervertebral disc: its microscopic
anatomy and pathology. Part II. Changes
in intervertebral disc concomitant with
age. Ibid, p 233
C o v en t r y MB, G h o r m l e y R K , K er n o h a n
JW : Intervertebral disc: its microscopic
anatomy and pathology. Part III. Patho
logical changes in intervertebral disc. Ibid,
p 460
F r ib e r g S: L ow back and sciatic pain caused
by intervertebral disc herniation. Anatomic
and clinical investigations. Acta Chir Scand
85 ( Suppl 6 4 ): 1, 1941
H ir sc h C, S c h a jo w ic z F : Studies on stru c
tural changes in lumbar annulus fibrosus.
Acta Orthop Scand 22: 184, 1953
I n k st e r RG: Osteology, in Cunningham’s
Textbook o f Anatomy, tenth ed, edited by
R o m a n es GJ, London, Oxford University
Press, 1964, p 75

79

18. F a r f a n H F , S u l l iv a n J D : Relation of facet
orientation to intervertebral disc failure.
Canad J Surg 10: 179, 1967
19. F a r f a n H F : Effects of torsion on interverte
bral joints. Canad J Surg 12: 336, 1969
20. R i t c h ie JH , F a h r n i W H: Age changes in
lumbar intervertebral discs. Canad ] Surg
13: 65, 1970
21. F i l i p p i A : La guarigione del disco intervertebrale dopo asportazione del nucleus pul
posus negli animali da esperimento. Chir
Organi M ov 20: 1, 1935
22. K ey ' JA, F o r d L T : Experimental interverte
bral disc lesions. J B one Joint Surg [Amer]
30A: 621, 1948
23. S m i t h JW , W a l m s l e y R: Experimental in
cision of intervertebral disc. J B on e Joint
Surg [Brit] 33B: 612, 1951
24. P e t t i t GD , editor: Intervertebral Disc Pro
trusion in Dog, New York, AppletonCentury-Crofts Inc, 1966, p 194
25. H a n s e n H J : Comparative views of pathology
of disk degeneration in animals. L a b Invest
8: 1242, 1959
R esu m e
Sur la colonne lombaire du lapin, nous avons
excise une seule facette articulaire posterieure en
vue detudier quelle en serait la repercussion sur
l’ensemble de l’articulation intervertebrale. Aux
niveaux operes, les changements constates sur le
disque et sur les facettes articulaires posterieures
differaient sensiblement de ceux qui s’observaient
sur des articulations-temoins. Les changements
degeneratifs ont ete causes par une agression
chirurgicale sur le disque (le disque lui-meme
n’etant pas touche). Ces changements etaient
semblables a ceux qui s’observent dans la maladie
discale chez 1’homme. Les auteurs estiment que
le role principal de la facette articulaire poste
rieure est de proteger le disque contre une in
stability rotative et d’eviter que l’ensemble de
l’articulation ne degenere. Les presentes constatations confirment cette vue et corroborent les
premiers travaux experimentaux et cliniques des
auteurs sur le sujet.
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SU CCESSFU L SKIN GRAFT ON REN AL ALLOGRAFT:
REPORT OF A CASE*
K. T. WU, M.D., F.R.C.S.[C], M. H. GAULT, M.D., M.Sc., F.A.C.P. and
L. D. MacLEAN, M.D., Ph.D., F.R.C.S.[C], M ontreal, Que.

W hen a transplanted kidney is placed in
the pelvic cavity, it is usually covered by
layers of fascia, subcutaneous tissue and
skin. An unusual case was recently ob
served at the Royal Victoria Hospital,
Montreal, in which a patients transplanted
kidney remained externally exposed for six
months and skin was successfully grafted
onto the exposed surface.

evidence of its rejection over a period of more
than six months, despite repeated evidences
of minor rejection of the renal allograft. A
plastic protective shield was designed and
used to cover and support the allograft. In
February 1970 the patient developed viral
hepatitis with jaundice, but this subsided dur
ing the next month.
In April 1970, four months after skin graft
ing, the transplanted kidney was well covered
with skin (Fig. 1). No sensation to pain or

C ase R eport
The patient, an 11-year-old girl, was first
admitted to the Royal Victoria Hospital in
December 1967 because of uremia. Dialysis
was instituted and she had a renal biopsy
which showed severe diffuse interstitial fibro
sis. In February 1969 she received a cadaver
renal allograft, but rejection during the fourth
week led to transplant nephrectomy and a
return to hemodialysis. She received a second
renal allograft in August 1969. The donor
was a 27-year-old man who had died of sub
arachnoid hemorrhage. Tissue typing showed
a B match, according to the criteria of Lee
et al.1 Prednisone and azathioprine, anti
lymphocyte globulin, and local irradiation
were used as immunosuppressive agents. The
transplant graft functioned well initially, but
a major rejection episode occurred six weeks
later, which responded to increased dosages of
prednisone. The kidney was explored in No
vember 1969 because of perinephric abscess
associated with ureteral obstruction. Frozen
section showed healthy cortical tissues with
out evidence of serious rejection and a
nephrostomy was performed. The grossly in
fected wound was left open and the large
transplanted kidney was thereby exposed ex
ternally. The renal function improved and the
exposed surface of the allograft continued to
ooze clear yellowish lymph-like material. Four
weeks after the kidney was exposed, a split
thickness skin graft obtained from the pa
tient’s right thigh was placed over the kidney.
Thereafter the oozing from the surface of the
renal allograft markedly diminished. The skin
graft was accepted and there has been no
"From the Transplant Service, Royal Victoria
Hospital, and the Department of Experimental
Surgery, McGill University, Montreal, Que.

Fig. 1.—Four months after transplantation, the
externally exposed renal allograft is well covered
with skin. A nephrostomy tube enters the upper
pole of the kidney.

touch was present over the skin graft. A
biopsy of kidney with overlying skin revealed
that the skin graft blended imperceptibly
with the kidney (Fig. 2). There was a thick
layer of connective tissue, with marked neo
vascularization between the dermal layer and
kidney cortex. The renal tissue showed fea
tures consistent with moderate cellular rejec
tion. Immunofluorescent studies of both skin
and renal grafts were done for immunoglobu
lins IgG, IgM and |8lG. No staining was seen
in the kidney or skin.
In April 1970 she was discharged from the
hospital with a nephrostomy tube in place.
D iscussion

The patient demonstrates that a trans
planted kidney can be exposed externally,
can maintain good function, and that the
recipient’s skin can be grafted successfully
onto this renal allograft.

January 1971

SKIN GRAFT ON RENAL ALLOGRAFT

81

Wheeler, Corson and Dammin2 have
grafted tissue slices from various organs
onto kidney cortex in isogeneic mice, but
have not grafted skin. The unique feature
in this patient—that there was no evidence
of alteration of the skin graft even though
there were episodes of minor rejection of
renal transplant—can be explained by the
fact that the immunologic properties of the
blood supplying the skin graft are not
significantly altered by its passage through
the renal allograft.
S um m ary

We have described an 11-year-old girl
whose skin was successfully grafted onto
an externally exposed cadaver renal allo
graft. No evidence of rejection of the skin
has been observed for more than six
months although she has had several epi
sodes of minor rejection of the trans
planted kidney.
Addendum

Follow-up examination in October 1970 re
vealed that the skin graft was still intact and
the exposed renal allograft was functioning.
Re f e r e n c e s

Fig. 2.—The recipient’s skin has been success
fully grafted onto the transplanted kidney ( x 30).

The indication for the skin graft in an
externally exposed kidney is not yet de
fined. In this patient, it was done to reduce
the amount of lymph drainage from the
denuded surface of the kidney and to close
the space between the kidney and the ab
dominal wall. Initially the kidney was held
in place only by the vascular pedicle,
ureter and dressings. Because of the possi
bility of distortion of the vessels and ob
struction of blood flow, especially if she
stood up, the patient was kept in bed for
approximately one month until it became
clear that adhesions between the kidney
and underlying tissue had developed.
When she was ambulatory, we designed a
plastic shield to conform with the shape
of the renal allograft and the abdominal
wall; this has been both effective and com
fortable.

1. L e e HM, H um e DM, V r e d e v o e D L, et al:
Serotyping for homotransplantation. IX.
Evaluation of leukocyte antigen matching
with clinical course and rejection types.
Transplantation 5 : 1040, 1967
2. W h e e l e r HB, C o r s o n JM, D a m m in G J:
Transplantation of tissue slices in mice.
Ann NY Acad Sci 129: 118, 1966

R esu m e
En aout 1969, une jeune fille de 11 ans
subissait sa deuxieme transplantation d’un rein de
cadavre, deux mois apres l’echec de la premiere.
Trois mois apres cette intervention, il fallut ex
plorer l’organe transplante, en raison de la per
foration du bassinet, de la formation d’un abces
perinephrique et de l’obstruction de l’uretere. Les
coupes congelees n’ayant revele aucun signe de
rejet, on proceda au drainage de l’abces, le rein
etant laisse en place et expose exterieurement,
puis on pratiqua une nephrostomie.
Un mois plus tard, on tentait une greffe cutanee
sur le rein transplante a partir de peau prelevee
chez le receveur. Une biopsie prise quatre mois
apres cette greffe montrait que la peau s’etait
unie imperceptiblement au rein transplante.
L ’autogreffe cutanee est restee saine pendant plus
de cinq mois, malgre plusieurs episodes de rejet
mineur de 1’homogreffe renale.
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an English summary and may, if the author
wishes, carry a more detailed summary in
French.

83

84

INSTRUCTIONS A NOS COLLABORATEURS

Vol. 14

LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concemant le Journal
devra porter la mention “Le journal eanadien de
chirurgie” et etre adressee a l’Editeur, Publica
tions de 1’A.M.C., 129 Adelaide Street West,
Toronto.
Le journal est publie a tous les deux mois. Le
prix de l’abonnement est de $15. par an ($7.50
par an pour les medecins qui sont residents en
chirurgie) et commence avec le numero de
janvier de chaque annee. Un exemplaire isole
coute $2.50 et est payable d’avance. (Nous
serions reconnaissants aux souscripteurs de vouloir bien ajouter a leur cheque le montant des
frais bancaires eventuels).
INSTRUCTIONS A NOS
COLLABO RATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap
ports cliniques etc. seront envoyes en deux
exemplaires, accompagnes d’une lettre deman
dant qu’on veuille bien considerer leur publica
tion dans L e journal eanadien de chirurgie. Us
ne seront acceptes qu’a la condition qu’ils
n’aient ete soumis qu’a notre Journal et qu’ils
ne soient pas reimprimes sans le consentement
expres de l’editeur et l’auteur. L ’acceptation
ou le refus des articles soumis releve du Conseil de la publication. Si la place est disponihle,
un nombre limite d’histoires cliniques pourront
etre publies. Les articles seront dactylographies
sur un seul cote d’un papier non ligne, a double
espace et avec une large marge. L ’auteur devra
toujours conserver une copie au papier carbone
du texte soumis. Tout article devra etre accompagne d’un resume. L ’orthographe sera
celle adoptee par le dictionnaire Larousse.
Quant a la terminologie scientifique, elle sera
basee sur le Dictionnaire des termes techniques
de medecine ou tout autre ouvrage de refe
rence serieux. Le Conseil de la publication se
reserve le droit d’apporter au texte les changements qu’il jugerait a propos pour assurer la
correction grammaticale et l’orthographe, pour
eliminer d’dventuelles obscurites ou pour rendre la presentation conforme au style du Jour
nal eanadien d e chirurgie. Aucun changement
important ne sera apporte au texte sans que
l’auteur art ete prealablement consulte. Les
auteurs recevront avant la publication des
epreuves d’imprimerie de leur texte, auxquelles
ils sont pries d’apporter le minimum de correc
tions.
Tires-a-part
On pourra commander des tires-a-part sur
une formule qui est envoyee avec les epreuves.
II est important de les commander avant la
publication de l’article, sous peine de devoir
payer un supplement pour une nouvelle com
position.

Bibliographie
Les references bibliographiques seront indiquees par des numeros dans le corps du texte.
Elies comprendront dans l’ordre: le nom de
l’auteur et ses initiales, en majuscules, le titre
abrege du Journal, le numero du volume, le
numero de la page et l’annee. Les abreviations
admises pour les noms de revues sont celles qui
figurent dans I’ln dex Medicus. Les renvois aux
livres comprendront dans l’ordre: le nom de
l’auteur, ses initiales, le titre de l’ouvrage, le
numero de l’edition (p. ex. deuxieme ed.), la
ville et le nom de la maison d’edition, et
l’annee de la publication; enfin, le numero de
la page s’il s’agit d’un renvoi precis. Pour
examples, voye, Tissue de janvier 1971 et ceux
a venir.
Illustrations
Le journal accepte de publier gratuitement
un nombre raisonnable d’illustrations en noir
et blanc. Les reproductions de cliches en couleurs seront publiees aux frais de Tauteur. Les
photographies seront imprimees sur papier brillant, ne seront ni montees ni calibrees et d’un
format maximum de 6" x 8". En ce qui conceme les radiographies, nous demandons des
copies et non pas Voriginal. On devra toujours
foumir un agrandissement de microphoto
graphies. 11 ne faut jamais ecrire ou dabtylographier un texte quelconque sur les photo
graphies. Une legende les identifiant pourra
etre jointe au dos. Dans les illustrations montrant des malades, ceux-ci ne pourront etre
reconnus, a moins qu’ils n’en aient donne le
consentement ecrit prealablement a la publica
tion. Les graphiques et diagrammes seront dessines a Tencre de Chine sur un bon papier a
dessin blanc. Le lettrage devra etre ecrit en
caracteres assez grands pour que, apre reduc
tion proportionnelle au format du Journal, ils
soient encore lisibles. Les legendes devant
accompagner les illustrations seront dactylographiees sur une feuille independante du
texte. Les illustrations ne seront ni roulees ni
pliees.
Langue vehiculaire
II doit etre clairement etabli que les collaborateurs ont pleine liberte de soumettre leurs
articles en frangais ou en anglais, a leur choix.
L ’acceptation de l’article sera entierement inde
pendante de la langue choisie par Tauteur. Si
le collaborateur le desire, il peut d6crire le
contenu de l’article en un sommaire ne depassant pas 300 mots et dans une langue differente
de la langue choisie pour Tarticle lui-meme.
Par exemple, un article ecrit en frangais doit
comporter un resume en frangais et peut, si
Tauteur le desire, etre accompagne d’un som
maire plus detaille en anglais.

January 1971

B O O K R E V IE W S

BOOK R E V I E W S
CORTICOSTEROIDS IN T H E TREATM ENT
O F SHOCK. Edited by William Schumer and
Lloyd M. Nyhus. 163 pp. Illust. University of
Illinois Press, Urbana, 1970. $10.00.

This short monograph contains the published
proceedings of a symposium conducted by the
University of Illinois College of Medicine on
the important but confused subject of cortico
steroids in shock. While not unanimous, most
of the distinguished participants believed that I
“pharmacological doses” of corticosteroids
should be used in septic shock—usually as 50
to 150 mg./kg. of hydrocortisone in a single
bolus, which might be repeated during the
subsequent 24 hours. One reason given for
this recommendation is that the distribution of
cardiac output is improved, even though the
total output is not increased. An improvement
in urine flow is the evidence for this. More
convincing is the concept that corticoids j
promote the normal respiratory cycle in the
cell and protect lysosomal membranes against
pH changes. It was shown in man in shock j
that corticoids: (1) decrease serum in
organic phosphate by incorporation into ATP;
(2) decrease lacticacidemia; and (3) decrease
aminoacidemia. All of the above suggest en
hancement of normal aerobic oxidation within
the cell.
This text assembles a large volume of in
teresting clinical and research data, and the
overall clarity is enhanced by three workshop
discussions which are reproduced verbatim, j
Anyone treating patients with septic shock will
find the book of considerable interest.

J

FACIAL IN JURIES. Richard Carlton Schultz.
264 pp. Illust. Year Book Medical Publishers,
Inc., Chicago, 1970. $15.00.

Dr. Schultz has written an authentic and wellconceived monograph. By his own admission,
this book was “conceived as a sort of primer
for other physicians who, by choice or singu
lar circumstance, provide a great portion of
this care”. The text is brief and extremely
well documented with step-by-step illustra
tions. The philosophy of the book is excellent,
but does contradict the purpose of the text,
viz. the author suggests that open reduction
and interosseus fixation is the method of choice
in most facial fractures. This approach re
quires more than preliminary training.
His concept of wound management is excel
lent and up to date, and should provide the
attending surgeon with many helpful hints.
Basic concepts are well demonstrated by
sketches, drawings and photographs. The
chapter on personal injury litigation is unique
and certainly will help those surgeons in-

"In abdominal surgery,
constipation caused by
hard, dry stools
frequently complicates
the postoperative course.
This hazardous
postoperative straining
can cause tissue trauma
or suture damage.
Straining should
obviously be avoided, but
we don’t want the
stimulated mobility of a
laxative either. So I rely
on Surfak from Hoechst.
It's a fecal softener but
not a laxative".
"Doctor, those
loudmouths behind us
are yelling again".
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volved in the treatment of facial injuries, most
of which terminate in the courts o f law.
Dr. Schultz does not include any formal
bibliography which is unusual and somewhat
disappointing. The book falls short o f the two
intensive texts now available on the treat
ment o f facial injuries but Dr. Schultz has
accomplished his original aim. This is a worth
while text for every surgeon’s consulting or
operating room.
CA RD IOVASCULAR PATHOLOGY. Vol. 3.
Suppl. to vols. 1 and 2. Reginald E. B. Hudson.
1166 pp. Illust. Edward Arnold (Publishers)
Ltd., London; The Macmillan Company of
Canada Limited, Toronto, 1970. $78.50.

D octor Hudson’s original two-volume m ono
graph, published in 1965, is recognized as a
most comprehensive and accurate treatise on
the whole field o f cardiovascular pathology.
This new volume 3, supplements and updates
the information found in the original books.
It is divided into 43 supplementary chapters,
each corresponding to a chapter in the original
books and incorporating all relevant new
knowledge. No group or department con
cerned with cardiovascular disease and already
having copies o f the two previous volumes can
afford to be without this supplementary vol
ume. The three volumes form a most impor
tant reference work and should be available
in all hospital libraries.
GASTREKTOM IE UND KARDIARESEKTION
BEIM MAGENKARZINOM. Pathologie-Klinik
—Operationstechnik
Folgeerscheinungen und
Ergebnisse. Rudolf Haring and Herman Franke.
210 pp. Illust. Intercontinental Medical Book
Corp., New York; Georg Thieme Verlag, Stutt
gart, Germany, 1970. DM 88,00. $24.80 (ap
prox.).

The surgical treatment of carcinoma o f the
stomach is thoroughly reviewed in this m ono
graph. The anatomy, pathology and surgical
technique are described in detail and are well
illustrated. Less emphasis is placed on physio
logic considerations. In particular the descrip
tions o f esophageal motility studies, the
cardiac sphincter mechanism and some aspects
o f the postoperative disturbances o f the gastro
intestinal canal are incomplete. An interesting
detail is the report on cholinesterase determi
nations preoperatively. The authors carried out
this determination in 3000 patients and sub
divided them in three groups as follows:
Group 1—low values, corresponding to de
creased energy stores; Group 2 —average
values, suggesting a good general condition of
the patient; Group 3—increased values, sug
gesting lability and irritability. The prognosis
was found to be better in Group 2 than in
Groups 1 and 3. For the gastrointestinal sur
geon this book is a useful review o f the
present state of the art. For others, it may
emphasize the extremely grave prognosis of
carcinoma o f the stomach.
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INAKTIVITATSOSTEOPOROSE. Klinische und
experimentelle Studie zum
Knochenumbau
durch Inaktivitat. Joachim Eichler. Aktuelle
Orthopadie Heft 3. 90 pp. Illust. Intercontinen
tal Medical Book Corp., New York; Georg
Thieme Verlag, Stuttgart, Germany, 1970. DM
36,00. $10.15 (approx.).

This monograph deals with the problems en
countered when an extremity o f a growing
organism is immobilized in a plaster cast. After
reviewing the literature related to the prob
lem, the author states that little is known
about the effect of immobilizing a child’s ex
tremity in a plaster cast. Immobilization of a
hind leg in a growing guinea pig has the fol
lowing effects: reduction o f bone growth, re
duction in bone weight and density, as shown
on radiographs, reduction o f the hydroxyl apa
tite and collagen content resulting in changes
in mechanical properties. The author suggests
that in children it might be advisable to avoid
prolonged immobilization in plaster by using
surgical fixation. The experimental methods are
described in detail and include quantitative
histology, interferometry and metabolic bal
ance studies. Although the conclusions are of
interest to the clinician, this book is recom
mended primarily for the experimental sur
geon.

INSTRUCTIONAL COURSE LECTURES. Vol
ume XIX. American Academy of Orthopaedic
Surgeons. 236 pp. Illust. The C. V. Mosby
Company, St. Louis, 1970. $21.45.

This volume deals with 10 important subjects
in the field o f basic sciences and clinical ortho
pedics. The clarity o f the text and the illustra
tions throughout are o f the highest possible
standards. This reviewer found these instruc
tional course lectures were of very high
calibre when he heard them delivered at meet
ings o f the Academy, and their reproduction
in this volume should make them of great
value to the reader. The lectures will be of
considerable value to the practising as well
as to the academic surgeon, helping him to
keep up to date with m odem trends, and they
will be o f great assistance to teachers of
orthopedic surgery and residents during their
training. Certainly all those engaged in teach
ing and in learning orthopedic surgery should
be thoroughly conversant with the material
presented in this book.
The subjects dealt with are the surgical
anatomy and exposures o f the foot and ankle,
clinical and pathological studies of fat em
bolism, the incidence and prevention o f
thromboembolic disease, clinical applications
o f electrodiagnostic studies, bracing for pa
tients with acquired spasticity, diagnosis and
management o f internal derangements o f the
knee joint, orthopedic management o f muscu
lar dystrophy and related disorders, unstable
intertrochanteric fractures, troublesome frac
tures and dislocations o f the hand, fractures
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in children, analysis and treatment of ankle
injuries produced by rotatory, abduction and
adduction forces, early care of severe ex
tremity wounds, a review of the Vietnam experience and its civilian applications, and the
articular cartilages: a review.
Many readers will look forward with great
anticipation to the publication of future volumes of this outstanding work.

I
|
|
J
I

NOUVELLE PRATIQUE CHIRURGICALE ILLUSTREE. 2e Serie. Fascicule III. Jean Quenu.
269 pp. Illust. Editions Doin, Deren & Cie, |
Paris, 1969. 82 F. $15.58 (approx.). Paperbound.

This book is part of a series covering subjects
such as bronchial anastomosis, pancreatectomy
and adrenalectomy. As a whole, the book is
well presented and the illustrations are good.
The indications for each operation are well
detailed and the text is sober. It is certainly a |
good reference book for operations that are
not currently practised.
On the other hand, the book has absolutely
no order. Being part of a series, we would
expect one volume to include thoracic sur
gery and another abdominal surgery etc., but
this is not the case. This presents a serious
problem to the reader if he wants to find a
particular operation. However, there is a good
table of contents at the end of the book.
The incision for resection of pheochromocytoma, which can be extended into the
thorax, has a great deal of logic to it. For the
hemicolectomy procedure, many surgeons will
approve the early ligature of the inferior
mesenteric vein. On the whole, each technique
is well illustrated and described, but the
lack of order in the chapters themselves is a
serious disadvantage.

A fte r anorectal surgery a
g o o d m any patients
develop co n stip a tio n ,
an d o c ca sio n a lly fecal
im paction, b e cau se of
the fear of pain. S u rfa k
from H oechst prom otes
th e form ation of soft,
form ed stools, a v o id in g
abrasions or further
irritation of inflam ed
structures, an d so acts to
prevent traum a and
constipation due to fear
of evacuation. S u rfa k is
a fecal softener, n o t a
laxative".
"T h a t's a bon sp ie l,
doctor".

OPERATIVE
TREATMENT
OF
BONE
TUMORS. 3rd International Symposium Janu
ary 24th-26th, 1969 in Basle, Switzerland.
Edited by George Chapchal. 182 pp. Illust.
Intercontinental Medical Book Corp., New York;
Georg Thieme Verlag, Stuttgart, Germany,
1970. DM 49,00. $13.50 (approx.). Paperbound.

This volume consists of a collection of papers
presented by an international group of ortho
pedic specialists meeting in Basle, Switzerland.
The papers are arranged in four groups:
Part I covers pathology, use of angiography
and lymphangiography in diagnosis, and the
difficulties encountered in making accurate
diagnoses. Part II is concerned with the man
agement of juxta-articular tumours and in
cludes discussions of homotransplantation as
well as the use of prosthetic devices. One
paper discusses research in the biochemistry
of plastic materials. Part III deals with the
continuing problems of resection in primary
and metastatic tumours. The final section
emphasizes case studies and follow-up over
varying periods of time and discusses the use
of chemotherapeutic agents in tumour therapy.
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One gains the impression that, as in all
tumour therapy, there is little standardization
in approach and much inconsistency in results.
However, the search continues for proper
combinations o f surgical extirpation and
chemotherapy.
This collection o f papers would probably
be o f most interest to practising orthopedic
surgeons and is o f little value to under
graduate students.
D ER RETROM AXILLARE RAUM. Eine Darstellung aus klinischer, rontgenologischer und
chirurgischer Sicht. Siegfried Zehm. Aktuelle
Oto-Rhino-Laryngologie Heft 3. 53 pp. Must.
Intercontinental Medical Book Corp., New York;
Georg Thieme Verlag, Stuttgart, Germany;
1970. D M 28,00. $7.90 (approx.). Paperbound.

This short but complex monograph deals with
the surgical treatment of benign and malig
nant retromaxillary tumours, appearing prim
arily in that region or secondarily invading
the retromaxillary space.
More than one-half of its pages deals with
anatomy, and tomograms o f the retromaxillary
region in normal individuals and in those with
retromaxillary tumours. They also describe the
symptomatology, pathology and differential
diagnosis of lesions in this area.
The author discusses the three main
methods o f surgical treatment—the oral, m id
face and retromaxillary methods o f tumour
removal, giving the indications for each ana
tomical approach. He discusses in detail the
operative technique and the complications that
can arise. In the malignant group, operation
should be com pleted by block resection o f the
cervical lymphatic glands. The author con
cludes that the benign tumour heals without
recurrence if it is totally removed. The p rog
nosis o f the malignant tumour is poor; none
o f the author’s four patients with primary
retromaxillary tumour survived two years after
a radical operation and irradiation therapy.
Only five o f 18 patients operated on for
secondary retromaxillary tumours survived for
five years without any sign o f recurrence.
Although radical surgery often produces
striking deformation of the face and some
temporary functional disturbances, the relief
o f the constant pain that was present before
treatment is certainly an improvement.
THE ROLE OF THE SURGEON IN M EDICAL
SCHOOL EDUCATION. Transactions of the
11th Annual Meeting of the Allen O. Whipple
Surgical Society. Edited by Harold G. Barker.
155 pp. Charles C Thomas, Publisher, Springfield, 111.; The Ryerson Press, Toronto, 1970.
$7.50.

T he Allen O. W hipple Society was originally
form ed to honour Dr. W hipple. Its member
ship now exceeds those who were trained by
this man and the Society proposes to address
itself to medical education, with particular
reference to the role of surgery and surgeons
in that process. This book, which reports the

Vol. 14

eleventh meeting of the Society, is a compila
tion of papers presented by invited guests and
members. It begins with a view of hospitals,
medical schools and curriculum innovation,
and notes the continuing difficulty created by
the need for constant change. Most recently
this change has been occasioned by an expan
sion o f our biological knowledge and our
abandonment o f the concept that each student
should learn something of everything. Chap
ter II by Dr. Raymond Allen contains a par
ticularly refreshing view of current ideas in
curriculum change and emphasizes that this
change is attitudinal rather than a shifting of
hours or courses.
The mid section o f the book—views of sur
geons presented b y our non-surgical col
leagues, allows them to comment upon us as
they see us. This section examines our hal
lowed and traditional views of the value o f a
surgical experience for all students, and we
may be left a little breathless and over
whelmed by these critical and careful observa
tions. The vantage point from which dean,
internist, social scientist, psychologist and
pathologist view the surgeon makes this essen
tial reading for all surgical educators.
The concluding section attempts to justify
the surgeon’s role in medical education. This
section proposes tactics, methods, assignments
and areas of interest rather than analyzing the
traditional patient-doctor-student relationship.
An excellent chapter by Lawrence A. Fisher
describes methodology o f curriculum construc
tion, objective formulation and examination of
the process of learning. However, this entire
section fails to grapple with the interrelation
ship o f patient-doctor-student, and does not
define the relevant components of that experi
ence which the student must extract in pre
paration for his future specialty. Despite this,
this perceptive and worthwhile book belongs
on the library shelf o f all those involved in the
surgical education o f the medical student.
UROLOGISCHE OPERATIONSLEHRE. Number
4. Abdominale Komplikationen bei und nach
urologischen Eingriffen. Operationen an der
Harnblase. Edited by G. W . Heise and E.
Hienzsch. 159 pp. Must. VEB Georg Thieme,
Leipzig, 1970. D M 50,00. $14.00 (approx.).
Paperbound.

This volume is one of a set o f 10 which will
cover the whole field of urologic surgery. It
consists of two parts: (1) abdominal complica
tions after urologic surgery and (2) bladder
operations. The first part is a brief survey of
the anatomy of the abdominal cavity and of
the most common procedures of abdominal
surgery including the treatment of ileus and
peritonitis. In the second part, the surgical
anatomy of the urinary bladder is reviewed
and the various surgical procedures are de
scribed. The book is well illustrated and in
cludes a selected bibliography. It appears to
be written primarily for the urologist in train
ing.
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Books R eceived
Books are acknowledged as received, but
in some cases reviews will also be made
in later issues.
Atlas of Extraocular Muscle Surgery. John A.
Dyer. 180 pp. Illust. W. B. Saunders Company,
Philadelphia; W. B. Saunders Company Canada
Limited, Toronto, 1970. $12.45.
Basic Immunology. E. R. Gold and D. B. Pea
cock. 416 pp. Illust. John Wright & Sons Ltd.,
Bristol; The Macmillan Company of Canada
Limited, Toronto, 1970. $14.50.
Body Fluid Replacement in the Surgical Patient.
An International Symposium, 1969 Sponsored by
the Departments of Surgery and Anaesthesiology
of the College of Physicians and Surgeons, Colum
bia University in Association With the Division
of Medical Sciences National Research Council.
Edited by Charles L. Fox, Jr. and Gabriel G.
Nahas. Grune & Stratton, Inc., New York; Long
mans Canada Limited, Toronto, 1970. $28.75.
Clinical Paediatric Surgery. Diagnosis and Man
agement. Edited by Peter G. Jones. 511 pp. Illust.
John Wright & Sons Ltd., Bristol; The Macmillan
Company of Canada Limited, Toronto, 1970.
$19.50.
Les Entretiens de Bichat 1970. Chirurgie et
Specialities. P.-L. Chigot and A. Beilin. 378 pp.
Expansion Scientific Franpaise, Paris, 1970. Price
not stated.
Epithelial Tumours of the Salivary Glands. R.
Winston Evans and Alan H. Cruickshank. Volume
1 in the Series Major Problems in Pathology.
Consulting Editor: James L. Bennington. 299 pp.
Illust. W. B. Saunders Company, Philadelphia;
W. B. Saunders Company Canada Limited, To
ronto, 1970. $15.70.
Extracranial Occlusive Cerebrovascular Disease.
Diagnosis and Management. Edwin J. Wylie and
William K. Ehrenfeld. 231 pp. Illust. W. B. Saun
ders Company, Philadelphia; W. B. Saunders
Company Canada Limited, Toronto, 1970. $14.05.
Gastro-Intestinal X-Ray Diagnosis. A Descrip
tive Atlas. D. H. Cummack. 351 pp. Illust. E. &
S. Livingstone Ltd., Edinburgh; The Macmillan
Company of Canada Limited, Toronto, 1970.
$27.50.
Hematologic Problems in Surgery. Harold Laufman and Robert B. Erichson. 249 pp. W. B.
Saunders Company, Philadelphia; W. B. Saunders
Company Canada Limited, Toronto, 1970. $10.80.
Hepatic Failure. Henry Brown. 137 pp. Illust.
Charles C Thomas, Publisher, Springfield, 111.;
The Ryerson Press, Toronto, 1970. $10.50.
The Intervertebral Disc. Anthony F. DePalma
and Richard H. Rothman. 373 pp. Illust. W. B.
Saunders Company, Philadelphia; W. B. Saunders
Company Canada Limited, Toronto, 1970. $17.85.
Laparoscopy, Culdoscopy and Gynecography.
Technique and Atlas. Melvin R. Cohen. Volume I
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in tile Series Major Problems in Obstetrics and
Gynecology. Consulting Editor; Emanuel A.
Friedman. 171 pp. lllust. W. B. Saunders Com
pany, Philadelpma; W. B. Saunders Company
Canada Limited, Toronto, 1970. $11.90.
Leber- und Pankreas-Schiiden durch Schock
und Narkose. Symposion auf der Insel Helogland
am 4./5.10.1909. Edited by Karl Horatz. 114 pp.
lllust. Intercontinental Medical Book Corp., New
York; Ceorg Thieme Verlag, Stuttgart, Germany,
19 iO. DM 22,00. $6.20 (approx.). Paperbound.
Normale und Pathologische Anatomie. Monographien in zwangloser Folge. Edited by Woligang Bargmann and Wilhelm Doerr. Heft 23. Syndaktylien. Anatomie, Entwicklung, therapeutische
Aspekte. Giinter M. Losch. 58 pp. lllust. Inter
continental Medical Book Corp., New York;
Ceorg Thieme Verlag, Stuttgart, Germany, 1970.
DM 38,00. $10.70 (approx.). Paperbound.
Organ Transplantation. 2nd ed. Edited by Felix
Largiader. 398 pp. lllust. Intercontinental Medical
Book Corp., New York; George Thieme Verlag,
Stuttgart, Germany, 1970. DM 98,00. $27.60
(approx.).
Penetrating Wounds of the Abdomen. Edited
by James E. Pridgen, J. Bradley Aust and George
W. Fisher. 126 pp. lllust. Charles C Thomas,
Publisher, Springiield, 111.; The Ryerson Press,
Toronto, 1970. $9.75.
Reconstructive Surgery of the Middle Ear.
Adolph Wolferman. 184 pp. lllust. Grune &
Stratton, Inc., New York; Longmans Canada
Limited, Toronto, 1970. $28.75.
Rypins’ Medical Licensure Examinations. Topi
cal Summaries and Questions. 11th ed. Edited by
Arthur W. Wright. 825 pp. J. B. Lippincott Com
pany, Philadelphia; J. B. Lippincott Company of
Canada Ltd., Toronto, 1970. $17.50.
Surgery and Biology of Wound Repair. Erie E.
Peacock, Jr. and Walton Van Winkle, Jr. 630 pp.
lllust. W. B. Saunders Company, Philadelphia;
W. B. Saunders Company Canada Limited, To
ronto, 1970. $23.25.
Surgery of the Chest. A Handbook of Operative
Surgery. 4th ed. Julian Johnson, Horace MacVaugh III and John A. Waldhausen. 428 pp.
lllust. Year Book Medical Publishers, Inc., Chi
cago, 1970. $15.40.
Urologische Operationslehre. Number 4. Abdominale Komplikationen bei und nach urologischen Eingriffen. Operationen an der Harnblase.
Edited by G. W. Heise and E. Hienzsch. 159 pp.
lllust. VEB Georg Thieme, Leipzig, 1970. DM
50,00. $14.00 (approx.). Paperbound.
Visual Anatomy. Volume One. Head and Neck.
Sydney M. Friedman. 227 pp. lllust. Harper &
Row Publishers, New York, 1970. $11.50.
Die Wiindheilung. Theoretische und praktische
Grundlagen. H. J. Hemandez-Richter and H.
Struck. 197 pp. lllust. Intercontinental Medical
Book Corp., New York; Georg Thieme Verlag,
Stuttgart, Germany, 1970. DM 39,00. $10.90
(approx.). Paperbound.

Tandearil Geigy
For symptomatic
treatment of
sprains
strains
contusions
muscular lesions
dislocations
fractures
Dosage — In trauma and its sequelae —
400-600 mg (4-6 tablets) daily in divided
doses for 4 days to a week.
In arthritis, extra articular rheumatism
and other medical indications — 400-600
mg per day (4-6 tablets). When improve
ment is obtained (generally two or three
days), the dose should be reduced to
the lowest effective level which gives
relief. It is suggested that the mainte
nance level not exceed 400 mg per day.
Tandearil should be taken at meal time or
with a glass of milk. In the absence of a
favourable response after a one week trial
period, it is recommended that adminis
tration of Tandearil be discontinued.
For indications in surgery — 400-600 mg
(4-6 tablets) daily in divided doses dur
ing the 24 hours prior to surgery. As
soon as oral medication can be resumed
after surgery, maintenance is 300-400 mg
daily for 3-4 days.
Contraindications — Tandearil is contra
indicated in patients with a history of
blood dyscrasia or drug allergy, or in
patients with severe renal, hepatic or
cardiac disease. It should not be given
to patients with clinical edema, to senile
patients or to patients with a history or
symptoms of peptic ulcer.
Precautions — A careful history, phys
ical examination and complete blood
count should be done before initiating
therapy. Patients receiving this drug
should be followed closely and should
be warned to discontinue Tandearil and
contact their physician immediately
should any of the following signs or
symptoms appear: fever, sore throat,
lesions in the mouth, black or tarry
stools, skin reactions or a sudden gain in
weight. Patients undergoing long term
therapy should have blood counts done
at monthly intervals. Care should betaken
in prescribing Tandearil to the elderly.
Side Effects — Nausea, vomiting, ab
dominal discomfort, rash, formation or
activation of peptic ulcer and sodium re
tention with edema are known to occur.
Availability — Tandearil tablets. Each
light brown coated tablet, imprinted
with fesy contains 100 mg oxyphenbutazone Geigy. Supplied in bottles of 50
and 500.
Full information is available on request.

Geigy Pharmaceuticals
Montreal 308, P.Q.
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NOTICES
HADEN MEMORIAL CONFERENCE
“DISORDERS OF THE RED C E L L ”
The Cleveland Clinic Educational Foun
dation will hold a postgraduate course in
hematology (Haden Memorial Conference
“Disorders of the Red Cell”) on February
10 and 11, 1971, in the Bunts Auditorium
of the Education Building. The course will
be presented by the Staff members of the
Foundation. The guest speakers will be:
William B. Castle, Professor of Medicine,
Harvard University, Emeritus Director of
the Thorndike Laboratory, Boston City
Hospital; Lemuel W. Diggs, Emeritus
Goodman Professor of Medicine, Uni
versity of Tennessee College of Medicine,
Section of Hematology, Memphis, Ten
nessee; Clement A. Finch, Professor of
Medicine, University of Washington,
Seattle, Washington; T. Hale Ham, Pro
fessor of Medicine and Director, Divi
sion of Research in Medical Education,
Case Western Reserve University, Cleve
land; John W. Harris, Professor of Medi
cine, Metropolitan General Hospital, Case
Western Reserve University; Robert W.
Kellermeyer, Associate Professor of Medi
cine, Case Western Reserve University;
and Anita M. Klein, Staff, Euclid Clinic
Foundation, Euclid, Ohio.
The registration fee for the course is
$45.00. Acceptances will be made in order
of application.
Accommodation may be obtained at The
Bolton Square Hotel, 8907 Carnegie
Avenue, and the Clinic Inn, 8945 Carnegie
Avenue (adjacent to the Cleveland Clinic
Education Building).
For further information write to: Edu
cation Secretary, The Cleveland Clinic
Educational Foundation, 2020 East 93rd
Street, Cleveland, Ohio 44106.
POSTGRADUATE COURSE IN
RHEUMATIC DISEASE
The Cleveland Clinic Educational Foun
dation will hold a course in rheumatic
disease on February 24 and 25, 1971, in the
Bunts Auditorium, Education Building.
The participating faculty will be members
of the Staff of the Foundation. Subjects
covered will be: manifestations of the con
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nective tissue diseases by systems; immu
nologic aspects of connective tissue dis
eases; and immunofluorescent studies,
electron microscopy and a review of drugs
used in the management of connective
tissue diseases.
The registration fee is $45.00, accept
ances made in order of application.
For further information write to: Edu
cation Secretary, The Cleveland Clinic
Educational Foundation, 2020 East 93rd
Street, Cleveland, Ohio 44106.
POSTGRADUATE COURSE
IN UROLOGY
The Cleveland Clinic Educational Foun
dation will hold a postgraduate course
“Advances in Urology” on March 10 and
11, 1971, in the Bunts Auditorium of the
Education Building. The course will be
presented by Staff members of the Foun
dation, and guest speakers will include:
Malcolm A. Bagshaw, Professor and Di
rector of Radiation Therapy, Stanford Uni
versity Medical Center; Joseph J. Kauf
man, Professor and Chairman, Department
of Urology, University of California at Los
Angeles School of Medicine; Lester Persky,
Professor and Chairman, Department of
Urology, Case Western Reserve School of
Medicine; and David C. Utz, Department
of Urology, Mayo Clinic Foundation.
The registration fee for the course is
$60.00 and acceptances will be made in
order of application.
Accommodation may be obtained at The
Bolton Square Hotel, and the Clinic Inn
(adjacent to the Cleveland Clinic Educa
tion Building).
For further information write to: Educa
tion Secretary, The Cleveland Clinic Edu
cational Foundation, 2020 East 93rd Street,
Cleveland, Ohio 44106.
FIRST WORLD CONGRESS OF THE
COLLEGIUM INTERNATIONALE
CHIRURGIAE DIGESTIVAE
The 1st World Congress of the Collegi
um Internationale Chirurgiae Digestivae
will be held May 20 to 23, 1971, in Sanremo, Italy. The following subjects have
been chosen for the symposia, round table
discussions and lectures: esophagoplasty;
(Continued on page 96)
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We coat our silk with silicone. Not wax. This lets you tie a
firm knot that won't slip. You can even snip knot ends short
without fear of their slipping. But that's not the only reason
for the silicone. It protects the suture against enzymatic
or body fluid invasion. You get a strand of physiologically
inert suture material.
And, our silk has exOne that's firm and I I l i 111 L J J c e p tio n a l te n s ile
uniform, too. And plistrength. Try Davis &
able. The sm ooth, D | J | T j r l Geek silicone coated
even silicone coating H || 3 H .■ silk for knots that
minimizes tissue drag. H m U m U J won'tgiveyoutheslip.
C Y A N A M ID OF C A N A D A LIM ITED , Montreal, Quebec
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surgical treatment of precancerous lesions
of the rectum and colon; chronic vascular
mesenteric insufficiency; emergency surgi
cal treatment of acute pancreatitis; surgical
treatment of primary and secondary liver
tumours; clinical experience of liver trans
plantation; and teaching of digestive sur
gery in universities and hospitals. During
sessions simultaneous translations will be
provided in English, French, German and
Italian. Registration fees are $45.00 for
active members and $20.00 for accom
panying persons.
For further information write to: Secre
tariat of 1st World Congress of Collegium
Internationale Chirurgiae Digestivae, II
Divisione Chirurgica, Ospedale S. Giovanni,
00184 Rome, Italy.

M ULTIPLE FOCI EPILEPSY

12TH SICOT CONGRESS
FELLOW SHIPS
The Israel Section of SICOT, in con
junction with the Orthopedic Association
of Israel, is offering 15 travel fellowships
to the 12th SICOT CONGRESS to be held
in Israel from October 9 to 13, 1972.
The fellowships include free air travel
and seven days full board in Israel during
the Congress.
These 12th SICOT Congress fellowships
will be awarded for the best original and
unpublished papers on an orthopedic sub
ject or any basic scientific subject con
nected with orthopedic surgery.
The competition is open to those up to
40 years of age. Papers should be sub
mitted in four copies. The final date for
submission of papers is January 31, 1972
and papers should be submitted to: Societe
Internationale de Chirurgie, Orthopedique
et de Traumatologie, 43, rue des ChampsElysees, Bruxelles 5, Belgium.

For successful surgical treatment of
multifocal epilepsy the dominant focus
must be accurately determined because
only this focus needs to be removed. The
authors define multifocal epilepsy. In con
ditions such as bitemporal epilepsy, in
which there are several independent foci,
removal of one focus not only fails to pro
duce improvement but may activate other
foci, thus aggravating the condition.
In the authors’ hands, removal of the
dominant focus and stereotaxic destruction
of secondary foci has produced good re
sults in isolated cases. Only prolonged ob
servation and more experience will permit
a final evaluation of this method.—Shefer
DP, Ivanov EV, Bein BN: Multiple foci
epilepsy: approach to surgical treatment.
Voprosyi Neirokhirurgii 3:1, 1969
LATE IRRADIATION NECROSIS
OF BRAIN
The author describes the late effects on
the brain of radiotherapy of brain tumours
and differentiates the effects from con
tinued growth of the treated tumour. He
studied 19 patients who had mega volt ir
radiation of a brain tumour. The late
effects of cerebral necrosis due to radio
therapy manifest themselves by a slowly
developing syndrome of focal lesions re
lated to the irradiated area. They are not
attended by any signs of increased intra
cranial pressure, characteristically there is
no radiographic evidence of a shift of the
midline and there are no changes in the
appearance of the ventricles in the pneu
moencephalogram.—Samoilov VI: Clinical
picture and diagnosis of late irradiation
necrosis of brain. Voprosyi Neirokhirurgii
6: 10, 1969
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The topical
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UNIVERSITY OF TORONTO

NEW

C.M .A . H E A D Q U A R T E R S B U IL D IN G
OTTAW A

Faculty of Medicine
DEPARTMENT OF OTOLARYNGOLOGY

SEPTO REHINOPLASTIC COURSE
February 8th-12th, 1971
FEE -

$200.00

Limited to 30 students. The course is designed
for those who have some knowledge but not
necessarily expert in the field of septorhinoplasty and mentoplasty. The course will in
clude preoperative assessment, photography,
surgical techniques, postoperative care and
complications, of septoplasty, rhinoplasty and
mentoplasty.

OFFICE SPACE FOR
RENT
T w o S m a ll O ffic e s A v a i l a b l e fo r rental
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Faculty o f M edicine,

1 8 6 7 A lta V ista Drive,

U n iv e rsity of Toronto,

O tt a w a

8, O nta rio,
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Telephone: (613) 731-9331.

ROYAL VICTORIA HOSPITAL

U N IV E R S IT Y O F T O R O N T O
Faculty o f M e dicin e

PROBLEMS IN
GENERAL SURGERY
MARCH 31, APRIL 1 & 2, 1971
T h is C o u r s e is d e s ig n e d fo r th e s u r 
g e o n in a c t iv e practice. S e s s io n s w ill
in c lu d e
g e n e ra l
su rg e ry ,
com m on
p e r ip h e r a l v a s c u la r s u r g e r y a n d c o v 
e r a g e o f p re a n d p o s t-o p e r a t iv e care.
T e a c h in g m e t h o d s to b e u tilize d a re
o p e r a t iv e clin ics, s e m in a r s a n d lec
tures. Recent a d v a n c e s w ill b e e m 
p h a s iz e d .
E n ro lm e n t is lim ite d to
fo rty -fiv e .
FEE: $ 1 0 0 . 0 0
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The Secretary,
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Royal Victoria Hospital,
Montreal 112, Quebec.

D IV I S IO N O F
P O S T G R A D U A T E M E D IC A L E D U C A T IO N
The O rth o p a e d ic D iv isio n o f the
D ep artm en t o f Su rge ry
and
The W o rk m e n 's C o m p e n sa tio n B o a rd O n ta rio
offe r

FRACTURES
AND ASSOCIATED TRAUMA
April 15th, 16th, 17th, 1971
Theme:
COMPLICATIONS OF
MUSCULO SKELETAL TRAUMA
A m o n g the G u est Faculty will be:
Dr. Paul Brown, Denver, C olora d o, U.S.A.
Professor M e rle D 'A u b ig n e , Paris, France
Professor H. W ille n e g g e r, Sw itzerland
F o r fu rth e r in fo r m a tio n contact:

The Director,
D iv isio n o f P o stg ra d u a te M e d ica l Education,
M e d ica l Sciences Building,
T oronto 5, O nta rio.

INSIDETHESYSTEM IS STILLSTERILE
before it punctures the internal
safety seal. A self-sealing latex
cap on the second port is pro
vided for adding supplemental
solutions; it is easily removed for
series hookups. The third port
can be clipped for use as a con
venient pouring spout. An exter
nal wrap protects sterility before
use. If it has been opened or
removed, you can immediately

see that the container has been
tampered with. UROMATIC is the
first and only plastic container
forTUR, cysto and irrigation solu
tions. For the patient safety of
a completely closed system —
and the convenience of easier,
faster procedures—
the UROMATIC way is
■
the first and only one
you should consider.

B A X T E R L A B O R A T O R IE S O F C A N A D A

uromcftc

Even if you do the procedure in
the basem ent. Because o n ly
UROMATIC plastic containers give
you a completely closed irrigation
system. Since there are no vents,
no room air can enter the system.
So airborne contam inants are
locked out. Even when the spike
of the set is inserted, no air can
get in— because the spike com
pletely occludes the port opening
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